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MATHEMATICAL MODELS OF ACUTE INFLAMMATION AND A FULL
LUNG MODEL OF GAS EXCHANGE UNDER INFLAMMATORY STRESS
Angela Marie Reynolds, PhD
University of Pittsburgh, 2008
This thesis focuses on the development and analysis of mathematical models of acute inam-
mation. These models were developed to understand multiple organ dysfunction syndrome
(MODS), which is a common cause of death in intensive care unit patients. MODS is char-
acterized by sequential organ failure caused by an overactive immune system. Therefore,
our modeling focused on the acute immune response, which is the generic initial response.
Understanding the complex interaction during this response will facilitate the development
of e¤ective treatments for MODS.
We rst derived a small scale model for the acute inammation to understand simple
dynamics between pro- and anti-inammation. We use this reduced model to explore the
role of anti-inammatory mediators, which were once hypothesized as a treatment for MODS
with less success than predicted. After the analysis of this reduced model, we expanded this
model into two more complex models.
The rst includes specic measurable immune mediators, unlike the four variable model.
This model also takes in account the interactions between the tissue and blood, which are
essential during an inammatory response. It is a minimum model for an organ. We used
this model to explore the spread of inammation between organs by linking two tissues units
to the same blood supply.
The second models the e¤ects of inammation on gas exchange in the lung. The lung is
typically the rst organ to fail during MODS. We developed a model for a single respiratory
unit ~25 alveoli). Linking the respiratory units (RUS) under various anatomical conditions
iii
we model the full lung. Methods were developed in order to reduce computation times of
the RU model. With shorter computation times we were able to implement more accurate
ventilation perfusion mismatch in the full model. To increase biological delity of the model
we have created a closed loop form of the RU model that accounts for variable arterial PO2
levels.
We have created multiple models that explore various aspects of MODS. We look at the
role of anti-inammation, spread of inammation and inammation within the lung in order
to understand the complex interactions prompting organ failure.
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1.0 INTRODUCTION
Multiple organ dysfunction syndrome (MODS) is a common cause of death in intensive care
units (ICU). The mortality rate for one organ failure is 18%, two or three organ failure
is 52% and mortality rates continue to increase with further organ failure [11] [42] [79].
MODS is characterized by an overactive immune response that causes sequential failure of
organs. MODS occurs often in sepsis patients. These patients have a systemic response to
an infection [79]. During MODS, treatment of the initial insult does not typically eliminate
the immune response. The immune system remains active and inammation spreads from
one organ to the next. Therefore, typical treatment protocols focus on the support of failing
organs. In hopes of obtaining a better understanding of the immune response and developing
better treatment options, we have turned to mathematics.
Typical treatments of MODS involve organ specic support with the administration of
antibiotics when infection is clinically observed or identied [74]. Lung and cardiac functions
are often compromised during sepsis and MODS. To combat this loss of lung function patients
are put on oxygen therapy to increase their oxygen levels. Severe loss of lung function requires
the use of a ventilator, which mechanically breaths for the individual. To increase cardiac
function, uids are typically given. This increases blood volume which leads to increases
in venous return of blood to the heart, which then causes increase in cardiac output [27].
Support of both these organs is required to restore perfusion, oxygenation of blood and
blood pressure ([73], Seely, A, personal communication). Fluids increase the ow of blood
increasing blood pressure. Blood pressure can also be increased with the use of vasopressor
agents, which increase resistance in the blood vessels ([27]). Combinations of these treatment
are used in patients in order to optimize blood pressure while minimizing side e¤ects of the
treatments. Failure of other organs requires organ specic support, such as dialysis for renal
1
failure.
These standard treatments do not alter the immune response driving the organ failure.
Anti-inammatory treatments, such as the administration of cortisol were explored in the
past, but showed not increase in survival ([78], [63], [65]). Developing treatments which alter
the immune response is di¢ cult because of the complex interactions between the immune
components. Mathematical models o¤er tools to investigate the mechanisms driving the
immune response and to explore the e¤ects of manipulating immune component levels. We
have developed multiple models for inammation in order to explore various aspects of
MODS.
Inammation is characterized by an activated immune system, therefore its intensity
is measured by the levels of immune cells and mediators. There are two types of immune
responses the immediate, hard-wired innate response and the more specic adaptive response.
During an infection by pathogen the innate response is the rst triggered and results in the
syndrome of acute inammation. This same response is triggered by wide variety of pathogen
[70]. Immune cells in the vicinity of the infection become activated increasing their ability to
ght pathogen. These activated cells: 1) produce proteins called pro-inammatory cytokines,
which recruit additional immune cells to the infection site, 2) produce proteins called anti-
inammatory cytokines, which inhibit the ability of the immune cells to produce cytokines
and ght infection, 3) trigger the adaptive immune response. The adaptive response is a
specic response to the type of pathogen. The adaptive immune system will selectively
activate cells capable of ghting the pathogen causing the inammation [34].
Experiments can modulate cytokine and cell levels to explore their role in inammation.
This gives insight into intracellular mechanisms and cell to cell interaction. However, the
complexity of the immune system makes predictions of the entire immune response in vivo
di¢ cult. Therefore, we turned to mathematics to gain insight into the full system from
knowledge of the simple cell to cell interactions.
We focused on the development and progression of MODS. During MODS, inamma-
tion often persists after elimination of the pathogen. So, we developed models for the acute
inammation. Many models for acute inammation have been developed containing vary-
ing degrees of complexity. For example, the Kumar et al. model is a small model which
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captures clinical outcomes of acute inammation [38]. The Vodovotz et al. model is large
scale and includes variables for both innate and acute inammation [75]. We have taken a
gradual approach in the design of our models. We rst derived a small scale model for acute
inammation to understand simple dynamics between pro- and anti-inammation. The pre-
cursor to this model, Kumar et al., did not contain a variable for anti-inammation. We
have included anti-inammation as a specic variable, since modulating anti-inammatory
cytokines was once hypothesized as a treatment for MODS. After we analyzed this reduced
model, we expanded it into two more complex models. The rst takes into account the
di¤usion between the blood and tissue compartments. The second models the e¤ects of
inammation on gas exchange in the lung.
These ordinary and partial di¤erential equations models were constructed through a mod-
ular approach where the dynamics of subsystems were analyzed. This approach allows one to
ensure that biologically known dynamical features of interaction between model components
are present in the model. Modeling MODS is a multiscale problem where understanding
both cell to cell and also organ to organ interactions is essential. However, multiscale mod-
eling is computationally intense. Therefore, when expanding the reduced model into the
compartmental model, complexity in the cell to cell interactions was added as needed to
capture the proper biological behavior. We did not include all signals and regulators of
acute inammation, but did include a few specic cytokines. Multiscale modeling within the
lung was necessary to properly capture gas exchange dynamics. This lead to a model which
is computationally intensive and required reduction techniques for practical simulations.
In the following chapters we develop and analyze these three models for acute inam-
mation: the reduced model, compartmental model (tissue/blood model), and the full lung
model. In chapter 2 we present the reduced model, which is our small scale model for the
acute inammation. It is a four dimensional system of ODEs, which models the activation
of the innate immune response and the production of pro- and anti- inammatories. These
inammatories give rise to positive and negative feedback on the pro-inammatory response.
We use this reduced model to explore the e¤ects of modulating anti-inammatory mediators.
In chapter 3, we expand the reduced model to include both the blood and tissue compart-
ments. This blood/tissue model is referred to as the compartmental model. Additionally,
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we breakdown pro- and anti- inammation from the reduced model into specic cells and
cytokines. This is a simple model for an organ and organ to organ interactions when linking
two tissue units to the same blood supply. Using the multiple organ model, we explore the
e¤ect of altering di¤usive and macrophage properties on the spread of inammation.
The lung is typically the rst organ to fail during MODS [42]. Thus, we model the lung
as a multiple compartment unit in chapter 4. We cannot use the compartmental model,
because it consist of two compartments and within the lung interactions occur between the
air, tissue, and blood. Typically, models for gas exchange in the lung do not explicitly model
the tissue compartment. However, we have included it because inammation accumulates
in the tissue and a¤ects the di¤usion of gas molecules. We developed a PDE model for gas
exchange and inammation on a single respiratory unit ( 25 alveoli), which accounts for
space along the capillary. We linked multiple respiratory units under various ventilation
perfusion ratios in order to model the full lung. With this model we explore the e¤ects of
inammation and shunting. Shunting is when the alveolar air space collapses eliminating
the gas exchange on a respiratory unit.
In chapter 5 we explore reduction methods for the full lung model to shorten simulation
times. First, a spatial reduction is developed that allows us to track the blood gas pressures
at the end of capillary. We also developed a temporal reduction, which eliminates the
breathing mechanism. This reduction is the most e¤ective at reducing computation times.
Therefore, the resulting non-breathing model is used to study ventilation perfusion mismatch
introduced under more complex means than in the full breathing model. Additionally, we
increased biological accuracy of the full lung model without breathing by linking the arterial
(entering the lung) pressure of O2 and CO2 to the O2 and CO2 pressures exiting the lung,
creating a closed loop model for the lung.
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2.0 A REDUCED MATHEMATICAL MODEL OF THE INNATE
INFLAMMATORY RESPONSE
2.1 INTRODUCTION
Acute biological stress, such as severe infection or trauma, leads to the development of an
acute inammatory response. This syndrome typically includes increases in heart and respi-
ratory rates, fever, and activation of the innate immune response. The goal of this response
is to promote adaptation of the organism to stress, eliminate threats to survival such as
pathogens, and promote tissue repair and healing. However, an excessive or inappropriate
inammatory response will lead to collateral tissue damage, organ dysfunction, a prolonged
healing phase, or possibly death. This state of excessive inammation is particularly common
in association with extensive physiological organ support as provided in modern intensive
care units [26] [68]. Organisms have developed regulatory mechanisms to contain the molec-
ular and cellular cascades initiated by excessive inammation. In general, pro-inammatory
elements that are key to ridding organisms of large numbers of pathogens also mobilize a neg-
ative feedback, or anti-inammatory response, which downregulates the initial inammatory
wave (Figure 1). Specic details of pro- and anti-inammatory responses may be sculpted
by the nature and magnitude of the initiating insults, as well as by genetic predispositions.
In prior work a reduced mathematical model of the pro-inammatory response was con-
structed by Kumar et. al. consisting of a response instigator (pathogen) and early and late
pro-inammatory mediators [38]. While that model captured a variety of clinically relevant
scenarios associated with the inammatory response to infection, the goal of the present
work is to gain insight into the presumed advantage and robustness instilled by the pres-
ence of a time dependent anti-inammatory response. While anti-inammation inhibits the
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Figure 1: Interactions included in our four variable model of the acute inammation. Arrows and bars
represent upregulation and inhibition, respectively. The bar between anti-inammation and inammation
corresponds to the inhibition of both the production of inammation and the ability of inammation to
interact with all other involved species.
subsequent build-up of pro-inammation and the damage to tissue that may be caused by
pro-inammation, it also mitigates the subsequent production of anti-inammatory medi-
ators. Thus, the overall e¤ects of anti-inammation on the outcome following pathogenic
infection, and how these e¤ects depend on parameters such as pathogen growth rate and the
anti-inammatory response rate itself, may be di¢ cult to predict by intuition alone but are
well-suited for dynamical systems analysis.
As the rst step in performing this mathematical analysis, we derive a reduced model
of the acute immune response that incorporates pro- and anti-inammation presented in
Reynolds et. al [58]. This model does not include components of the adaptive immune
response, such as T-cells and specic anti-bodies. Therefore, this model describes the generic
response to pathogenic insult [33]. Our derivation proceeds through several stages, based on
the calibration of subsystems to generally accepted features of the interactions of particular
immune system components, as observed in previous experimental studies. We construct a
reduced model of inammation from these subsystems, where the impact of dynamic anti-
inammation is evaluated through simulations and bifurcation studies. Our results illustrate
the health advantage conferred by a dynamic anti-inammatory response and suggest that
the rates of this response may be well tuned to yield optimal outcomes following pathogenic
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infection. Our ndings also point to risks associated with manipulation of the levels of the
anti-inammatory mediator present, either before an initial infection or following an initial
infection that is on its way to, but has not yet reached, a healthy resolution. We conclude
with a discussion in which we elaborate on these and other possible therapeutic implications
of our results.
2.2 METHODS
Our reduced model of the acute inammatory response consists of a system of four di¤erential
equations in which the dependent variables represent the levels of pathogen (P ), activated
phagocytes (N) such as activated neutrophils, tissue damage (D), and anti-inammatory
mediators (CA) such as cortisol and interleukin-10 [58]. This model describes the interactions
depicted in Figure 1. We develop this model by rst considering the two-variable subsystems
N=P and N=D, treating CA as a parameter, then combining these subsystems to form a
three-variable subsystem, and nally incorporating the dynamics of the anti-inammatory
mediator to create the reduced model. We adopted a subsystem approach to ensure that the
interactions of the model variables are consistent with biological observations.
Baseline parameter values for both the subsystems and the reduced model are provided
in Tables 1 and 2 are selected to remain within the given ranges and constraints found in
the experimental literature. This baseline parameter set is used for all simulations except
where noted in the text. Parameters that could not be documented from existing data
were estimated such that the subsystems behave in a biologically appropriate manner for
plausible levels of the anti-inammatory mediators. Furthermore, when the pathogenic in-
sult is replaced by endotoxin as an initiating event, as presented in [18], the resulting model
qualitatively reproduces the responses of immune mediators measured experimentally during
repeated endotoxin administrations. Units for the model variables and many of the associ-
ated parameters cannot be determined, since the variables represent various types of cells,
signaling proteins such as cytokines, and/or other mediators concurrently. More precisely,
these variables quantify the response of the immune function they represent rather than, for
example, an exact cell count. Therefore, units of most parameters related to these variables
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are not in conventional form, but rather in terms of the associated variable.
Throughout the analysis of the reduced model and its subsystems, we will be tracking the
existence and values of xed points, determining the parameter regimes in which particular
xed points are stable, and locating bifurcations. A xed point is a point where the deriv-
atives of all variables in the system are zero, also known as a critical point or equilibrium
point. This occurs where the nullclines of the system intersect. We will refer to a xed point
as stable if the real part of each eigenvalue associated with the linearized system at that
xed point is negative. In the systems that we consider, it is exactly the stable xed points
that represent possible asymptotic steady states attained by open sets of initial conditions.
A bifurcation occurs when a change in a parameter alters the number of xed points and/or
their stability, and thus changes the number and nature of the asymptotic steady states of
the system [66].
The reduced model displays three physiologically relevant equilibrium points, which cor-
respond to biological states of health, aseptic death, and septic death, respectively. The
health state is a xed point with P = 0, N = 0, D = 0, and CA = sc=c, which, when
stable, is the desirable asymptotic behavior. The aseptic death state, which corresponds
to an outcome where pathogen has been eliminated but with high and persistent immune
activation and damage, is a xed point where P = 0, N > 0, D > 0 and CA > 0. The
third possible equilibrium is septic death, where all variables are nonzero, which corresponds
to a state in which there is insu¢ cient immune activation to clear pathogen. Note that a
healthy outcome viewed as a return to an equilibrium point is an idealized construct. In
fact, the complex biological systems we are considering are out of equilibrium and a return
to mediator levels within the basin of attraction of the health state is a desirable outcome.
However, in the reduced model, solutions with initial conditions in the basin of attraction
of health asymptotically approach health. Thus, for simplicity we refer to the xed point,
(0; 0; 0; sc=c) as the health state.
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Name Value Description Comments Sources
kpm 0:6=Munits/ hr Rate at which the non-
specic local response
(M) eliminates pathogen
(P )
Estimated to be considerably less
e¢ cient than a phagocyte driven
response, and therefore can be
overwhelmed with a modest to
large inocula of pathogen.
kmp 0:011=Punits/ hr Rate at which the non-
specic local response
(M) is exhausted by
pathogen (P )
sm 0:005 Munits/hr Source of non-specic lo-
cal response (M)
Chosen to balance known natural
half-life of non-specic antibodies
(see below)
m 0:002=hr Decay rate for the non-
specic local response
Range based on the reported half-
lives of immunoglobulin G and A,
non-specic antibodies probably
key in the non-specic local im-
mune response.
([34] [80])
kpg Variable The growth rate of
pathogen
([64]; [70])
p1 20106 pg/cc Maximum pathogen pop-
ulation
Estimated from a lethal model of
E. Coli rat peritonitis
Vodovotz, per-
sonal communi-
cation
kpn 1:81=N
units/ hr Rate at which activated
phagocytes (N) con-
sume pathogen
Based on observed mean rate of
phagocytosis by macrophages in
the presence of unlimited supply
of targets.
[13]
knp 0:1=N
units/ hr Activation of resting
phagocytes (NR) by
pathogen
knn 0:01=N
units/ hr Activation of resting
phagocytes by already
activated phagocytes
and their cytokines
snr 0:08=NRunits/ hr Source of resting phago-
cytes
This parameter was chosen to
ensure a stable concentration of
resting phagocytes in the absence
of inammation.
nr 0:12=hr Decay rate of rest-
ing phagocytes
(macrophages and
neutrophils)
We used a half-life of 6 hrs. [14]
n 0:05=hr Decay rate of ac-
tivated phagocytes
(macrophages and
neutrophils)
Activated cells have a prolonged
half-lives due to delayed apopto-
sis, n < nr.
[14]
knd 0:021=D units/hr Activation of phagocytes
by tissue damage (D)
The peak of the activated
phagocyte response elicited from
pathogen (knp) is greater than
that triggered by damage (knd)
[3]
Table 1: Parameters for the reduced model of acute inammation
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Name Value Description Comments Sources
kdn 0:35=D units/ hr Max rate of damage
production by activated
phagocytes (and/or as-
sociated cytokines/free
radicals)
xdn 0:06=N
 units/ hr Determines level of ac-
tivated phagocytes (N)
needed to bring damage
production up to half its
maximum
d 0:02=hr Decay rate of damage;
combination of repair,
resolution, and regenera-
tion of tissue
We calculated the parameter data
of the half-life of HMG-1, a his-
tone tethering protein leaked dy
damaged cells.
[76]
c1 0.28 CAunits Controls the strength of
the anti-inammatory
response
Set such that f(x) =
x=
 
1 + (CA=c1)2

corresponds
to  75% inhibition when CA
reaches maximum value in
respones to an insult.
[32]
sc 0:0125 CAunits/hr Source of the anti-
inammatory mediator
Organims have constitutive lev-
els of anti-inammatory e¤ectors.
The source parameter was chosen
to balance their documented half-
life.
kcn 0:04 CAunits/hr Maximum produc-
tion rate of the anti-
inammatory mediator
kcnd 48 N
units=Dunits Relative e¤ectiveness
of activated phagocytes
versus damage in in-
ducing the production
of anti-inammatory
mediators
c 0:1=hr Decay rate of the anti-
inammatory mediator
Anti-inammatory signals have
downstream cellular e¤ects not
explicitly modeled herein, lasting
longer than the e¤ector cytokine
or molecule producing it. There-
fore, our parameter value was set
at the lower limit of reported half-
lives of anti-inammatory e¤ec-
tors. This still probably is a
higher bound for this parameter.
[6], [12], [24],
[31]
Table 2: Table of parameters continued.
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M + P kpm    ! M P is destroyed at the rate kpm when it encounters M .
M + P kmp    !P M is consumed at the rate kmp when it encounters P .
 sm   !M Source of M .
M m   ! Death of M .
Table 3: Table 2 Reactions involving the local immune response (M) and pathogen (P )
2.2.1 The non-specic local immune response: the M=P subsystem
A normal individual in a healthy state has a baseline capacity to respond and resolve local
infections. This resides in the presence of cells, such as tissue macrophages as well as other
non-specic physical and biological defenses, such as defensins and non-specic antibodies.
[51] [54] [57] This non-specic local response is rapid and e¤ective, but can be overwhelmed
with large inocula or rapidly dividing pathogens. To account for this non-specic local
removal of pathogen, we assume the reactions in Table 3, with the non-specic local response
(defensins, non-specic antibodies and tissue macrophages) and pathogen levels represented
by the variables M and P , respectively.
From the reactions in Table 3, based on mass action kinetics, we derive the following
preliminary equations:
dM
dt
= sm   mM   kmpMP
dP
dt
=  kpmMP
For simplicity, we assume that the local response reaches quasi-steady-state and substi-
tuteM = sm=(m+kmpP ) into the pathogen equation. Further, to incorporate the dynamics
of the pathogen population into our model, we used a logistic growth term, kpgP (1   PP1 )
Therefore, we obtain the pathogen equation, equation (2.1).
dP
dt
= kpgP (1  P
P1
)  kpmsmP
m + kmpP
(2.1)
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Here, the pathogen growth rate and the carrying capacity of the pathogen population
are represented by kpg and P1, respectively. The units for kpg are per hour while P1 has
the same units as P , 106pg/cc. P = 0 is always a xed point of equation (2.1). We nd that
a saddle-node bifurcation gives rise to two additional xed points, say p1 < p2, which exist
for kpg > 4kmpsmP1=(P1kmp + m)
2, or equivalently for kpg > 0:059 with the parameters in
Tables 1 and 2. When they rst arise, p1, p2 are positive. Direct linearization and algebraic
manipulation show that P = 0 is stable for kpg < kpmsm=m = 1:5, where it loses stability
in a transcritical bifurcation with p1, and that the largest xed point is stable whenever it
exists. Thus for 0:059 < kpg < 1:5, this subsystem is bistable.
2.2.2 The N=P subsystem
A key component of the acute immune response is the removal of the pathogen by phago-
cytic immune cells, such as activated neutrophils and macrophages. Resting phagocytes are
activated by pathogen and by previously activated phagocytes via the binding of endotoxin
and pro-inammatory cytokines [33]. Once activated, a phagocyte becomes e¢ cient at elim-
inating pathogens. When the growth rate of the pathogen is low, activated phagocytes are
capable of clearing the pathogen in normal individuals. However, if the growth rate is high,
then a su¢ ciently large inoculum of pathogen can induce a persistent infection despite the
attack by activated phagocytes. This dependence on kpg and the interaction between resting
and activated phagocytes are essential in developing the N=P subsystem, which consists of
equations (2.2) and (2.3).
dP
dt
= kpgP (1  P
P1
)  kpmsmP
m + kmpP
  kpnNP (2.2)
dN
dt
=
snrR1
nr +R1
  nN (2.3)
where R1 = knnN + knpP
To derive equations (2.2)-(2.3) we rst take into account the activation of the resting
phagocytes (NR). In particular, from the system of reactions given in Table 4, we derive the
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NR knpP + knnN

            ! N
 Activation of the resting phagocytes
(NR) is induced by the presence of
pathogen (P ) and by positive feedback
from the activated phagocytes (N) via
pro-inammatory cytokines.
 snr   ! NR Source of NR.
NR nr    ! Death of NR.
N n   ! Death of N
.
Table 4: Reactions involving resting (NR) and activated phagocytes (N)
following equations:
dNR
dt
= snr   nrNR  R1NR
dN
dt
= R1NR   nN
where R1 = knnN + knpP
When a resting phagocyte encounters an agent capable of activating it, however, the
activation process is rapid. Thus, we assume that the variable NR is in quasi-steady-state,
reducing the NR=N system to a single equation, equation (2.3). When this equation is
combined with the pathogen equation, equation (2.1), derived above, and an additional
term is included to encode the direct consumption of pathogen by activated phagocytes, we
obtain system, equations (2.2)-(2.3).
Linearization of equations (2.2)-(2.3) about the health xed point (P;N) = (0; 0) yields
real eigenvalues that are negative for kpg < kpmsm=m and m > snrknn=nr. Since the second
of these inequalities holds for the parameters in Tables 1 and 2, the condition kpg < kpmsm=m
is once again the criterion for the stability of health, as in the M=P subsystem.
We provide a further analysis of the xed points of equations (2.2)-(2.3) below, but
rst, to more accurately model the immune response, we introduce the anti-inammatory
mediator in this subsystem. At this point, we simply encode anti-inammatory e¤ects in a
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parameter CA. By treating the anti-inammatory mediator as a parameter, we can manually
manipulate it to verify that sustained variations in its level induce biologically appropriate
alterations in the N=P dynamics, such that this subsystem will behave appropriately once
dynamic anti-inammatory mediators are incorporated.
Figure 2: Bifurcation diagrams for the N=P subsystem. (A) The bifurcation diagram generated for
CA = 0.2 with bifurcation parameter kpg. There is a Hopf bifurcation at kpg = 1.187, where the system
becomes bistable between septic death and health, and a transcritical bifurcation at kpg = 1.5, where health
loses stability. (B) Two parameter bifurcation diagram. We follow the existence of stable septic death (the
bold line) and the transcritical bifurcation (the dashed line) from (A), with CA as the second parameter.
This divides the kpg -CA plane into regions labeled by the set of stable outcomes that exist. In the shaded
region there are no stable xed points and the system oscillates. The diamond represents the point where
the bifurcation giving rise to stable septic death changes from a Hopf (below the diamond) to a saddle-node
bifurcation (above the diamond).
In normal individuals, the anti-inammatory mediator inhibits the activation of phago-
cytes and reduce the ability of activated phagocytes to attack pathogen [71]. We incorporate
this inhibition into the N=P subsystem by replacing R1 with f(R1) and N with f(N) in
equation (2.2), for f(V ) = V=

(1 +

CA
c1
2
. The parameter c1 is set such that when the
anti-inammatory mediators reach their maximum level in response to an infection, their
inhibitory e¤ects are roughly equivalent to a seventy-ve percent reduction in the inhibited
element, as seen in [32]. While it would have been reasonable to consider di¤erent levels
of inhibition by the anti-inammatory mediator for each interaction, we consider uniform
inhibition for simplicity.
For low pathogen growth rate (kpg), the resulting N=P subsystem has only the stable
health state, whose existence is independent of CA. There is a saddle node bifurcation at
kpg = 0:8829 for the parameters in Tables 1 and 2 with CA xed to 0.2. The corresponding
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bifurcation diagram is displayed in Figure 2A, which was created, as were all other gures
in this paper, using XPPAUT [23]. Of the pair of xed points born in the saddle node bifur-
cation, the lower (with respect to N) is a saddle separatrix, while the upper, corresponding
to septic death (P > 0; N > 0), is initially unstable. As kpg increases further, there is a
Hopf bifurcation at kpg = 1:187, which stabilizes septic death. Finally, health loses stability
through a transcritical bifurcation at kpg = 1:5. The stable branch that is created corre-
sponds to negative levels of pathogen and activated phagocytes and is therefore not included
in the bifurcation gure. In summary, for 1:187 < kpg < 1:5 and CA = 0:2, this subsystem
features bistability between health and septic death.
This bifurcation structure remains qualitatively similar for nearby values of CA, while for
su¢ ciently elevated CA levels, septic death is stable as soon as it appears and we no longer
observe a Hopf bifurcation. We examined the criteria for existence of stable septic death in
a two parameter bifurcation kpg-CA plane. A curve divides the plane in two regions (solid
curve in Figure 2B). For parameter values on the left of the curve, stable septic death does
not exist, while on the right, it does. Also in Figure 2B, at kpg = 1:5, there is a dashed
vertical line that denotes where the health state loses stability. This line further divides
the plane, creating a total of four regions: health, health/septic death, septic death, and a
shaded region. The rst three regions are labeled by the stable states that corresponding
parameter values support. In the shaded region, septic death does not exist, and health
is unstable. Therefore, there is no stable xed point and trajectories oscillate. This does
not represent a biologically observed state; however, once we combine subsystems below,
oscillations will no longer occur.
In Figure 3, we see the e¤ect of CA on the level of activated phagocytes (N) in the septic
death state when it rst becomes stable. From Figure 2B, we know that as CA increases,
the kpg value at which the stable septic death state appears decreases. Biologically, this
corresponds to a prediction that holding CA at a larger constant level induces a greater
inhibition of the immune response, allowing a less virulent pathogen to induce a septic death
outcome. In theory, this inhibition of N could allow an initial enhancement of the build-up
of P , which would subsequently evoke a large rise in N, leading to a high-N septic death
state; alternatively, the combination of higher CA and low kpg could suppress the level of
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Figure 3: Activated phagocytes levels at the bifuraction for the onset of septic death. A plot of the solid
curve from (B) in (N, kpg) space shows the level of activated phagocytes reached at the onset of stable
septic death as a function of kpg. Again a diamond marks the change from a Hopf bifurcation (above the
diamond) to a saddle-node bifurcation.
N seen in septic death. Figure 3 shows that in fact the latter possibility occurs, such that
the activated phagocytes levels reached in septic death decrease, along with the pathogen
growth rate, as the anti-inammatory increases.
For parameters corresponding to the region of septic death/health in Figure 2B, the
N=P subsystem is bistable. As noted above, a saddle separatrix, specically the stable
manifold of a saddle xed point, separates the two stable states, as we see Figure 4A-B for
CA = 0:2. Notice the boxed region in Figure 4A. Zooming in on this region, as in Figure 4B,
we see that the P nullcline and the stable manifold of the saddle point divide the P axis into
three regions. Suppose that an initial pathogen load, P0, is introduced to the system, which
had previously been in the health state. When P0 falls in the rst region, to the left of the
P nullcline, the non-specic local response is able to eliminate the pathogen without any
transient pathogen growth. If P0 falls in the middle region, between the P nullcline and the
stable manifold, then the pathogen is able to overcome the local response and initially grow
before the activated phagocytes respond and clear the infection. If P0 is in the nal region, to
the right of the stable manifold, then the immune response is unable to heal the individual.
When the subsystems are combined, and the anti-inammatory mediator is allowed to evolve
dynamically, we shall see that these regions persist, with qualitatively similar properties.
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Figure 4: Nullclines for the N=P subsystem. (A), (B) A plot of the nullclines for this subsystem with
CA = 0.2 and kpg = 1.25. The system is bistable between the health and septic death xed points with a
saddle point separating them. The unstable and stable manifolds of the saddle point are included in (A)
and by zooming in on the boxed region, we see in (B) that the P axis is divided into three regions by the
P-nullcline and the stable manifold of the saddle point.
Thus, this analysis of the N=P system with constant anti-inammatory mediator is helpful
in understanding the role of the activated phagocytes in the pro-inammatory response to
pathogen.
2.2.3 The N=D subsystem
When activated phagocytes respond to an infection, their presence in the tissue not only kills
pathogens, but may also lead to collateral tissue damage [26] [68]. Damaged tissue releases
pro-inammatory cytokines, which causes further phagocyte activation. This positive feed-
back interaction between phagocytes and damage also exists in the absence of pathogen and
can be triggered by other stimuli, such as tissue trauma. Therefore, the N=D system should
be bistable between health and aseptic death over a range of the anti-inammatory media-
tor. Modeling the interactions between activated phagocytes and damage, we developed the
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N=D subsystem, which consists of equations (2.4) and (2.5).
dN
dt
=
snrR2
nr +R2
  nN (2.4)
dD
dt
= kdnfs(N
)  dD (2.5)
Where R2 = knnN + kndD
and fs(V ) =
V 6
V 6 + x6dn
:
As in the N=P system, equations (2.2)-(2.3), the activated phagocyte equation in the
N=D system is derived by rst considering a system of equations that includes the resting
phagocytes and subsequently assuming that the resting phagocytes are in quasi-steady-state.
The only di¤erence between the N equations, equations (2.3) and (2.4), appears in the
activation of resting phagocytes, which we now take to be a¤ected by D rather than P .
Correspondingly, R1 from equation (2.3) is replaced by R2 = knnN + kndD in equation
(2.4).
At low counts, activated phagocytes do not cause signicant damage. However, as they
accumulate in response to an infection, the activated phagocytes will cause tissue damage to
accrue. Finally, once levels of activated phagocytes are su¢ ciently high, damage saturates,
such that the activation of additional phagocytes has little impact on damage creation. We
model this nonlinearity in the induction of damage by activated phagocytes via the Hill type
function, fs, in equation (2.5). The coe¢ cient in fs must be chosen to be su¢ ciently large
to produce a reasonable basin of attraction for health in the N=D system (see Appendix A
for further explanation). We subtract the term in equation (2.5) to represent tissue repair,
resolution, and regeneration. Linear stability analysis of the health state, (N; D) = (0; 0),
shows that the eigenvalues are negative for n > snrknn=nr , which is the same condition
that arose for the N=P subsystem and always holds for our baseline parameter set.
As in the N=P subsystem, we introduce the anti-inammatory mediator (CA) into the
N=D subsystem as a parameter to ensure that our other parameter choices give the desired
bistability for all physiological levels of CA. As in the previous subsystem, the inclusion of
the anti-inammatory mediator leads to inhibition of activated phagocytes by two means.
Specically, the activation process itself is inhibited, which we model by replacing R2 with
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f(R2) in equation (2.4), where f is the same saturating function dened for inhibition in
the N=P subsystem. The ability of activated phagocytes to cause damage is also inhibited
by the anti-inammatory mediator, which we model by replacing N with f(N) in the
Equation (2.5).
As in the N=P subsystem, the nullclines of the modied N=D subsystem intersect such
that there are two stable xed points separated by a saddle node for appropriate values of
CA. Similarly to Figure 4A-B, Figure 5 shows the nullclines and invariant sets of the N=D
subsystem with CA = 0:2. The stable manifold of the saddle point denes the threshold
between health and aseptic death. The parameters and the Hill coe¢ cient are chosen so
that this threshold allows activated phagocytes to adequately respond to an inoculum of
pathogen without triggering aseptic death.
Figure 5: Nullclines for the N=D subsystem. A plot of the nullclines shows that the stable health and
aseptic death xed points are separated by a saddle point. The stable and unstable manifolds of the saddle
point also are included.
In the bifurcation diagram for the anti-inammatory mediator in Figure 6, we see that
the N=D subsystem displays bistability between health and aseptic death for CA < 0.626.
Note that as the level of CA increases the level of activated phagocytes reached at aseptic
death is decreased. This trend makes sense, since the anti-inammatory mediator inhibit the
activation of phagocytes. Eventually, this inhibition prevents the system from equilibrating
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at a state where N remains elevated; specically, as CA increases, the nullclines pull apart
and eventually do not intersect. This occurs at the saddle node CA = 0:626 and causes this
subsystem to lose bistability. We note that this value lies above the physiological relevant
range for CA and also is consistent with the intuition that high CA levels prevent the explosion
of N needed for aseptic death.
Figure 6: Bifurcation diagram for the N =D subsystem. A bifurcation diagram with the bifurcation
parameter CA, showing bistability between health and aseptic death that is lost through a saddle-node
bifurcation as CA increases through 0.6264.
2.2.4 The Three-Variable Subsystem
We combine the above two systems by including e¤ects of both pathogen and damage on the
rate at which the resting phagocytes are activated. To do this, we let R3 = knnN+ knpP +
kndD and again assume that the resting phagocytes are in quasi steady state to obtain the
system of equations (2.6)-(2.8).
dP
dt
= kpgP (1  P
P1
)  kpmsmP
m + kmpP
  kpnNP (2.6)
dN
dt
=
snrR3
nr +R3
  nN (2.7)
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dD
dt
= kdnfs(N
)  dD (2.8)
Where R3 = knnN + knpP + kndD and fs(V ) =
V 6
x6dn + V
6
Model (2.6)-(2.8) exhibits the combined dynamics of the previous two subsystems. The
conditions for stable health are unchanged from the N=P subsystem, since D = 0 at the
health xed point. In particular, health is stable for low pathogen growth rate (kpg), but
loses stability at a transcritical bifurcation at kpg = 1:5 as kpg is increased. Since this
instability is induced by the pathogen dynamics, it follows that even after this stability loss,
the healthy state retains a two-dimensional stable manifold, such that small perturbations
in the non-pathogen components lead to healthy resolutions. For low or moderate growth
rate, the system inherits the existence of stable aseptic death from the bistability of the
N=D subsystem. Consequently, for low pathogen growth rate, the physiological outcomes
after pathogenic infection are health, achieved when the initial pathogen level is low, and
aseptic death, arising when the initial inoculum of pathogen is large enough that the resulting
phagocytic response results in large tissue damage.
As in the N=P subsystem, increasing pathogen growth rate leads to a bifurcation that
introduces the possibility of septic death. Figure 7 shows a bifurcation diagram with CA =
0:2, in which we see that this bifurcation is a Hopf at kpg = 1:707. This diagram also
shows the transcritical bifurcation that destabilizes the health state at kpg = 1:5; the second
branch of equilibria participating in this bifurcation is not shown, since it corresponds to
a non-physiological state with negative pathogen and activated phagocytes. Since health is
already unstable for kpg < 1:707, there are only two possible stable outcomes, aseptic death
and septic death, until kpg = 2:769, when aseptic death loses stability through a second
transcritical bifurcation. Aseptic death loses stability when kpg becomes so large that the
immune system cannot clear the pathogen, preventing stability of a state with a nonzero
pathogen level and leaving septic death as the only stable state for the system.
Despite the bistability between aseptic and septic death for 1:707 < kpg < 2:769, initial
conditions with only pathogen elevated, and all other variables at healthy levels, always
lead to septic death for xed CA. The aseptic death outcome is attainable if tissue trauma
(D0 > 0) occurs in the absence of pathogen or if the initial level of activated phagocytes
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Figure 7: Bifurcation diagram for the three-variable subsystem for kpg with CA = 0:2. Health and aseptic
death both lose stability through transcritical bifurcations, at kpg = 1:5 and kpg = 2:769, respectively. At
kpg = 1:702 there is a saddle-node bifurcation giving rise to two initially unstable xed points. At kpg = 1:707,
a Hopf bifurcation creates a stable state, which corresponds to septic death.
(N0 > 0) is elevated (with or without pathogen). A pre-activated immune system allows the
infection to be cleared, avoiding septic death. However, activated phagocytes continue to be
elevated in response to the pathogen, and this triggers aseptic death.
Next, we follow the bifurcation points in a two-parameter bifurcation diagram in the
kpg-CA plane (Figure 8). The existence of septic death is represented by the solid curve.
For a combination of parameters on the right of this curve, this system enters septic death
(given a su¢ cient inocula for pathogen), while on the left septic death does not exist. The
transcritical bifurcation where healthy loses stability is represented by the vertical dashed
line at kpg = 1:5. To the right of this line the health state is stable. The transcritical
threshold corresponding to the loss of stability of aseptic death is represented by a blue
dashed curve. Also, for CA levels above the horizontal, dashed line, aseptic death does not
exist due to the same saddle point bifurcation we showed in the N=D subsystem. Therefore,
aseptic death is not a possible outcome above the horizontal, dashed line or to the right of
the blue dashed curve. Combining these bifurcation structures we are able to label each
region, as we did in Figure 2B, by the stable states they support.
22
Figure 8: Two paramter bifurcation diagram for the three-variable subsystem for kpg and CA generated
by following the bifurcations from Figure 7. The black solid curve represents the onset septic death. The
diamond is the a switch from a Hopf (below) to a saddle-node bifurcation. Each region is labeled by the
possible outcomes in that parameter regime. Transcritical bifurcations are the dashed curves. The dashed,
horizontal line corresponds to where the aseptic death state loses existence due to a saddle-node bifurcation
as CA is increased.
From the two parameter bifurcation diagram in Figure 8, we observe that for CA > 0:234,
the bifurcation giving rise to the existence of septic death occurs at a kpg < 1:5. Therefore,
if 0:234 < CA < 0:626 (indicated by the horizontal, dashed line in Figure 8, there is a range
of kpg for which all three outcomes are stable. As in the case with CA = 0:2 and bistability
between aseptic and septic death, the path to aseptic death is sensitive to initial conditions
and there is a propensity to enter septic death when only pathogen is initially introduced.
2.2.5 The Four-Variable Model
We complete the model derivation by introducing time-dependence to the anti-inammatory
mediator CA, thereby obtaining our four-variable reduced model of the acute immune re-
sponse. The production of the anti-inammatory mediator is associated with the presence
of activated phagocytes [19] and elevated markers of tissue damage [67]. As discussed in the
development of the various subsystems considered above, the anti-inammatory mediator
(CA) regulates the immune response by inhibiting the production and e¤ects of activated
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phagocytes and damage. More specically, the presence of CA decreases the ability of acti-
vated phagocytes to react to other cell types, reducing their e¤ectiveness against pathogen,
their induction of damage, and their production of additional CA [19]. The recruitment
of CA by tissue damage (D) is similarly inhibited. Further, CA compromises all means of
activation of resting phagocytes.
As in the various subsystems, inhibition of activated phagocytes by the anti-inammatory
mediator (CA) is incorporated in the model by replacing N with f(N) = N=

1 + CA
c1
2
in
equations (2.6) and (2.8). The inhibition of the activation of resting phagocytes is modeled
by replacing R3 with R = f(R3) = f(knnN + knpP + kndD). Note that f limits to zero
as CA approaches innity, and therefore if CA levels are manipulated to be su¢ ciently high
(above the maximum reached in response to an infection), then they will correspond to
nearly complete inhibition of immune activation, which is experimentally observed [16].
The CA equation contains a source of CA, denoted sc, and a termmodeling the production
of anti-inammatory mediator from damage and activated phagocytes, which takes the form
kdn(N
 + kcndD)=(1 + N + kcndD), before inhibition is incorporated. This expression is
a Michaelis-Menten type term, in which kcnd controls the e¤ectiveness of damage, relative
to activated phagocytes, in producing CA. Including inhibition in this term, we obtain
kdnf(N
 + kcndD)=(1 + f(N + kcndD)).
Finally, incorporating these changes and additions into our three variable model, equa-
tions (2.6)-(2.8), results in our four variable model, which consists of equations (2.9)-(2.12).
We shall refer to equations (2.9)-(2.12) as the reduced model, because it describes a highly
abstracted representation of the complexity of the acute immune response.
dP
dt
= kpgP (1  P
P1
)  kpmsmP
m + kmpP
  kpnNP (2.9)
dN
dt
=
snrR
nr +R
  nN (2.10)
dD
dt
= kdnfs(f(N
))  dD (2.11)
dCA
dt
= sc + kdn
f(N + kcndD)
1 + f(N + kcndD)
  cCA (2.12)
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Where R = f(knnN + knpP + kndD);
f(V ) =
V
1 +

CA
c1
2 ,
and fs(V ) =
V 6
x6dn + V
6
2.3 RESULTS
The reduced model, equations (2.9)-(2.12), exhibits the same physiological xed points as
discussed above for the three-variable model. The health state is a xed-point with P = 0,
N = 0, D = 0, and CA = sc=c. The anti-inammatory mediator is non-zero in this state,
corresponding to the background level of these cytokines that exists in healthy individuals.
In aseptic death, P = 0, but N, D, and CA are nonzero. All variables are non-zero in septic
death. Model dynamics for initial conditions leading to health, aseptic death or septic death
are depicted in Figures 9A, 9B and 10A, respectively.
Figure 9: Transients from the evolution of the reduced model with a healthy and an aseptic death
outcome. A) Health, simulation were run with kpg = 0:3/hr and initial conditions P = 1, N = 0, D = 0, and
CA = 0:125. B) Aseptic death with kpg = 0:3 and initial conditions P = 1:5, N = 0, D = 0, and CA = 0:125.
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Figure 10: Transients from the evolution of the reduced model with septic outcome and the bifurcation
diagram for the four-variable reduced model. (A) Septic death with kpg = 0:6, such that septic death is a
possible outcome, and initial conditions P = 1, N = 0, D = 0, and CA = 0:125. (B) Bifurcation diagram,
septic death comes into existence via a saddle-node bifurcation at kpg = 0:5137. Health and aseptic death
lose stability by transcritical bifurcations at kpg = 1:5 and 1:755, respectively. Emerging stable states are
not shown, since they are non-physiological. For kpg < 0:5137, the model is bistable between health and
aseptic death. The model has all three states stable for 0:5137 < kpg < 1:5. There is bistability between
aseptic and septic death for 1:5 < kpg < 1:755: Finally, above kpg = 1:755, the only stable state is septic
death.
The qualitative dependence of the existence of stable states on the pathogen growth
rate kpg is maintained as in the three-variable model. As kpg is increased, the septic death
state comes into existence via a Hopf bifurcation at kpg = 0:514 and the aseptic death state
loses stability at kpg = 1:755, as can be seen in the bifurcation graph presented in Figure
10B. As in the subsystems, health loses stability at a transcritical bifurcation at kpg = 1:5.
The second branch of equilibria involved in this transcritical bifurcation corresponds to a
non-physiological state and is not included in the Figure 10B.
Utilizing both the three-variable subsystem, with the anti-inammatory mediator treated
as a parameter, and the reduced model, we explore several aspects of the role of CA: (1) we
investigate the e¤ects of allowing CA to dynamically depend on other model variables, which
we compare to results found by holding the anti-inammatory response at various constant
levels, (2) we vary parameters that govern the speed of the anti-inammatory response, (3)
we analyze the e¤ects resulting from the presence of initially elevated or depleted CA levels
when an infection is introduced, and (4) we consider the e¤ects of reducing or elevating
(resetting) CA after an infection has progressed for multiple hours and then allowing the
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full model to evolve, a manipulation that simulates a therapeutic intervention with an anti-
inammatory mediator.
Figure 11: The basin of attraction for the health state depends on CA. For each constant CA level
shown, the three-variable subsystem was used to determine the level of initial pathogen were the onset of
death occurs (aseptic or septic), over a range of kpg. Using the reduced model, with initial conditions with
background initial conditions, the same was done, giving rise to the curve labeled Dynamic. The dotted
portion of the CA = 0:7 curve (black) represents a range of where healthy is the only outcome.
We rst ask whether the dynamics of the anti-inammatory response are important,
or whether a similar protection against runaway inammation is achieved by the inclusion
of a constant presence of the anti-inammatory mediator in the model. In Figure 11, we
compare the outcomes associated with a dynamic CA response and those found with a variety
of constant levels of CA. At di¤erent kpg values, we determine the level of initial pathogen
that is the threshold between health and death (aseptic or septic). The curve associated with
CA = 0 lies below all other curves: the presence of the anti-inammatory mediator, whether
dynamic or constant, allows a larger initial pathogen load or growth rate to be tolerated over
all physiologic (> 0) values of the pathogen growth rate, kpg. An interesting result arising
from simulation of the reduced model is that a dynamic anti-inammatory mediator is almost
always more e¤ective than constant levels of the anti-inammatory mediator at producing a
healthy outcome following infection. Indeed, the curve associated with dynamic CA in Figure
11 is above all other curves for most kpg levels. The only exception is that at low growth
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rate (kpg < 0:307), the curve for CA = 0:7 (very high CA) ends and is continued by a dotted
line, which crosses above the curve for dynamic CA. In this region, with CA = 0:7, the only
outcome is health, and hence the threshold between health and death is no longer dened.
For infections of such low virulence, even large anti-inammatory levels will not thwart
inammation to a degree that allows runaway infection and death. Teleologically, our model
demonstrates that a dynamic anti-inammatory response increases the robustness of the
immune response to infection, allowing the body to recover over a broad range of pathogen
growth rate, yet in a way that minimizes life-threatening tissue damage.
Figure 12: The threshold between health and death depends on the initial anti-inammatory mediator
and pathogen levels in the reduced model. At each kpg value indicated we nd the initial CA level that is the
threshold between health and death outcomes, given that N and D initially are at zero. Initial conditions
to the left of each curve lead to health. Those to the right give rise to either death. The blue dashed line
indicated the baseline level of CA.
Given that a dynamic anti-inammatory response is advantageous, we now consider
how the rate of this response a¤ects the overall outcome following infection. Considering a
trajectory that is in the basin of attraction of health but close to the threshold between health
and death, we altered the time scale of CA by modifying the rate constants reecting the
production (kcn) and decay rate (c) of the anti-inammatory mediator simultaneously. A
slight increase in these rates helped the system to restore health sooner, but larger increases
favored septic death. On the other hand, slowing down the anti-inammatory dynamics
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causes the trajectory to proceed to aseptic death. Similar results are obtained over a broad
range of pathogen growth rates.
Next, we use the reduced model to explore the impact of baseline anti-inammatory
mediator levels on response to infection. First, we vary the initial level of CA (CA0) for a
given initial level of pathogen (P0) and determine the threshold between health and death at
this P0. This was repeated for multiple values of P0 at xed kpg values. As depicted in Figure
12, this process denes, for each kpg value, a boundary between health and death illustrated
by the corresponding curve. Because the local non-specic immune response in our model
is not inhibited by CA, the threshold between health and death cannot fall below the level
of pathogen that the local response is capable of clearing, regardless of the initial levels CA.
Thus, a vertical asymptote, close to the kpg = 1 curve, is reached for large kpg. The dotted
line in Figure 12 indicates the level of CA0 found in the healthy state (background), call it
CA0. From Figure 12, we see that the e¤ect of CA0 is generally stronger at lower kpg. For
such kpg, a reduction in CA0 from CA0moves the threshold for death to lower P0. Conversely,
increasing CA0 allows the system to handle higher P0. However, the changes that occur for
higher kpg, while milder, are opposite to these. Moreover, even for low kpg, the threshold for
death shifts back to lower P0 when CA0 is made su¢ ciently large. Indeed, it appears that the
background CA level, CA0 , is fairly optimally situated to allow for maximal or near-maximal
threshold P0 for a fairly broad range of high pathogen growth rates values, without undue
compromise of protection at lower kpg. Interestingly, however, this background level is not
globally optimal.
For solutions to the reduced model with initial conditions in the basin of attraction of the
health state, CA returns to baseline signicantly later than all other variables (Figure 9A).
Therefore, after an infection is cleared, there is a period of time when only CA is elevated,
a window of relative immune suppression. Figure 12 allows us to consider the e¤ects of
introducing a second infection during this window. Although, for high kpg, the baseline level
of CA leads to a larger basin of attraction for health than does elevated CA, the elevated
levels of CA found immediately after an infection are only mildly detrimental. At these
levels, CA o¤ers signicant protection against a subsequent infection of a low or moderate
kpg (see also [18]).
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Figure 13: Figure 9: Altering the anti-inammatory mediator levels after an infection has progressed
can dramatically alter outcome. In this example, we allow an infection, triggered by an initial pathogen
injection of 0.36 with kpg = 0:6=hr, to progress for ten hours. After this, the anti-inammatory mediator
(CA) is increased (dashed lines) or decreased (solid lines) without altering pathogen, activated phagocytes,
and damage levels. The curve labeled NORMALis the time course obtained without manipulation of the
CA level from its normal level of 0.303, and all other curves are labeled by their adjusted CA levels, as
introduced at ten hours.
Multiple clinical trials have been conducted in which an anti-inammatory mediator is
administered as treatment to individuals with severe clinical sepsis (i.e., typically a highly
inamed state), where death is a frequent outcome ([4], [42]). To mimic treatment aimed at
modulating the anti-inammatory mediator after an initial infection, we devised an in silico
experiment where initial pathogen is injected into the reduced model, equations (2.9)-(2.12).
The infection is allowed to evolve for several hours at which point we instantly decrease
or increase the level of CA, to simulate a therapeutic intervention aimed at depleting or
raising the availability of CA. The simulation then proceeds according to equations (2.9)-
(2.12). Initially, we ran simulations where the intervention was performed at eight, ten,
and twelve hours after pathogen injection. The results depicted in Figure 13, obtained for
the ten hour intervention, are representative of the case with moderate pathogen growth
rate, where the simulation still results in health restoration, yet the solution lies near the
threshold between health and aseptic death. In Figure 13, a su¢ ciently small depletion of
CA (e.g. CA = 0:24) still yields a healthy outcome, but resolution to health takes longer.
More substantial depletion of CA (e.g. CA = 0   0:2) pushes the system to aseptic death:
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activated phagocytes clear the infection successfully yet are insu¢ ciently inhibited, such
that persistent collateral tissue damage results. If instead CA values are instantly raised
beyond 0.35, the simulation leads to septic death due to an excessive inhibition of activated
phagocytes, which cannot mount a substantial attack on the pathogen. Therefore, over the
time window explored, a modest increase in the anti-inammatory mediator may indeed be
slightly benecial (e.g. CA = 0:32 in Figure 13), but it is important to prevent an overly
large increase. This nding could be particularly crucial in clinical circumstances where the
body cannot mount a su¢ cient anti-inammatory response ([4], [5]). In such situations, a
modest transient increase in anti-inammation mediator would change the outcome from
aseptic death to health, but larger increases would be problematic.
Finally, we explored the sensitivity of these results to pathogen growth rate and timing
of intervention. For larger kpg, the thresholds between health, aseptic death, and septic
death are quite close together. As we raise kpg from the example in Figure 13, we nd that
interventions featuring signicant increases in CA continue to promote septic death, while
signicant decreases favor aseptic death. However, for su¢ ciently large kpg, aseptic death
becomes less of a threat, while there is a propensity for a pathogenic explosion leading to
septic death. In these cases, the removal of most or all of the CA present at the time of
intervention is optimal for yielding a return to health. We note that if the delay before
intervention is increased for moderate kpg, then a greater CA input is needed to avoid aseptic
death, since N builds up during the time before intervention. In cases of high kpg, excessive
delays before removal of CA can eliminate their ameliorative e¤ects by prolonging the period
of insu¢ ciently restrained pathogen growth. These results highlight further that the outcome
of anti-inammatory therapy will be highly sensitive to the nature of the infection being
treated and the details of the therapeutic protocol.
2.4 DISCUSSION
We have derived a reduced model of the acute inammatory response to infection that
includes an anti-inammatory mediator. Simulation and bifurcation analysis of this model
suggest that anti-inammation plays several important roles in the restoration of health.
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First, anti-inammation expands the basin of attraction of health compared to that present
in models lacking anti-inammation [38], which is a desirable feature, given that we expect
health to be a robust state. Second, we demonstrate an advantage, in terms of healthy
resolution of infection, conferred by the dynamic nature of the anti-inammatory response,
in comparison to a tonic response. This advantage holds in all situations except for the
mildest of infections, which, in any case, do not present a vital threat. This is illustrated
in current clinical practice, where distressing symptoms associated with mild infections are
alleviated by the co-administration of antibiotics and anti-inammatory mediators. The
reduced model also underlines the importance of the di¤erent response rates of substances
promoting inammation, represented in the model by N, and of the anti-inammatory
mediator that limit this response. Specically, our results suggest that these rates are fairly
well tuned to optimize healthy outcomes to pathogenic infection. Further, we have used
simulations of our model to explore how variations in levels of the anti-inammatory mediator
present initially or at some time after initial infection a¤ect the restoration of health following
an inammatory response.
We followed a systematic, modular approach to model development, building our reduced
model from subsystems, each one with biologically plausible dynamics. Indeed, by building
up this model through modules, we gain a clear understanding of how each element and
interaction in the system contributes to the overall network dynamics. We also ensure
that the nal model behaves in a way that is consistent with situations in which particular
features are absent, such as tissue damage without pathogen exposure, or are experimentally
manipulated.
Our results illustrate the point that administration of an anti-inammatory mediator
during the response to an infection may compromise outcome (Figure 13). The adminis-
tration of pharmacological doses of steroids, which are potent natural anti-inammatory
mediators, in severely septic patients has clearly resulted in worse survival. ([63], [65]) This
situation corresponds in our model to either the maintenance of tonic elevated levels of the
anti-inammatory mediator or the transient administration of the anti-inammatory me-
diator, in patients who would otherwise survive or evolve to aseptic death, causing septic
death (Figure 13). The association between signicant immune suppression and infectious
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complications is clearly an ongoing concern for several groups of patients. Fortunately, the
anti-inammatory mediator, in addition to being conducive to the healing phase of injury,
also plays a role in the acute phase of infection as well. A signicant body of recent evidence
suggests that low-dose immunosuppression with an anti-inammatory mediator may in fact
improve outcome in patients with severe infection, particularly in patients with an insu¢ -
cient anti-inammatory response ([4], [5]). Our simulations highlight the dependence of the
outcomes of such interventions on pathogen virulence (Figure 12) and timing of intervention,
as discussed in the previous section. Therefore, studies such as we have performed may be
useful for subsequent investigations of anti-inammatory therapeutic agents. For example,
the only approved therapeutic agent for patients with severe sepsis, recombinant human ac-
tivated Protein C, has anti-inammatory properties ([9], [35], [50]) and the proper degree of
modulation with this agent, alone or in combination with others, remains a very active focus
of clinical research ([15], [43]). How the various features of the inammatory response inter-
act to govern the outcome following multiple insults, including pathogen, trauma, endotoxin,
or other stimuli, warrants intensive computational exploration ([18]).
The biological relevance of our analysis and conclusions are limited by the signicant over-
simplication present in our reduced model and the di¢ culty in translating functions such as
pro-inammation, anti-inammationand damageinto measurable quantities. Future
directions for study include a more detailed biological characterization of anti-inammatory
substances, since they di¤er widely in the timescale and specicity of their activity, and a
detailed mathematical analysis of the use of anti-inammatory mediators as therapeutic
agents, depending on timescale as well as time and intensity of intervention. The experimen-
tal and clinical relevance of these e¤orts will continue to grow as methods are developed to
better link reduced models and more complex models, both from top-down and bottom-up
approaches.
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3.0 COMPARTMENTAL MODEL OF ACUTE INFLAMMATION
3.1 INTRODUCTION
The reduced model of acute inammation was su¢ cient for exploring the role of anti-
inammatories. However, in order to more accurately model acute inammation within
an organ, we expand the reduced model to account for the interplay between blood and
tissue during acute inammation. Though pathogen is typically introduced via the tissue,
the blood supplies immune cells need to eliminate severe infections. During the inamma-
tory response, local tissue macrophages are activated. These activated macrophages produce
cytokines that di¤use into the blood and trigger a local inux of activated neutrophils, fa-
cilitating the elimination of pathogen [48]. The interplay between compartments is essential
in eliminating infection and restoring homeostasis during severe insults. Additionally, we
model specic cytokines and immune cell types, which have been measured clinically.
We developed this model by initially focusing on the immune mediators within tissue
and then expanding the model to include the blood components. Additionally, we examined
individual terms to properly model their e¤ects on the full model. Once the structure of the
equations was established for a single unit of tissue the parameters were tted using heuristics
from data for IL-10, TNF, neutrophils, macrophages and pathogen. Stable outcomes (health,
aseptic death, and septic death) and dynamics are similar to the results seen in the reduced
model. However, we have included specic cytokines, cells, and tissue integrity rather than
variables representing all pro-inammatories, all anti-inammatories, and general damage.
We included in this model the interactions shown in Figure 14.
Once the single tissue unit model was developed, capturing the cell to cell level inter-
actions, we linked multiple tissues to the same blood supply to model the communication
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Figure 14: Interactions included in the compartmental model. Di¤usion is represented by black arrows
and immune interactions are represented by the red (up-regulation) and blue (down-regulation) arrows. In ad-
dition, the anti-inammatory cytokine IL-10 inhibits all interactions including neutrophils and macrophages,
the species with dashed border.
between organs via the blood. During MODS there is propagation of inammation from one
organ to the next. This tissue/blood model is a minimal model for most human organs. The
lung does not have this construct, having three compartments. Therefore, in the following
chapter we develop a three compartmental model of the lung. Here, in this chapter we focus
on organs which consist of tissue interacting with the blood only. This covers a variety of
organs, including as the kidney and liver.
These organs have signicant di¤erences, many of which we introduced into this model.
Primarily, we consider di¤erences in blood-tissue permeability and the background level of
macrophages residing in the tissue. These di¤erence are considered, since both di¤usion and
macrophages play a major role in the immune response. Permeability controls the neutrophil
response and the exchange of mediators between organs and the blood. Macrophages play
a signicant role. They ght local infection and produce immune mediators, which di¤use
into the blood. The liver has high levels of macrophages and typically fails after the kidney
during MODS, which has fewer macrophages [42].
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3.2 DEVELOPMENT OF THE MODEL
3.2.1 Isolated Tissue
Initially, we focused on the interactions including pathogen, macrophages and antibodies
within the tissue. The e¤ects of both tissue macrophages and antibodies were included in the
reduced model. However, they were grouped together into a single variable. In this model,
they are represented by distinct variables. The resting and activated tissue macrophages
are represented by the variables, M and M, respectively. All other antibodies and cells
activated at the onset of infection are referred to as the background immune response, B.
This background response, B; can immediately eliminate low levels of pathogen, P . Given
the immediate response of B and its ability to eliminate P , the B variable is assumed to
be in steady state. This assumption gives rise to the term,  sbkpbP=(b + kbpP ) in the P
equation, equation (3.1), which has the same form as the analogous term in the reduced
model. Also, as in the reduced model, we assume logistic growth of pathogen giving us the
rst term in the P equation, equation (3.1). See Tables 5-12 for further explanation of the
parameters.
dP
dt
= kpgP (1  P
p1
)  sbkpbP
b + kbpP
  kpmMP (3.1)
dM
dt
=  mM   kmpMP + sm (3.2)
dM
dt
=  mM + kmpMP (3.3)
The tissue macrophages are not capable of ghting infection until they are activated by
either pathogen or pro-inammatory cytokines. Therefore, when a resting tissue macrophage,
M , meets a pathogen, P; we haveM+P !M+P whereM is activated tissue macrophage.
This reaction gives rise to the second term in both the M and Mequations, equations (3.2)
and (3.3). Activated macrophages are capable of eliminating pathogen. For this reason, we
also haveM+P !M, which gives rise to the third term in the P equation, equation (3.1).
The rst terms in equation (3.2) and equation (3.3) model the decay of macrophages. Note
that, as in the reduced model the activated cells have slower decay rates, m > m. The
bone marrow provides a source of resting macrophages, sm, see equation (3.2). Therefore,
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resting cells are in the tissue at background and their source supplies resting cells during the
infection.
Once activated, macrophages produce both pro- and anti-inammatory cytokines. Pro-
inammatory e¤ects were included in the reduced model, however, there were no specic cy-
tokines. Here, we modeled the pro-inammatory cytokine, TNF. The compartmental model
also focuses on a specic anti-inammatory, interleukin-10 (IL-10). These two cytokines
were chosen because they have high biological relevance and are commonly measured in ex-
periments for many animal types. The rst terms in equations (3.4) and (3.5) describe the
decay of the cytokine and the second terms model production from activated macrophages.
dTNF
dt
=  tTNF + kmatM (3.4)
dIL10
dt
=  iIL10 + kmaiM (3.5)
Once produced, TNF can bind to resting macrophages and cause activation. Therefore,
we include the reaction M + TNF ! M into this system. TNF does not appear on the
right side of the arrow, since it is consumed during activation. This reaction gives rise to
the second term in the M , M, and TNF equations, equations (3.7)-(3.9). This activation
is assumed to be nonlinear, since multiple TNF bind to a macrophage in order to activate it.
Note that, we refer to both the variable and the actual cytokine by TNF, but the variable
appears as TNF . The same convention is used for IL-10.
dP
dt
= kpgP (1  P
p1
)  sbkpbP
b + kbpP
  kpmfi(M)f(P; xmp; hmp) (3.6)
dM
dt
=  mM   kmtcellfi(M)f(TNF; xt; ht) (3.7)
 kmpfi(M)f(P; xmp; hmp) + sm
dM
dt
=  mM + kmtcellfi(M)f(TNF; xt; ht) (3.8)
+kmpfi(M)f(P; xmp; hmp)
dTNF
dt
=  tTNF   kmtmolfi(M)f(TNF; xt; ht) (3.9)
+kmatfit(f(M
; xmt; hmt))
dIL10
dt
=  iIL10 + kmaifi(f(M; xmi; hmi)) (3.10)
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where fi(M) = M
0B@ (1  ci)
1 +

il10
il101
hi + ci
1CA ,
fit(M
) = M
0B@ (1  cit)
1 +

il10
il10t1
hit + cit
1CA
and f(v; xv; hv) =
vh
vh + xhv
IL-10 e¤ects the ability of macrophages to be activated, to deplete pathogen, and to
produce cytokines. Therefore, M is replaced by fi(M) =M(1  ci)=

1 +

il10
il101
hi
+ ci
andM with fi(M) in all terms but those modeling decay and production of TNF in equations
(3.6)-(3.10). The parameter ci determines the maximum inhibition ofM. When IL10!1,
M ! ciM. This is a Hill-type term with IL101 determining the level at which IL10s
inhibition of M is at half strength. This function form is used for all inhibition included in
our compartmental model.
The main role of TNF is to act as a trigger to the onset of the innate immune re-
sponse, once it di¤uses into the tissue. TNF is produced only in the early stages of infec-
tion whether or not the insult is survivable [44]. In order to model this early production
of TNF, the production term has a higher level of inhibition than the other reactions in-
volving macrophages. Using the function for the inhibition of the production of TNF ,
fit(M
) =M(1  cit)=

1 +

il10
il10t1
hit
+ cit; which has the same form as fi(M) but with
cit << ci; so that production is nearly thwarted when IL10 is high. Also il10t1 < il101 so
the that onset of the inhibition of production occurs at a lower IL10. We replace M with
fit(M
) in the TNF production term in equation (3.9).
Macrophages are the only producers of cytokines in our model. In order to control the
dynamics of the cytokine populations we introduced nonlinearities via a Hill-type production
term, see equations (3.9) and (3.10). This combined with fit, allows the model have a signif-
icant levels of TNF that occurs after approximately twelve hours during a mild survivable
insult. Also, the Hill-type term for IL10 production allows M to be more e¤ective during
the initial stage of infection.
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Unlike in the reduced model, variables are measured in the units used clinically. There-
fore, pathogen now ranges from 0 to 20,000. Assuming linear terms for activation of
macrophages by pathogen and the elimination of pathogen as we did in equations (3.1)-(3.3)
gives rise to improper dynamics. If the rate constant is set such that the proper dynamics oc-
curs at low pathogen, then at high pathogen the elimination and activation terms are so large
that death outcome is eliminated. If the rates of these reactions are reduced to adjust for large
population we do not get proper levels of activation and elimination at the onset of inamma-
tion. Consider the elimination of P by M term, kpmfi(M)P , as the rate of elimination per
M, kpmP , multiplied by fi(M). In this form, this rate is linear in P . At low pathogen levels
there is dependence on concentration, since concentration determines the likelihood thatM
encounters P . However, at high pathogen, pathogen is readily available and the rate at which
pathogen is eliminated should be determined by the ability of the activated macrophages to
ght the infection. Therefore, in order to model elimination properly we replace kpmfi(M)P
in equation (3.1), with kpmfi(M)P hmp=(P hmp + x
hmp
mp ) = kpmf(P; xmp; hmp)fi(M). This
can simply be viewed as there being a maximal rate at which macrophages can eliminate
pathogen. This maximum is achieved when the concentration of pathogen is su¢ ciently high.
The same derivation is used for activation of macrophages by pathogen. There is a maximal
rate at which a resting macrophage can be activated, so P is replaced by f(P; xmp; hmp) in
all activation terms. Including these changes we the have nal form of the equations for the
tissue components in the absence of di¤usion, see equations (3.6)-(3.10).
3.2.2 Immune components within the blood
The activation of macrophages and the ensuing production of TNF produces a signal to the
neutrophils, which are phagocytic cells that once activated are highly capable of destroying
pathogen. In this model we assume that activated, but not resting, neutrophils can di¤use
into the tissue. Therefore, activation of neutrophils by pathogen and TNF occurs only in
the blood. The reactions of the activation and resulting terms are of the same form as the
activation of macrophages, see the second term in equations for Nb, Nb and TNFb, equations
(3.12), (3.13) and (3.14). Note the rst term in equations (3.12)-(3.15) model the intrinsic
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decay of these variables.
dPb
dt
= kpbgPb(1  P
pb1
)  sbbkpbbPb
bb + kbbpPb
  kpnfib(Nb)f(Pb; xnp; hnp) (3.11)
dNb
dt
=  nbNb   kntcellfib(Nb)f(TNFb; xtb; htb) (3.12)
 kmpbfib(Nb)f(Pb; xnp; hnp) + snb
+ksnbf(cN

b + dN
; xsnb; hsnb)
dNb
dt
=  nbNb + kntcellfib(Nb)f(TNFb; xtb; htb) (3.13)
+knpbfib(Nb)f(Pb; xnp; hnp)
 (1  rb)kpncellfib(Nb )f(Pb; xnp; hnp)
dTNFb
dt
=  tbTNFb   kntmolfib(Nb)f(TNFb; xtb; htb) (3.14)
dIL10b
dt
=  ibmaxIL10b (3.15)
where fib(Nb ) =
Nb (1  cib)
1 +

il10b
il10b1
hib + cib and f(v; xv; hv) = vhvh + xhv
As with resting macrophages there is a source of resting neutrophils from the bone
marrow. For the neutrophil population, however, we assume that the bone marrow increases
the source of the resting neutrophils in response to increasing inammation. To include
this e¤ect we modeled the source with the nal term in equation (3.12). This term is a
nonlinear function of the total amount of blood and tissue activated neutrophils, Nb and
N, respectively. Note the subscript b is used to denote components in the blood and no
subscript denotes those in the tissue.
The structure of the equation for pathogen in the blood is the same as the one for
pathogen in the tissue. We still assume logistic growth and the presence of the background
immune mediators capable of eliminating the pathogen immediately. Therefore, the rst
two terms in the blood pathogen equation, equation (3.11), are the same as in the tissue
pathogen equation, (3.6).
Inhibition of neutrophil activation is similar to the inhibition of macrophage activation,
but dependent on IL10b with the level of inhibition determined by cib and IL10b1. The
IL10b equation is included here, due to the inhibition of neutrophils . The source of IL10b
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to the blood is via di¤usion. The modeling of di¤usion is discussed in the next section, so
here the only term in the IL10 equation, equation (3.15), is its decay.
Neutrophils are able to destroy pathogen. Therefore we have the reaction, P + N !
rbN
, where rb  1. During the elimination of pathogen the activated neutrophils are
depleted. The parameter rb determines the proportion of activated neutrophils which are
destroyed during elimination. Accounting for this and the inhibition of neutrophils, we
develop the last term of both the pathogen and activated neutrophil equations, equations
(3.11) and (3.13).
3.2.3 Tissue Integrity
When inammation occurs in tissue, the tissue becomes damaged by the presence of radicals,
such as nitric oxide. Therefore, in this model we track the level of radicals and the integrity
of the tissue with the variables, RAD and TI, respectively. TI = 1 in the absence of
inammation. If signicant radicals accumulate, RAD increases, and TI will drop to zero,
representing fully damaged tissue incapable of repairing itself. In order to model the ability
of tissue to repair itself, we initially set dTI
dt
= ktgTI(1  TIT1 )(TI   a), with 0 < a < 1. This
is similar to logistic growth with the extra factor. ktg is the repair rate of the tissue and T1
is set to one, representing 100%. This equation and has three xed points, TI = 0, TI = a,
and TI = 1. This TI equation is bistable between TI = 0 (fully damage) and TI = 1 (100%
integrity) with the threshold between these outcomes determined by the unstable xed point
a. If TI falls below a it is unable to repair and falls to zero. We set a = 0:1, therefore if
tissue integrity falls below 10% it is unable to recover. Adding the depletion of TI when
it meets a radical,  krttRAD TI to this growth term, we have the TI equation, equation
(3.16).
dTI
dt
= ktgTI(1  TI
T1
)(TI   a)  krttRAD TI (3.16)
dRAD
dt
=  rRAD + krtrRAD TI + knarfin(N) (3.17)
+knatrN
TI + krntpNP TI + krtmpMP TI
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In this model, all damage to tissue is assumed to be caused via radicals, which are pro-
duced in four ways. The presence of activated neutrophils in the tissue causes tissue damage
that releases radicals (knatrNTI). Tissue is also damaged as both activated macrophages
and neutrophils eliminate pathogen producing radicals (krntpNP TI and krtmpMP TI).
Radicals are also released by activated neutrophils (knarfin(N)). Radicals cause further
damage to the tissue increasing their own levels, krtrRAD TI. These terms all appear in
the radical equation, equation (3.17). The rst term in this equation is the intrinsic decay
of RAD. Only the term knarfin(N) is inhibited, since it is a cell function of the N and
IL-10 inhibits all cell functions of macrophages and neutrophils. All other damage terms
are not the result of cell function, but rather population size and therefore they are not
inhibited. Radical production is not dependent on the level of the activated macrophages
since in healthy tissue they are present in the tissue in resting state. Once produced, radicals
cause depletion of TI, krttRAD TI in equation 3.16. Radicals also activate macrophages in
the tissue and neutrophils in the blood once they have di¤used. The terms associated with
these actions occur in the nal form of the equations for M , M, Nb, and Nb , equations
(3.23), (3.24), (3.33), and (3.34).
3.2.4 Di¤usion
During an immune response the endothelial layer of the tissue changes its permeability allow-
ing cells, pathogen, and molecules to di¤use more e¢ ciently. These changes are dependent
on levels of TNF and the accumulation of tissue damage. In order to model this, we create a
variable for inammation of the tissue layer, Z. This variable is needed since di¤usion cannot
be directly dependent on TNF and/or TI. Changes in permeability have a longer half-life
than the immune mediators TNF and the repair rate of TI. Therefore, we developed the Z
variable such that its growth is dependent on the level of TNF and 1 TI and set its decay
to be less than the decay of TNF and the rate of tissue repair, z < t and z < ktg. The
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Z equation is given by equation (3.18).
dZ
dt
= (ktzf(TNF; xtz; htz) + kzti(1  TI))(1  Z)  zZ (3.18)
dn(Z) = dbn(1 + dfnZ) (3.19)
dmol(Z) = dbmol(1 + dfmolZ) (3.20)
dp(Z) = dbp(1 + dfpZ) (3.21)
Di¤usion is then modeled for activated neutrophils, molecules, and pathogen with the
functions, (3.19), (3.20), and (3.21), respectively. Each of these functions has the form
dx(Z) = dbx(1+dfxZ). The parameter dbx is baseline di¤usion of x in the absence of inam-
mation and dfxZ is the facilitation of di¤usion during inammation. Activated neutrophils
di¤use into tissue by a process called migration. They roll along the surface of the tissue,
only entering inamed tissue. To model this, we set dbn to be very small with large dfn: Small
molecules, radicals, TNF, and IL-10 readily di¤use in the absence of inammation. There-
fore, changes in endothelial cells do not increase molecules di¤usion as much as neutrophil
di¤usion. Accordingly, dbmol; the baseline di¤usion of molecules, is large with small dfmol
relative to dbmol. Individual pathogens are larger than molecules, so we also set dbp < dbmol.
When modeling di¤usion, we also accounted for the formation of pathogen colonies and
the compartment volumes. Pathogen within the tissue forms colonies at high concentrations.
Therefore, the di¤usion is dependent on the surface area of the population. The surface area
is not the only determining factor. Other constraints limit the di¤usion such that it is less
than that corresponding to surface area alone. To capture this dependence of pathogen
di¤usion from tissue to blood on the surface area of P , we dene a function for the rate at
which P di¤uses from the tissue, dpt(P ) = atP 2=3=(1+ btP 1=3). We derive this function form
by assuming that the volume of the colony formed is proportional to the concentration of the
pathogen , P: Hence, the radius and the surface area of the colony are proportional to P 1=3
and P 2=3; respectively. This determined the numerator of dpt(P ); atP 2=3. To capture other
constraints on di¤usion we divided this by (1 + btP 1=3): The exponent 1/3 on the bottom
is chosen so that in the limit as P ! 1; dpt(P ) < P 2=3. Due to the ow of blood these
pathogen colonies do not occur as easily in the blood. Therefore we assume the rate of
di¤usion from blood to tissue is linearly dependent on PB and modeled with dpb(Pb) = abPb.
43
Additionally, we need to account for the volumes of each compartment. First, let us focus
on the simplest case, the passive di¤usion of molecules. Parameters are dened such that
dmol(Z)([X]b  [X]) is the rate at which molecules of X di¤use. Note that, this is dependent
on the di¤erence in concentration, but it denes the exchange of molecules. Therefore,
when this term has to be divided by the volume of the compartment we get the change
in concentration for that compartment. For example, dmol(Z)(IL10b   IL10)=VT is the
di¤usion term for IL-10 that appears in the IL10 equation with VT denoting tissue volume.
This method is used to derive the di¤usion terms for radicals, TNF, and IL-10, see the
equation and parameter section, Section 4.6.1.
Neutrophils di¤use via migration, therefore the rate of di¤usion is not dependent on
the di¤erence in concentration. Instead it is dependent on the concentration of the blood
neutrophils available for migration. Hence, the di¤usion term in the blood takes the form
 dn(Z)Nb =VB with VB equal to blood volume, and dn(Z)Nb =VT in the tissue. These terms
occur in the Nb and N
 equations, (3.34) and (3.25). Once the neutrophils enter the tissue,
they are capable of eliminating pathogen. As in the blood, they are destroyed during this
process. So, the elimination terms for P and N have the same form in the blood and tissue,
see equations (3.25) and (3.22).
Above we saw that rate of pathogen di¤usion from the blood is determined by dpb(Pb)
and its di¤usion from the tissue by dpt(P ): Therefore, the actual terms for pathogen di¤usion
are of the form, dp(Z)(dpb(Pb) dpt(P ))=Vx, with Vx = VB or VT . These terms appear in the
equations of P and Pb, equations (3.22) and (3.32).
3.2.5 Decay of Inhibition
IL-10 dynamics are essential in eliminating the immune response after the pathogens are
eliminated. They are solely produced by macrophages. However, IL-10 is elevated until
after macrophages are eliminated. If the decay rates of IL-10 in the tissue and the blood
are simply modeled as  iIL10 and  ibIL10b as in equations (3.10) and (3.15) and we
assume the documented decay rates for IL-10, IL10 returns to zero before M does. When
this occurs, the low levels of damage produced during a macrophage response are able to
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sustain theM population, since inhibition has dropped. In order to model IL10 correctly we
assume that the decay rate of IL10 is a function of IL10, such that high IL10 corresponds to
a minimal decay rate. We replace  imax with  imax+(imax-imin)il10hi=(xhii + il10hi) =
 imax + (imax   imin)f(IL10; xi; hi) to get Equation (3.27). The same type is used for
IL10b, giving the equation (3.36).
3.2.6 Equations and Parameters
Here we summarize the equations and parameters for the full blood/tissue compartment
model.
Tissue Equations:
dP
dt
= kpgP (1  P
p1
)  sbkpbP
b+kbpP
  kpmfi(M)f(P; xmp; hmp) (3.22)
 kpnfin(N)f(P; xnp; hnp) + dp(Z)dpb(Pb)  dpt(P )
VT
dM
dt
=  mM   kmtcellfi(M)f(TNF; xt; ht) (3.23)
 kmrcellfi(M)RAD   kmpfi(M)f(P; xmp; hmp) + sm
dM
dt
=  mM + kmtcellfi(M)f(TNF; xt; ht) (3.24)
+kmrcellfi(M)RAD + kmpfi(M)f(P; xmp; hmp)
dN
dt
=  nN   (1  r)kpncellfin(N)f(P; xnp; hnp) +
dn(Z)N

b
VT
(3.25)
dTNF
dt
=  tTNF   kmtmolfi(M)f(TNF; xt; ht) (3.26)
+kmatfit(f(M
; xmt; hmt)) +
dmol(Z)(TNFB   TNF )
VT
dIL10
dt
= ( imax + (imax   imin)f(IL10; xi; hi))IL10 + kmaifi(M) (3.27)
+
dmol(Z)(IL10b   IL10)
VT
+ kmaifi(f(M
; xmi; hmi))
dRAD
dt
=  rRAD + krtrRAD TI + knarfin(N) + knatrNTI (3.28)
+krntpN
P TI + krtmpMP TI +
dmol(Z)(RADb  RAD)
VT
(3.29)
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dTI
dt
= ktgTI(1  TI
T1
)(TI   a)  krttRAD TI (3.30)
dZ
dt
= ktz(f(TNF; xtz; htz) + kzti(1  TI))(1  Z)  zZ (3.31)
Blood Equations:
dPb
dt
= kpbgPb(1  P
pb1
)  sbbkpbbPb
bb+kbbpPb
  kpnbfib(Nb )f(Pb; xnpb; hnpb) (3.32)
+dp(Z)
dpt(P )  dpb(P )
VB
dNb
dt
=  nbNb   kntcellfib(Nb)f(TNFb; xtb; htb) (3.33)
 knpbcellfib(Nb)f(Pb; xnpb; hnpb)
 knrbfib(Nb)RADb + snb + ksnbf(cNb + dN; xsnb; hsnb)
dNb
dt
=  nbNb + kntcellfib(Nb)f(TNFb; xtb; htb) (3.34)
+knpbfib(Nb)f(Pb; xnpb; hnpb) + knrbfib(Nb)RADb
 (1  rb)kpncellfib(Nb )f(Pb; xnpb; hnpb) 
dn(Z)N

b
VB
dTNFb
dt
=  tbTNFb   kntmolfib(Nb)f(TNFb; xtb; htb) (3.35)
 dmol(Z)(TNF   TNFB)
VB
dIL10b
dt
= ( ibmax + (ibmax   ibmin)f(IL10B; xi; hi))IL10B (3.36)
+
dmol(Z)(IL10  IL10b)
VB
dRADb
dt
=  rbRADb + knarbfinb(Nb ) +
dmol(Z)(RAD  RADb)
VB
(3.37)
Hill Function:
f(v; xv; hv) =
vh
vh + xhv
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Name Value Description
kpb; kpbb 0:461=B units hr Rate at which the non-specic local response in
tissue (B)/blood (BB) eliminate pathogen in the
tissue (P ) and blood (PB)
kbp 0:0001=P units/ hr Rate at which B is exhausted by P
kbbp 0:02=P units/ hr Rate at which BB is exhausted by PB
sb, sbb 0:0075B units/hr Source of B and BB
b; bb 0:0023=hr Decay rate for the B and BB
kpg Various The growth rate of P=PB
p1=pb1 20; 00 P units Maximum P=PB population
kpm 2.8 P units/hr/M units Rate at which activated macrophages (M) elim-
inate P
kmp 40/hr Rate at which pathogen activates of resting phago-
cytes (M) by P
xmp=xmp 20 P units Determines level of P needed to bring elimination
of P byM and activation ofM to half their max-
imums
hmp 3 Hill coe¤ecient for the elimination and activation
terms containing P .
Table 5: Table of parameters for the compartmental model
Inhibition Functions:
fi(x) = x
0B@ (1  ci)
1 +

il10
il101
hi + ci
1CA fit (x) = x
0B@ (1  cit)
1 +

il10
il10t1
hit + cit
1CA
fin(x) = x
0B@ (1  cin)
1 +

il10
il10n1
hin + cin
1CA finb(x) = x (1  cinb)
1 +
 
il10b
il10nb1
hinb + cinb
!
Di¤usion Functions:
dn(Z) = dbn(1 + dfnZ) dpt(P ) =
atP
2=3
1 + btP 1=3
dmol(Z) = dbmol(1 + dfmolZ) dpb(Pb) = abPb
dp(Z) = dbp(1 + dfpZ)
Parameter values are presented in the Tables 5-12.
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Name Value Description
sm, snb 10 /M units/hr Source of M and resting blood neutrophils (NB)
m; nb 0:12/hr Decay rate of M and NB
m, n, nb 0:05/hr Decay rate of activated macrophages M
and acti-
vated neutrophils N in the blood and tissue
kmtcell 20=hr Rate at which TNF (TNF ) activates M
kmtmol 5P units/M -units hr Rate at which TNF is consumed during the acti-
vation of M
xt 20 P units Determines level of TNF needed to bring activa-
tion by M by TNF to half its maximum
ht 2 Hill coe¤ecient for the activation of M by TNF .
kmrcell 0.01/RAD-units/hr Rate at which radicals (RAD) activate M
Table 6: Table of parameters for the compartmental model continued
Name Value Description
kpn 5:8=hr Rate at N eliminates pathogen (P )
kpncell 5=hr Rate at N is destroyed when it eliminates
pathogen (P )
r 0:98 Population of the N that survives the elimination
of P
xnp 1500 P units Determines level of P needed to bring elimination
of P by N to half its maximum
hnp 3 Hill coe¤ecient for the elimination term byN con-
taining P .
t=tb 1:8=hr Decay rate for TNF and TNFB
kmat 3; 000 P units/hr Rate of TNF production by M
xmt 80 M units Determines level ofM needed to bring TNF pro-
duction to half its maximum
hmt 2 Hill coe¤ecient for the producttion term of TNF
by M
imax=ibmax 0:34/hr Maximum decay rate for IL10 and IL10B
imin=ibmin 0:005/hr Minimum decay rate for IL10 and IL10B
kmai 1; 000 P units/hr Rate of IL10 production by M
xmi 140 M units Determines level ofM needed to bring IL10 pro-
duction to half its maximum
hmi 2 Hill coe¤ecient for the production term by
TNF by M
xi 8 P units Determines level of IL10=IL10B needed to cause
its decay rate to decrease to half its maximum
hi 2 Hill coe¤ecient for the production term by
TNF by M
Table 7: Table of parameters for the compartmental model continued.
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Name Value Description
r=r 4/hr Decay rate for RAD and RADB
krtr 0:1/hr Rate at which RAD is produced when RAD is in
the tissue
knar=knarb 0:01RAD units/Nunits/hr Rate at which RAD=RADB is released by N=NB
knatr RAD units/Nunits/hr Rate at which RAD is produced when N is in
the tissue causing damage
krntp 0:2 RAD units/Nunits/hr/P units Rate at which RAD is produced when N elimi-
nates P is in the tissue
krtmp 1 10 5RAD units/Nunits/hr/P units Rate at which RAD is produced when M elimi-
nates P is in the tissue
ktg 2/hr Repair rate of the tissue intergrity(TI)
T1 1 TI maximum, corresponds to 100% intergrity
a 0:1 Below TI = a, tissue is unable to repair itself.
krtt 0:01=RADunits=hr Rate at which RAD deplete TI
ktz 0:5=hr Rate at which TNF and tissue damage (1   TI)
cause inammation (Z)
xtz 20 P units Determines level of TNF needed to bring produc-
tion of Z by TNF to half its maximum
htz 2 Hill coe¤ecient for the production term of Z by
TNF
kzti 0:1 Relative e¤ectiveness of TNF versus tissue dam-
age in producing Z
z 0:01=hr Decay rate of Z
Table 8: Table of parameters for the compartmental model continued.
Name Value Description
kpnb 0:04=hr Rate at NB eliminates pathogen (PB)
kpnbcell 5=hr Rate at NB is destroyed when it eliminates pathogen
(PB)
rb 0:98 Population of the NB that survives the elimintaion of
PB
xnpb 0.1 P units Determines level of PB needed to bring activation of
NB and P elimination by NB to half their maximums
hnpb 1 Hill coe¤ecient for the blood pathogen elimination
term by NB
kntcell 2/hr Rate at which TNFB activates NB
kntmol 0.8 P units/M units/hr Rate at which TNFB is consumed during the activa-
tion of NB
Table 9: Table of parameters for the compartmental model continued
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Name Value Description
xtb 2 P units Determines level of TNFB needed to bring activa-
tion by NB by TNFB to half its maximum
htb 2 Hill coe¤ecient for the activation of NB by TNFB
knrb 0.1/RAD units//hr Rate at which radicals (RAD) activate NB
ksnb 3 N -units/hr Rate at which the source of NB increases
c 1 E¤ectiveness of N and increasing the source of rest-
ing neutrophils (snb)
d 1 E¤ectiveness of NB and increasing the snb of N
xsnb 200 N-units Determines level of N + NB needed to bring in-
creases in snb to half their maximum
hsnb 2 Hill coe¤ecient for the production term of Z by TNF
Table 10: Table of parameters for the compartmental model continued.
Name Value Description
ci 0:05 Maximum inhibition level of fi, inhibition of
macrophage functions
cit 110 6 Maximum inhibition level of fit;inhibiton of TNF
production
cin 0:15 Maximum inhibition level of fin; inhibiton of tis-
suse neutophils
cinb 0.15 Maximum inhibition level of finb;inhibtion of
blood neutrophils
hi 3 Hill coe¤ecient for fi
hit 5 Hill coe¤ecient for fit
hin 1 Hill coe¤ecient for fin
hinb 1 Hill coe¤ecient for finb
il101 200 il10-units Determines level of IL10 needed to bring
macrophage inhibtion to half its maximum
il10t1 60 il10-units Determines level of IL10 needed to bring the in-
hibition of TNF production
il10n1 80 il10-units Determines level of IL10 needed to bring tissue
neutrophils inhibition to half its maximum
il10nb1 80 il10b-units Determines level of IL10B needed to bring blood
neutrophils inhibition to half its maximum
Table 11: Table of parameters for the compartmental model continued.
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Name Value Description
dbn 0.005 L/hr Baseline di¤usion of neutrophils
dfn 50 E¤ectiveness of Z in increasing neutrophil
di¤usion
dbp 1 Baseline di¤usion of pathogen
dfp 1 E¤ectiveness of Z in increasing pathogen
di¤usion
dbmol 10 L/hr Baseline di¤usion of molecules (RAD,
TNF , and IL10)
dfmol 1 E¤ectiveness of Z in increasing molecule
di¤usion
at 50 L/hr/(P units) 1=3 Constant in the numerator of dpt
bt 0.8 (P units) 1=3 Constant in the denominator dpt
ab 2000/hr Rate of pathogen di¤usion in the dpb
Table 12: Table of parameters for the compartmental model continued
3.2.7 Multiple Tissues
When linking two tissues to a single blood unit, we assumed the same structure for all
equations in both tissues. The blood equations are unchanged other than the di¤usion and
the source of resting neutrophil terms. Di¤usion terms have the same structure, but now
account for di¤usion in and out of both tissues. For example, dmol(Z)(IL10   IL10b)=VB,
the di¤usion of IL-10 as it appears in the IL10b equation, is replaced with dmol1(Z1)(IL101 
IL10B)=VB + dmol1(Z2)(IL102  IL10B)=VB, when we are considering two tissues connected
to the same blood supply. Note that the variable, function, and parameter names contain
a 1 or 2 to denote the tissue unit they are from. We are considering each tissue unit to
represent an organ, so we will refer to the tissue units as organ 1 and organ 2.
The source of Nb is dependent on the total activated neutrophils. So in the linked form of
the model this term becomes snb + ksnbf(cNb + dN
; xsnb; hsnb). Initially, all parameters are
assumed to be the same for each organ and their values are given in Tables 5-12. Di¤erences
in the organs will be introduced via the baseline di¤usion parameters, dbp and dbn and via the
source of macrophages, sm. We focus on the di¤usion and resting macrophages, because these
are known to di¤er from organ to organ and have signicant roles in curing inammation.
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3.3 RESULTS
3.3.1 Single Organ
The single organ has three outcomes, health, aseptic and septic death. Health corresponds
to a xed point with all immune components equal to zero except TI = 1 (tissue integrity is
100%), M = sm
m
and Nb =
snb
nb
. Health is stable for kpg < 1:5. Note that kpg is the pathogen
growth rate. Aseptic death is a xed point for all kpg with tissue integrity equal to zero
(TI = 0), inammation high (Z 6= 0) and all other variables recovering to their healthy state
values. Pathogen has been eliminated, but the damage accumulated during the elimination
of pathogen has destroyed the tissue. Septic death is a xed point with tissue integrity zero,
resting cells depleted and all other variables elevated including inammation and pathogen.
In septic death the immune system is unable to eliminate pathogen and it remains activated
due to the presence of pathogen. Septic death becomes stable at kpg  0:425. Therefore,
the model is bistable for kpg < 0:425; between health and aseptic death, and tristable for
0:425 < kpg < 1:5. We set kpg = 0:6 for all of the simulation in this section.
Figure 15: Transients of the tissue immune components from a single unit during a healthy outcome.
This insult was triggered by setting initial tissue pathogen to 100 and all other varibales are at background
level. Macrophages are the only phagocytes activated during this insult (neutrophil activation was turned
o¤). kpg is set to 0.6/hr.
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3.3.1.1 Without neutrophils: We will initially explore the results of the tissue com-
partment and then add the blood compartment. However, we will not completely isolate the
tissue. Di¤usion is active, but neutrophils activation is turned o¤. Figure 15 shows a healthy
outcome under these conditions. Note that macrophages reside in the tissue while resting,
so tissue damage is not caused by their presence in the cell. Therefore, the only change
in tissue integrity is caused the by-products of the macrophage and pathogen interactions.
In this simulation there is low pathogen concentration, so we have minimal tissue damage.
Also in this simulation, IL10 decays to zero after activated macrophages (M) do, due to
the concentration dependent decay rate of IL10. TNF is produced initially, but inhibition
of the macrophages by IL10 eliminates this production. Therefore, the TNF population
drops well before the activated macrophage population.
Figure 16: Transients of the tissue immune components from a single unit during a death outcome. This
insult was triggered by setting initial tissue pathogen to 500 and all other varibales are at background level.
Macrophages are the only phagocytes activated during this insult (neutrophil activation was turned o¤). kpg
is set to 0.6/hr.
During a lethal insult the macrophage population is overwhelmed by the pathogen con-
centration yielding a state similar to septic death, see Figure 16. This insult was triggered by
setting initial pathogen in the tissue to 500. This is not really septic death because TI 6= 0.
Tissue integrity is not zero, because damage is minimal in the absence of neutrophils. In this
simulation, activation by pathogen consumes the resting macrophage population. The TNF
transient is very similar to the nonlethal simulation, since it is dependent on early levels
of macrophages, which are similar in both the lethal and nonlethal cases. Inammation is
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the same in both cases, since it is dependent on TNF and TI. TI changes are minimal
during the lethal insult and TNF is same in both scenarios, therefore inammation is nearly
unchanged from the healthy outcome.
3.3.1.2 With neutrophils: When including the neutrophil population, the insult of an
initial tissue pathogen of 500 is survivable, see Figure 17. Tissue integrity is compromised
more than in the macrophage only immune response, but it is able to repair itself. Also,
IL10 does not recover until after neutrophils have reached background levels as is the case
with macrophages.
Figure 17: Transients for a healthy outcome in the single unit compartmental model. The insult was
triggered by initially setting tissue pathogen to 500 and all other varibales are at background level. kpg is
set to 0.6/hr.
Aseptic death occurs when the insult is increased, see Figure 18. This simulation was
run with initial tissue pathogen set to 850. Any initial pathogen level less than 842 results
in health, between 842 and 1061 results in aseptic death and above 1061 results in septic
death. During the aseptic outcome in Figure 18, inammation does not recover due to the
depletion of TI. Here, tissue damage is driven by the krntpNP TI term. High initial levels
of pathogen as neutrophils become activated cause tissue damage to drop below the threshold
for tissue repair.
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Figure 18: Transients for an aseptic outcome in the single unit compartmental model. The insult was
triggered by initially setting tissue pathogen to 850 and all other varibales are at background level. kpg is
set to 0.6/hr.
In Figure 19 we see the transients for a septic outcome triggered by an initial tissue
pathogen of 1200. High pathogen within the tissue corresponds to high pathogen in the
blood, but at signicantly lower levels,  0:73. This is true for all simulations shown here.
This huge di¤erence is due to the fact that di¤usion of tissue pathogen is dependent on
surface area and the relative sizes of the tissue and blood compartments .
Neutrophil levels in Figure 19 are signicantly lower than those in Figure 18. This is be-
cause of the consumption of neutrophils as pathogen is eliminated term,  (1 r)kpncellfin(N)
f(P; xnp; hnp) in equation 3.25. In the aseptic case, pathogen is eliminated early on and
once they are absent neutrophils are able to reach higher levels, since this term is zero.
In the septic case pathogen is elevated throughout this term in nonzero lower the level of
neutrophils. Despite the lower neutrophil levels, tissue damage is still driven by the term
krntpN
P TI as in the aseptic case. This term contributes throughout the response in the
septic case. Therefore, TI = 0 occurs more quickly in the septic case, because of the higher
initial pathogen and the elevated pathogen levels throughout.
These outcomes can be reached by insults via blood pathogen at drastically lower levels.
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Figure 19: Transients for a septic outcome in the single unit compartmental model. The insult was
triggered by initially setting tissue pathogen to 1200 and all other variables are at background level. kpg is
set to 0.6/hr.
An insult of PB0 = 8:49 will cause aseptic death. Due to the large constant for di¤usion into
the tissue, there is an immediate loss of blood pathogen. Blood pathogen drop drastically
to their typical levels during insults via the tissue pathogen. An insult of PB0 = 10:72 will
result in septic death. After the quick initial drop in blood pathogen, transients for all insults
are similar to those seen during an insult triggered by tissue pathogen.
3.3.1.3 Summary: This single unit models the immune response within one organ. The
local tissue macrophage population can eliminate low pathogen insults. They trigger neu-
trophil activation and neutrophils enter the tissue. However, there is minimal damage, since
the macrophages have eliminated the pathogen present. Neutrophil elimination of pathogen
causes more radical production than neutrophil inux. If the local macrophages are over-
whelmed, there is a range of initial tissue pathogen for which neutrophils can eliminate
pathogen while causing repairable tissue damage. However, at larger initial pathogen, neu-
trophils inux combined with pathogen elimination can produce enough radicals to fully
damage the organ even when the pathogen is eliminated, which is the case in aseptic death.
The immune response can also be overwhelmed. Pathogen is not eliminated and immune
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components are elevated and cause the organ to fail, the case of septic death.
3.3.2 Multiple units
Linking two organs (tissue units) to the same blood supply, we look at the spread of inam-
mation as it would be seen during MODS. Di¤erences in organs are evident in function and
structure. Therefore, we alter parameters to explore how these di¤erence a¤ect the spread
of infection and inammation. We rst consider linking two identical and then linking two
organs, where one has altered di¤usion of pathogen and neutrophils. We also consider two
linked organs, where one has an increased source of resting macrophages.
Figure 20: Thresholds for death in the single organ and for two identical organs linked to the same blood
supply. A. A plot of the onset of aspetic and septic death versus initial pathogen load for a single organ, two
identical organs with the initial tissue pathogen introduced into only one organ (P0 in 1), and two organs
with the initial pathogen evenly distributed between the two organs (P0-even). B. Tissue integrity during
insults to the two organ systems. The tissue pathogen is introduced in only one organ near the threshold
for the onset of aseptic death in the rst, but not the second organ. C. Tissue pathogen transients when
pathogen introduced in one organ. The black curve results in both organs septic, the blue dashed curve
results in both organ aseptic, and the red curve results in rst organ aseptic and second healthy.
3.3.2.1 Identical organs: Linking two identical organs and initiating the insult via the
tissue pathogen in one organ, we see that the threshold for both aseptic and septic death
is increased compared to a single unit, see gure 20A. Distribution of the pathogen and
inammation increase the survival of the system. When the insult is introduced into one
of the two organs, there is a range of initial tissue pathogen, where the organ that received
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the insult is aseptic, but the other organ is healthy, see Figure 20A. Figure 20B shows the
transients near the onset of aseptic death in one organ. There is more tissue damage in organ
1, even when both organs result in health (black curves). This is true for both the more and
less di¤usive cases. As the initial tissue pathogen load in organ 1 (P10) is increased, tissue
1 integrity (TI1) drops below the level at which it can repair itself (TI = 0:10), before the
tissue 2 integrity (TI2) falls this low, therefore aseptic death occurs rst in organ 1. Further
increases in P10 will cause TI2 to fall below 0.10 and both organs will be aseptic. Therefore,
we have captured the spread of inammation even when the pathogen is eliminated.
In Figure 20C, we have plotted tissue pathogen within organ 1 (P1) for scenarios were
the initial pathogen load is introduced into a single organ. With P10 = 1150, pathogen is
eliminated in both organs, but organ 1 has TI1 = 0. An insult of P10 = 1410 leads to aseptic
death in both organs. This insult is close to the threshold for the onset of septic death.
The pathogen population can grow signicantly, but is eventually eliminated by the immune
response. P10 = 1450 leads to septic death in both organs. There is no range for P10 were
organ 1 or 2 is septic while the other is aseptic. When both organs are septic, both P1 and
P2 increase to nearly 18000 and then drop to their values at septic death, which is 14317 for
both organs.
Distributing the initial pathogen between both organs further increases the initial tissue
pathogen load survivable by the two organ system. In Figure 20A the upper line is the
thresholds for aseptic and septic death versus P0, where P0 has been evenly distributed
between both organs, P10 = P20 and P0 = P10 + P20. Though the entire system is surviving
a higher P0, when death outcomes occur, each individual organ is dying at a lower initial
tissue pathogen than what is survivable by a single unit.
In Figure 21, we look at the cause of this increased sensitivity in the individual organs.
We compare the transients for tissue pathogen, neutrophils and radicals from an insult of
650 P units to a single unit (blue dashed curves) and 650 in each organ (black curves), which
corresponds to P0=1300. For the multiple organ simulation, there is only one curve, because
results match for both organs, since they are identical with the same initial conditions. More
radicals accumulate in tissue during an insult to the two organ system than to the single
organ. These high levels of radicals are due to the radical production terms, krntp1N1P1 TI1
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Figure 21: Comparsion of transients from a single organ and multiple organ system with the initial tissue
pathogen load evenly distributed. Transients are plotted for tissue pathogen, neutrophils, and radicals for
the single (blue dashed) and multiple organs (black) models. Additionally, tissue radicals are plotted with
krntp2 = 0 and krntp2 = 0 (red curve). krntp1 = krntp2 = 0 eliminates the production of radicals during
the elimination of pathogen by neutrophils in both organs. The multiple organ curves (black) represent the
level in both organs. Results match for both organs, since the organs are identical with the same initial
conditions.
and krntp2N2P2 TI2, which account for the radicals produced when neutrophils ght pathogen
within the tissue. Pathogen does not grow within the tissue during the insult to the two
organ system, but is nonzero for nearly 12 hours, where as pathogen is eliminated within six
hours after the insult in the single organ. Pathogen is high in the tissue, since less pathogen
di¤uses from two organs into one blood compartment. This causes the neutrophil population
to not reach as high of levels as those seen in the single unit overall, since neutrophils are
eliminated during the elimination of pathogen. However, while pathogen is nonzero, we have
similar levels of radicals and neutrophils for both the multiple and single organ transients.
Once P drops to zero, krntpNP TI is zero, and less radicals are produced. We see that
this term is the main contributor by plotting the radical levels in the two organ system
with krntp1N1P1 TI1 = 0 and krntp2N

2P2 TI2 = 0 (see the red curve in Figure 21). Having
more signicant damage when pathogen is present has been seen experimentally. Neutrophil
inux was found to be less harmful in the absence of infection. TNF promotes inammation
without signicant injury to the muscle [56].
The septic death threshold of each individual unit is lower than in the single organ,
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because septic death is determined by the neutrophil population. The local macrophage
population is already overwhelmed before the thresholds of aseptic death are reached. Both
organs are calling on the same blood supply of neutrophils and therefore exhausting it at
lower levels in the individual, but with sum greater than the level seen in the individual
organ.
3.3.2.2 Altered neutrophil and pathogen di¤usion: We continue to look at the
spread of inammation by looking at two non-identical organs linked to the same blood
supply. First, we explore changes in the di¤usive properties. One organs parameters remain
as seen in Tables 5-12. For the other we either increase or decrease the permeability of
the tissue to pathogen and neutrophils. Molecule di¤usion is not altered. For the less
di¤usive case we set dbp2 = dbp=20 and dbn2 = dbn=20 and for the more di¤usive case we set
dbp2 = 1:5dbp and dbn2 = 1:5dbn. More signicant increases cause septic death to become
unstable with the single unit. This minimal change causes septic death to lose stability in
the multiple organ case. However, there is a signicant change in transients for su¢ ciently
high pathogen (after the both aseptic threshold). Where these this signicant change in the
transients occurs is referred to as the both "aseptic" threshold In Figure 22, we compare
transients which result in the various death outcomes. Above the both "aseptic" threshold
transients seem to be going to septic death, but then there is a sudden drop of pathogen to
zero. So, even though they technically are aseptic during the early relevant hours of disease
the appear to be septic. Therefore, we compare this threshold to the septic threshold.
Single organ: Comparing changes in di¤usive properties on a single unit, Figure 23A,
we see that there is no aseptic death in the less di¤usive case. Neutrophils are not as e¤ective
at eliminating disease, since they cannot enter the tissue. Therefore, septic death occurs well
before the initial pathogen load is high enough to cause signicant tissue damage via the
krntpN
P TI term. Signicant levels of radicals are not produced until pathogen is at levels
only seen in septic death. Therefore, TI = 0 only when septic death occurs. Neutrophils,
however, accumulate more in the tissue when the tissue is more di¤usive. Therefore, the onset
for aseptic death is earlier for the more di¤usive organ. Increasing the baseline di¤usion pulls
this onset of aseptic death even lower. Onset of septic death is at a much higher P0 due to
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Figure 22: Tissue pathogen transients from the two organ model for the Both Septic, Both Aseptic and
"Both Aseptic" outcomes. Insults to the identical organs system were introduced by setting initial tissue
pathogen in one organ to 1400 and 1500 resulting in Both Aseptic and Both Septic, respectively. The more
di¤usive system consists of one normal organ, which has parameter values from Table 1, and a second organ
with set dbp = 1:5dbp, dbn = 1:5dbn; and all other paremeter values unaltered. Insults were caused by setting
initial tissue pathogen in the normal organ at 1500 and resulting in Both Aseptic and Both "Aseptic",
respectively.
the high tissue neutrophils inux allowing more e¤ective elimination of pathogen.
Two organ system: In Figure 23B we see the e¤ect of linking organs were the second
organ is either less di¤usive, the same, or more di¤usive than the rst organ. In this gure
the tissue pathogen insult is introduced into the rst organ, the normal organ. The less
di¤usive case only improves the thresholds for aseptic death slightly compared to the single
normal organ in Figure 23A. Compared to the two identical organs, the less di¤usive organ
causes signicant decreases in the thresholds for the onset of death. During an insult to the
identical case, there is a more signicant exchange of pathogen into the second organ. Also,
neutrophils are able to di¤use more freely into the second organ to ght the pathogen that
di¤uses into it. This causes a higher threshold than they are in the less di¤usive case, were
pathogen cannot di¤use as freely. Limited di¤usion into the second organ causes high levels
in the normal organ that the immune response is not able to eliminate.
With the more di¤usive second organ inammation can spread causing death in the
second organ, but not the rst. As in the single unit, increased permeability allows pathogen
and neutrophils to di¤use easily into the second organ causing more tissue damage than in
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Figure 23: Thresholds for aseptic and septic death in the single and two organ system with various
di¤usion constants. A. A plot of the onset of aspetic and septic death versus initial pathogen load for
a single organ with decreased di¤usion, dbp = dbp=20 and dbn = dbn=20, normal di¤usion, and increased
di¤usion, dbp = 1:5dbp and dbn = 1:5dbn. B. Two organs linked to the same blood supply with the second
organ less di¤usive, normal, and more di¤usive. The parameter values for these organs match those of the
single organ with comparable di¤usion from A. Initial tissue pathogen was introduced into the reference
organ.
the rst organ. Therefore, the second organ has a lower aseptic death threshold than the
rst, even though the insult was introduced via the rst organ. This is an example of the
lethal inammation in the non-insulted second organ when the insulted organ recovers. This
is a common phenomenon in organ failure. MODS typically begins with loss of pulmonary
function [42], even when trauma or infection is not introduced into the lung.
In the more di¤usive case, both organs go aseptic before both organs go aseptic in
the identical case. This is due to higher total tissue neutrophils, which cause more tissue
damage. Higher overall neutrophils allow for better elimination of pathogen and therefore
both "aseptic" occurs at a higher level than both septic in the identical organ case.
In Figure24 we still are considering a two organ system with one normal organ and the
other organ either more or less di¤usive. However, for these simulations, we have introduced
the insult in the altered organ. In the less di¤usive case the threshold for septic death is
nearly the same as for a less di¤usive single organ, see Figures 23A and 24. Also as in the
single tissue there is no aseptic death. The thresholds for the two system is determined by
the less di¤usive organ, since exchange of neutrophils and pathogen is limited.
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Figure 24: Thresholds for aseptic and septic death in the two organ system with various di¤usion
constants and initial pathogen in either the second organ or both organs. A. A plot of the onset of aspetic
and septic death versus initial pathogen load for a two organs with decreased di¤usion, dbp = dbp=20 and
dbn = dbn=20, normal di¤usion, and increased di¤usion, dbp = 1:5dbp and dbn = 1:5dbn. The initial tissue
pathogen insult was introduced to the organ with altered di¤usion. B. Two organs linked to the same blood
supply with the second organ less di¤usive, normal and more di¤usive. The parameter vaules for these organs
match those of from A. Initial tissue pathogen was evenly distributed between both organs.
When we insult the more di¤usive organ, as in the normal case, the more di¤usive organ
goes aseptic before the normal organ. However, this it is not surprising, since the insult was
initiated in this organ. Again, increased neutrophils in the overall system bu¤ers against the
onset of septic death, so both "aseptic" occurs at a higher initial tissue pathogen than both
septic.
In Figure 24B we distributed P0 in both organs evenly. As in the identical case, overall
more P0 is survived when distributed than when it is introduced to either the normal or
altered organs. This holds true for both the more and less di¤usive case. However, in all
cases, individual units die at lower insults than in they were not linked. This is due to less
di¤usion of pathogen, since two organs are feeding into the same blood supply. This is causing
increased production of radicals during the elimination of pathogen, since pathogen remains
nonzero longer. The septic threshold occurs when the blood neutrophils are overwhelmed.
It occurs at same level of inammation in the single and two organ system, since both have
the same blood dynamics. Therefore, the slight increases in the septic death threshold for
the two organ system are due to the local macrophages. Two local macrophage populations
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contribute to the removal of pathogen, so higher initial pathogen is needed to reach the level
of inammation in the blood that will overwhelm the system. These increases are limited
by the levels that overwhelm the local macrophages.
3.3.2.3 Altered Source of Macrophages The local macrophages play a large role
in determining the thresholds for death. Changes in di¤usion only a¤ect the neutrophil
population. Therefore, we also introduced heterogeneity in organs by increasing the source
of resting tissue marcophages. This allows us to look at the e¤ect of changing the local
immune response on overall dynamics. We set sm = 2sm, which increases the background
level of resting macrophage in addition to supplying more resting macrophages during the
insult.
Single organ: In Figure 25A, we look at thresholds for a single organ that is normal,
more di¤usive, and has an increased macrophage source. Also, included is the threshold for
the onset of death when the source of macrophages is increased and neutrophils dynamics
removed. This threshold is signicantly increased compared to the corresponding threshold
with a normal sm level. Here, it is at 960 and with normal source it is only 486. Note that
it is labeled with "septic" because unlike actual septic death this outcome has minimal loss
of tissue integrity because of the absence of neutrophils.
The increased ability of the local immune system enables higher thresholds for both
aseptic and septic death, Figure 25A. Increasing macrophages does not increase damage.
Therefore, the onset of aseptic death is at higher P0 compared to the normal case. Protection
against inammation via high tissue macrophages levels is seen in the liver. The liver has
high levels of tissue macrophages and acts as the rst line of defense for many insults entering
via the gut [55]. Yet, it is rarely becomes inamed.
The onset of aseptic death in the increased sm case is actually above the onset of septic
death in the normal organ. The main cause of radical production is via neutrophil elimination
of pathogen when N and P are nonzero, since macrophages are eliminating more pathogen
this term is contributing less, avoiding TI = 0 until higher P0.
Two organ system: In Figure 25B, we compare linked organs, where the rst organ
is normal and the second is either normal or has increased sm. Introducing the insult into
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Figure 25: Thresholds for aseptic and septic death in the single and two organ system with the second
organ normal, more di¤usive or with increased macrophage source. A. A plot of the onset of aseptic and
septic death versus initial pathogen load for a single organ with increased macrophage source (sm = 2sm)
and neutrophil activation turned o¤, normal source and di¤usion, increased di¤usion (dbp = 1:5dbp and
dbn = 1:5dbn) and increased macrophage source (sm = 2sm). B. Two organs linked to the same blood supply
with the second normal or increased sm. The parameter vaules for these organs match those of the single
organ with comparable di¤usion from A. Initial tissue pathogen was introduced into the normal organ (in
1st), altered organ (in 2nd), and evenly distributed to both (in both).
the normal (rst) organ or altered (second) we see an increase in the survival of the system.
When the insult is the normal organ the threshold for aseptic death is increased past the
onset of aseptic death in both, but not past the onset of septic death. However, insulting the
organ with increased macrophages does push the onset of aseptic death past the threshold
for both septic in the normal case. Increased elimination of pathogen when the pathogen in
introduced to the high macrophage tissue avoids tissue damage, bu¤ering against the onset
of aseptic death. This e¤ect continues to drive the late onset of aseptic death when the insult
is distributed evenly between both organs.
3.3.2.4 Summary In Figure 26, we compare the parameter changes that were most
e¤ective at increasing survival, increasing the source of resting macrophages and di¤usion
of pathogen and neutrophils. Overall, increasing macrophages is the most e¤ective means
to increase survival. A more di¤usive second organ allows more inux of neutrophils and
pathogen increasing tissue damage. Therefore, this two organ system is more sensitive than
if the second organ has an increased source of macrophages. Also, in the more di¤usive case,
there is a range of P0; where when P0 is introduced into the normal organ, the normal organ
survives and aseptic death occurs in the more di¤usive organ. Therefore, even though the
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overall system is less sensitive the more di¤usive organ itself is more susceptible to the spread
of infection. This is not the case for increased macrophages. The system and the organ are
both more resist to inammation.
Figure 26: Thresholds for aseptic and septic death in the two organ system with the second organ normal,
more di¤usive or with increased macrophage source. The onset of aspetic and septic death is ploted versus
initial pathogen load for two organ systems where the second is normal, has increased di¤usion, dbp = 1:5dbp
or dbn = 1:5dbn, and increased macrophage source (sm = 2sm). Initial tissue pathogen (P0) was introduced
into the normal organ (in 1st), altered organ (in 2nd), and evenly distributed to both (in both).
Insults can also be triggered in this multiple organ model also by altering the initial level
of blood pathogen. Insults via the blood pathogen are similar to results shown here. The
more di¤usive organ goes aseptic rst. Therefore, if di¤usion of the second organ is decreased,
the normal organ becomes aseptic rst and if the second organ has increased di¤usion, it
will become aseptic rst. With an increase in the source of macrophages the normal organ
becomes aseptic rst. These outcomes are due the term modeling damaged cause during
the elimination of pathogen by neutrophils in the tissue. It is greater in the more di¤usive
organs therefore, they become aseptic rst. In the increased macrophage case, macrophages
eliminate more pathogen than in the normal organ and therefore this term contributes less
to the production of damage.
Code which simulates the single organ and two organ system is in Appendix C.
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3.4 DISCUSSION
We have derived a compartmental model of the acute immune response within an organ. It
expands upon the previous reduced model in Chapter 2, Reynolds et al., to include dynamics
both in the tissue and blood [58]. As in the reduced model, we have outcomes corresponding
to health, aseptic death and septic death. However, we have included TNF and IL-10 as
variables and t their transients to heuristic data. TNF is produced in the initial stages of
inammation and IL-10 is elevated after the activated macrophage population has returned
to rest.
The model was developed starting from the tissue and then expanded to included di¤usion
and neutrophil activation within the blood. Terms were added as needed to properly capture
the known biological dynamics. Complexity was minimized, since the model was to be
linked with itself to model organ communication. Having more variables and parameters
makes understanding the overall behavior of the system less intuitive. Another motivation
for minimizing complexity was to implement this compartmental immune system in our
pulmonary lung model, presented in the follow chapter.
Once the single organ model was developed and analyzed, we linked two organs together
to look at the spread of inammation. MODS is characterized by the spread of inam-
mation causing sequential organ failure. Therefore, understanding the spread of infection
and inammation is a rst step in developing ways to stop the progression of MODS. We
used the linked organ model to look at parameter changes that alter di¤usion and the local
macrophage population.
Di¤erences in di¤usion alter the outcomes of the system. More di¤usive organs allow
for more inux of neutrophils and therefore protect against the onset of septic death. The
damage cause by neutrophils in their elimination of pathogen increases the likelihood of
aseptic death. Less di¤usive organs can avoid aseptic death, but are highly susceptible
to septic death. This is because neutrophils cannot inltrate and therefore do not cause
tissue damage, but they also do not eliminate the pathogen. Linking a normal organ to a
less di¤usive organ increases the sensitivity of the whole system. Linking to an organ with
increased di¤usion overall protects the system, but the more di¤usive organ itself is more
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sensitive to aseptic death.
Changing the local macrophage population by altering their source increases levels of
resting macrophage at the onset and throughout the inammatory response, protecting the
tissue. Linking a normal organ to an organ with increased macrophages protects the system
from all forms of death. We have seen that the main driver of tissue damage is the elimination
of neutrophils by pathogen. This terms e¤ects are increased by changes in di¤usion because
it alters the levels of pathogen and neutrophils. It is reduced by the increases in macrophages,
since macrophages eliminates more pathogen Therefore, even though neutrophil levels rise
there is less damage due to lower pathogen levels.
This model gives us the means to explore many aspects of the spread of inammation.
Linking it with our pulmonary model we can look the spread of inammation to the lung.
The lung is typically the rst organ to fail during MODS. Linking our full lung model and our
two compartmental organ, we can explore what aspects of the lung make it more susceptible
to inammation. Also, we have included specic cytokines in order to have variables that
correspond available data. For example, we have included IL-10 rather than simply anti-
inammatories. Therefore, we can further calibrate this model with data. As in the reduced
model we can look at the e¤ect of altering the anti-inammation. However, here we will be
altering IL-10, therefore experimentally testing of our hypotheses is more realistic than when
using the reduced model. Once we have a greater understanding of acute inammation, the
model can used to explore means by which to hinder its spread.
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4.0 PULMONARY GAS EXCHANGE UNDER INFLAMMATORY STRESS
4.1 INTRODUCTION
There is substantial literature on mathematical models of gas exchange, that has focused
on di¤erent aspects of the process of gas transfer and distribution between ambient air and
blood, including distribution of ventilation, transport between alveolar air space and pul-
monary capillaries, red blood cell rheology, hemoglobin dynamics and acid-base physiology
[7]. These models span di¤erent anatomical scales and have generally been useful to study
airow distribution, deposition of particulate drugs in airways, and determine the severity
of shunting within the lung.
New imaging techniques ([47], [69]) and cell-type identication tools ([52]) are providing
a unique opportunity to construct and calibrate increasingly complex and realistic models
that integrate the large body of existing knowledge with these newer data and provide
modeling tools with signicant translational impact into the understanding, and modication
of, human disease. In the realm of critical care medicine, acute lung injury (ALI) is an
inammatory process that can be triggered by chemical, infectious or traumatic stimuli. ALI
typically requires mechanical ventilatory support and is the most frequent manifestation of
multisystem organ dysfunction, which is the leading cause of death in the ICU ([62]). ALI
also has long-term consequences for those who survive the acute phase. Substantial public
and corporate resources are devoted to prevent and treat ALI. There are also good animal
models of ALI ([20]) and its pathophysiology is increasingly well understood.
To our knowledge, existing modeling e¤orts have not attempted to describe the progres-
sion of ALI following a local or systemic inammatory stimulus. We therefore describe such
an attempt, where the direct e¤ects of inammatory mediators on lung tissue are modeled,
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with their impact on lung volumes, lung water content and gas exchange ability. This is
the rst step in constructing a truly multiscale representation of gas exchange under inam-
matory stress, with an explicit representation of the time evolution of ventilation-perfusion
inequalities under such conditions.
4.2 METHODS
4.2.1 Overview
In order to explore changes in lung function during an infection we modeled gas exchange and
the inammatory response within a small portion of the lung. We consider the local dynamics
on a respiratory unit (RU), which consists of 25 alveoli and the capillaries surrounding them
([27]). We constructed a model of gas exchange within RU consisting of partial di¤erential
equations for oxygen, oxyhemoglobin, carbon dioxide, and bicarbonate. A RU consists of
three compartments, the alveolar air space, lung tissue and capillary blood. There are
variables expressing the partial pressure of oxygen (PO2) and carbon dioxide (PCO2) in
all three compartments, while oxyhemoglobin (Hb4) and bicarbonate (HCO 3 ) are only
in the blood. We model the following biological processes: di¤usion of oxygen and carbon
dioxide, hemoglobin uptake of oxygen, and enzymatic reactions governing carbon dioxide and
bicarbonate levels. We assume di¤usion occurs across two distinct barriers within the RU,
the blood/tissue and tissue/alveolar air space barriers. Tidal breathing regulates alveolar gas
pressures of oxygen and carbon dioxide within the alveolar space. Following the development
of a model of the gas exchange subsystem, we incorporate a response to an inammatory
stimulus, the inammation subsystem, leading to the development of ALI. This additional
subsystem consists of equations for neutrophils and tumor necrosis factor (TNF), a canonical
pro-inammatory cytokine, in both the blood and tissue compartment. Figure 27 illustrates
the interactions included within the single RU.
The RU is modeled as a one-dimensional spatial domain along the length of the capillary.
Therefore, variables for the partial pressure of oxygen and carbon dioxide in the blood and
tissue and the concentration of saturated hemoglobin in the blood all vary in time and
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Figure 27: Interactions included within the single RU model. Resting and activated neutrophils are
represented by N0 and NA, respectively.
space. We assume alveolar air space to be well mixed. Under this assumption, variables in
this compartment are functions of time only. Space along the compartment is modeled as N
units of equal length and variables are modeled on each unit. Therefore, the variable names
are oxygen/carbon dioxide in blood on unit i, GBi/CBi, in the tissue on unit i, GTi=CTi,
and in the alveolar air space, GA/CA with i = 1; ::N . For our simulation we have set
N = 20. Oxyhemoglobin and bicarbonate on unit i, are Hb4i and HCO 3i, respectively.
After developing the gas exchange subsystem, we will derive the immune variables based on
their known interactions and e¤ects on gas exchange.
4.2.2 Di¤usion
Di¤usion, the exchange of molecules and cells across both the alveolar air space/tissue and
tissue/blood barriers, is the only form of interaction between the compartments. Previous
models for gas exchange depict di¤usion as movement from the alveolar space to the blood
across a tissue barrier ([7], [28], [36]). However, we consider lung tissue as a compartment,
not merely a barrier. We have chosen this approach to better reect the impact of tissue
volume changes caused by inammation on gas exchange between air and blood. In order
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to properly model the e¤ects of inammation, we derive terms for di¤usion driven by PO2
and PCO2 gradients across each barrier, tissue/blood and air/tissue.
Gas di¤usion across the tissue/blood barrier is described in equations (4.1)-(4.3). Model
parameters are described in Tables 13-19. The Gj parameters scale partial pressure to molar
concentration, for example, [O2]j = Gj PO2 = 
G
j Gj in compartment j. The parameters
expressing di¤usion rates from compartments j to k are of the form DGjk. The volumes of
each compartment, blood, tissue, and alveolar air space, are represented by VB0, VT0, and
VA0, respectively. Note that, DGTB(GTi  GBi)=N expresses the number of oxygen molecules
di¤using from tissue to blood per second on the ith unit of space. Division of this type of
term by the compartmental volume in that space unit, for example VB0/N; and  on a given
compartment yields the change in partial pressure in that compartment due to di¤usion on
a given space unit along the capillary.
Di¤usion across the tissue/air barrier is more complex because the alveolar air space
compartment is assumed to be well mixed while the tissue compartment is not. As in the
above derivation, DGTA(GTi GA)=N is the number of molecules that will di¤use from air to
tissue per second on each unit of space. In the tissue compartment this term is multiplied by
negative one and divided by VT0
N
and GT . This then simplies to the second term of equation
(4.2). For the air equation, equation (4.3), one sums over all units to account for exchange
with each unit of the tissue and then divides by VA0.
dGBi
dt
=
DGTB(GTi  GBi)
GBVB0
(4.1)
dGTi
dt
=
DGTB(GBi  GTi)
GT VT0
+
DGTA(GA  GTi)
GT VT0
(4.2)
dGA
dt
=
DGTA
GAVA0N
NX
i=1
(GTi  GA) (4.3)
4.2.3 Blood/O2
As blood traverses the capillary through a RU, oxygen di¤uses into the blood and reacts with
hemoglobin in the blood. Rather than accounting for the full dynamics of all four oxygen
binding sites on hemoglobin tetramers, we consider hemoglobin as being either partially
saturated (Hbm) or fully saturated (Hb4), where m is a Hill factor derived empirically from
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the oxyhemoglobin dissociation curve ([36]). We refer to Hbm as unsaturated hemoglobin.
Oxygen binds to Hbm to form Hb4 at the rate k+ and it detaches at the rate k  from Hb4,
to return to Hbm. The reaction between unsaturated and saturated hemoglobin and oxygen
is modeled by equations (4.4)-(4.6).
dHbm
dt
=  k+HbmGmB + k Hb4 (4.4)
dHb4
dt
= k+HbmG
m
B   k Hb4 (4.5)
dGB
dt
=
DGTB(GT  GB)
GBVB0
+m
 k+HbmGmB + k Hb4
GB
(4.6)
Total concentration hemoglobin, THb, is conserved. Thus, Hbm can be replaced with
THb Hb4. Therefore, equations (4.4)-(4.6) reduce to equations (4.7) and 4.8, with ddtTHb = 0.
dHb4
dt
= k+(THb  Hb4)GmB   k Hb4 (4.7)
dGB
dt
=
DGTB(GT  GB)
GBVB0
+m
 k+(THb  Hb4)GmB + k Hb4
GB
(4.8)
The temporal dynamics are much faster than the spatial dynamics. We therefore assume
quasi steady state for the saturated hemoglobin to determine parameter values. This is
necessary to develop an equation for percent saturation of hemoglobin that is dependent on
GB only. Percent saturation of hemoglobin is an increasing sigmoid function of the partial
pressure of oxygen. Using the data for this curve we nd thatm = 3:6 andRH = k
 
k+
= 177916
[30]. Incorporating ow of these molecules in the blood and the di¤usion terms described
earlier yields equations (4.9)-(4.10). Speed of blood (cm/s) is represented by v0. This
subsystem now includes both the spatial and temporal dynamics for O2 in the blood.
@Hb4
@t
= k+(THb  Hb4)GmB   k Hb4   v0
@Hb4
@x
(4.9)
@GB
@t
=
DGTB(GT  GB)
GBVB0
+m
 k+(THb  Hb4)GmB + k Hb4
GB
  v0@GB
@x
(4.10)
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4.2.4 Blood/CO2
As dissolved CO2 and bicarbonate traverse the RU, bicarbonate releases CO2 into the blood
stream. This occurs by a catalyzed enzymatic reaction in which bicarbonate is the substrate.
The reverse reaction is of the same type, however, with CO2 as the substrate [10]. These
reactions are modeled by the rst two terms of Equation (4.11)-(4.12).
These terms are Michaelis-Menten type where the kcat parameters represent the maxi-
mum rate of the catalytic reaction and km is the Michaelis constant, the level of the substrate
for which the reaction occurs at half kcat. CB is the PCO2, hence the substrate in terms
of the equation variables is CBCB, the concentration of CO2. Finally, we incorporate blood
ow and di¤usion between tissue and blood in this subsystem as done previously for O2 in
the blood. Therefore, the CO2/bicarbonate subsystem in the blood including temporal and
spatial dynamics is described by equations (4.11) and (4.11).
@HCO 3
@t
= kcatCB
CBCB
kmCB + CBCB
  kcatHC HCO
 
3
kmHC +HCO
 
3
  v0 @
@x
HCO 3 (4.11)
@CB
@t
=
1
CB

kcatHC
HCO 3
kmHC +HCO
 
3
  kcatCB 
C
BCB
kmCB + CBCB

  v0 @
@x
CB (4.12)
4.2.5 Tissue/O2 & CO2
Within tissue, the only additional interaction modeled is the di¤usion of gas molecules,
expressed by the reaction-di¤usion equations (4.13)-(4.14).
@GT
@t
=
DGTB(GB  GT )
GT VT0
+
DGTA(GA  GT )
GT VT0
 DGT @
2GT
@x2
(4.13)
@CT
@t
=
DCTB(CB   CTi)
CT VT0
+
DCTA(CA   CT )
GT VT0
 DCTr2i
@2CT
@x2
(4.14)
4.2.6 Air/O2 & CO2
An average healthy human breathes about 15 times a minute with an inhalation:expiration
time ratio of 1:3. We assumed a total tidal breath of 500 ml, with 150 ml of dead space
ventilation, yielding an e¤ective alveolar ventilation of 350 ml per breath, with residual total
alveolar volume at the end of expiration 2300 ml [27]. This corresponds to an inux of
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2.92x10 5 ml of new gas per RU per breath, termed VC0, and an end expiration (residual)
volume of 1.92x10 4 ml per RU (VAmin0). In order to develop equations for the changes in
partial pressures of O2 and CO2 in alveolar gas, we rst derive equations for the change in
alveolar volume on a RU, equations (4.15)-(4.17).
sh(t) =
1
1 + e (tin mod(t;tin+tout))
(4.15)
dy
dt
=
VC0sh(t)
 1
  y
 2
(4.16)
VA0(y) = VAmin 0 + y (4.17)
The variable y in equation (4.16) is a measure of the alveolar volume change. During
inspiration there is growth in y and it decays during expiration. In order to model the increase
and decrease in y we use a smoothed Heaviside function, sh(t): This function appears in the
growth term and is approximately one during inspiration and zero during expiration, see
equation (4.15). The length of inspiration is tin = 1 second and length of expiration is
tout = 3 seconds. The parameter, ; controls the abruptness of the functions switch from
one to zero. For our calculation we set  to 20. Increasing this would increase the abruptness
of the change. The s are chosen such that in tin seconds y reaches VC0 and decays to zero
in tout seconds. Therefore, the equation of alveolar air volume, equation (4.17), is VAmin0 at
end of expiration and VAmin0 + VC0 at the end of inspiration.
We are now ready to model the change in alveolar air space partial pressures of O2 and
CO2. We will refer to the partial pressure of the O2 and CO2 in the air as Gair and Cair;
respectively. Under normal conditionsGair is 150 mmHg and Cair is 0 mmHg [27]. In order to
properly model the changes in partial pressure, we track the changes in number of molecules
and convert to a partial pressure change as we did with di¤usion between compartments. The
number of oxygen molecules in the alveolar space is the concentration of O2 times the volume
in the alveolar space, VA0[O2]. During inspiration the change in number of molecules due to
breathing, not di¤usion, is from the intake of external air. Therefore, we set the derivative
of number of O2 molecules in the alveolar air space equal to the derivative of to the number
of molecules in the inspired air, which results in the equation:
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ddt
(VA0(y)[O2]) =
d
dt
(y[O2]air):
We applied the product rule to both sides of this equation to get:
VA0(y)
d
dt
[O2] +
d
dt
(VA0(y))[O2] =

d
dt
y

[O2]air + y
d
dt
[O2]air:
We assumed that there is no change in outside air concentration and solved for d
dt
[O2]; which
resulted in:
d
dt
[O2] =
 
d
dt
y

[O2]air   ddt(VA0(y))[O2]
VA0(y)
:
Taking the derivative of equation (4.17) we see that d
dt
VA0(y) =
d
dt
y. Therefore the above
equation simplies to:
d
dt
[O2] =
 
d
dt
y

([O2]air   [O2])
VA0(y)
:
Letting R = 1
VA0(y)
d
dt
y through by A we derive for the partial pressure for oxygen in the
alveolar air space:
d
dt
GA = (Gair(t) GA)R: (4.18)
During expiration we assume that the air within the RU is well mixed; therefore all
expired air has the same concentration. With this assumption there is no change in concen-
tration and therefore pressure during expiration. Including di¤usion, we model changes in
alveolar PO2 during breathing by equation (4.19). The equation for CO2 has the same form.
dGA
dt
=
DGTA
GAVA0
NX
i=1
(GTi  GA) +

Inspiration (Gair(t) GA)R
Expiration 0

(4.19)
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4.2.7 Immune subsystem
We use a simple model of the inammatory response which includes TNF and neutrophils ([1],
[53]). TNF activates circulating neutrophils in the blood. Once activated, neutrophils can
di¤use into the tissue via migration. Migration or tra¢ cking is the process where neutrophils
di¤use into tissue which has elevated levels of inammatory factors. These inammatory
factors cause a transformation of the tissue layer such that activated circulating neutrophils
adhere to the tissue and di¤use locally.
Since we are considering a simple immune response that does not include macrophages
or a damage variables, we created a positive feedback loop in the pro-inammatory response
by having activated neutrophils in both the blood and tissue produce TNF. We made this
assumption despite the fact that TNF production is mostly due to macrophages in order to
keep this immune subsystem as simple as possible. This pro-inammatory feedback exist in
our compartmental model, but it is via the variable RAD.
In this immune subsystem model TNF di¤uses between the tissue and blood barrier by
passive di¤usion. Inammation is a function of many factors not included in this model
which sustain inammatory e¤ects even after the levels of TNF and activated neutrophils
have dropped. Therefore we incorporate into our model a di¤erential equation which tracks
the overall level of inammation. The growth of inammation is dependent on TNF levels.
However, it decays at a slower rate than TNF.
We model these biological interactions with equations (4.20)-(4.24). This subsystem
consists of equations for TNF in the blood, TNFB, and activated neutrophils on each unit
of the blood, NABi, and for both TNF and activated neutrophils on each unit of the tissue
compartment, TNFi and NAi. Note that unlike other variables in this subsystem TNFB is
not a function of space, since it is well mixed in the blood. The inammation variable is a
function of space and time. It is a measure of the local tissue inammation and is represented
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by Zi.
dTNFB
dt
=  
TB
TNFB   N0TNF
2
B
1 + "TNF 2B
+
NX
i=1
rp(Zi)(TNFi   TNFB)
NVB0
(4.20)
+
NX
i=1
NABi
dNABi
dt
=  NBNABi +
N0TNF
2
B
1 + "TNF 2B
  rv(Zi)N

Bi
VB0
  v0riNABi (4.21)
dTNFi
dt
=  
T
TNFi +
rp(Zi)(TNFB   TNFi)
VT0
+ NAi +DTr2iTNFi (4.22)
dNAi
dt
=  NNAi +
rv(Zi)NABi
VT0
  ri(NAiriTNFi) (4.23)
dZi
dt
=  zZi +
kzg(TNFi + TNFB)
2
k2tz + (TNFi + TNFB)
2
(1  Zi) (4.24)
Where rp(x) = mpx+ b
rv(x) =
xq
kq + xq
The rst term of all equations models decay of the variable. The second terms of equa-
tions (4.20) and (4.21) model the activation of resting neutrophils by TNF in the blood. This
reaction is modeled by a Hill type equation with a Hill coe¢ cient of two. This nonlinearity
models the need for multiple TNF molecules to activate a neutrophil. A similar term appears
as the second term of the TNFB equation because TNF is consumed during this process.
The third term in equations (4.20)-(4.21) and the second terms of equations (4.22)-(4.23)
model di¤usion. These terms do not have the same form because the mechanisms by which
neutrophils and TNF di¤use during an infection are di¤erent. Neutrophils di¤use by mi-
gration and this is dependent on local inammation. Once inammation has accumulated
locally there are signicant changes in activated neutrophil di¤usion, however these e¤ects
saturate for higher levels of inammation, hence there is a maximum rate for the di¤usion of
neutrophils. Due to these properties of neutrophil di¤usion we model this with a Hill type
function, rv(Zi). Note that resting neutrophils are assumed not to di¤use; therefore, there
is no activation of neutrophils within the tissue. Also, once an activated neutrophil di¤uses
into to the tissue we assume that it does not di¤use back into the blood. TNF di¤usion
is increased during an infection because tissue becomes more porous to all small molecules.
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We take this dependence to be linear and is model with the function rp(Zi). Di¤usion for
both TNF and activated neutrophils are modeled as with the gas molecules with the rv(Zi)
or rp(Zi) taking the role of the di¤usion constant.
The nal term in equation (4.20) is the production of TNF from activated neutrophils.
This sum is an numerical estimate for the integral 
R L
0
NABi(x; t)dx. This integral accounts
for TNF produced by the activated neutrophils throughout the blood compartment. We
denote the length of the capillary with L. The nal term of equation (4.21) is ow of
neutrophils in the blood. The nal term of the equation (4.23), represents chemotaxis of
tissue neutrophils towards TNF. The nal two terms of the tissue TNF equation, equation
(4.22), are production from neutrophils and di¤usion of TNF within the tissue compartment.
We model the local inammation with equation (4.24), which consists of two terms,
growth and decay. The growth of inammation is dependent on the local and blood TNF. We
model this dependence using a Hill type function. This nonlinearity is used since there must
be substantial levels of TNF in the tissue to trigger inammatory changes and the growth
rate of inammation saturates. The decay term depends on the level of inammation. Note
that the inammation variable has a maximum value of 1, which corresponds to tissue being
severely inamed.
4.2.8 Full single RU model: E¤ects of inammation on gas exchange.
During an inammatory response there is swelling of the tissue layer. The tissue swells into
both the alveolar air space and capillary space. Additionally, inammation decreases the tidal
volume inspired during a breath cycle and increases blood velocity such that constant ow is
maintained. In our model we take into account these volume changes and the e¤ects on VC0
and v0. To do this we replace, VB0, VT0, VAmin0 and v0 with VB, VT , VAmin, and v respectively.
VB, VT , and VAmin are functions of the average of the local inammation variables, Zi. VB
is a sigmoidal function that decreases as Zi increases and has maximum VB0, equation
(4.25). VAmin is a similar shaped function, but with a maximum of VAmin0, and it a tracks
the minimum of the alveolar air space (volume at the end expiration), equation (4.27). As
increases the amount volume lost from the blood and alveolar air space is added to the volume
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of the tissue giving equation (4.26). Note the parameters are set such that mvta > mvtb. This
is due to the fact that it is easier for the tissue volume to expand into the alveolar air space
than into the blood compartment. As the tissue volume increases this causes a decrease in
the lungs ability to increase its volume during inspiration (decrease of VC) and we model
this by Equation 4.28. The velocity of blood is determined by v = v0 = VB0VB , in order to
maintain constant blood ow during an infection.
VB(Zi) =
VB0
1 +mvtbZi
(4.25)
VT (Zi) = VT0 + VB0   VB0
1 +mvtbZi
+ VAmin0   VAmin0
1 +mvtaZi
(4.26)
VAmin (Zi) =
VAmin0
1 +mvtaZi
(4.27)
Vc(Zi) =
Vc0
1 +mvtcZi
(4.28)
Taking into account these changes due to inammation, we have the nal form of our
model, Equations 4.29-4.42. Note that, we have not included feedback from the breathing
subsystem onto the immune subsystem. Therefore, the immune subsystem can be simulated
separately. Its output is then used as input to the gas exchange subsystem.
4.2.9 Equations and Parameters
Blood Equations
dGBi
dt
=
DGTB(GTi  GBi)
GBVB(Zi)
+m
 k+(THb  Hb4i)GmBi + k Hb4i
GB
(4.29)
 v(Zi)riGBi
dHb4i
dt
= k+(THb  Hb4i)GmBi   k Hb4i   v(Zi)riHb4i (4.30)
With k  = RHk+
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dCBi
dt
=
DCTB(CTi   CBi)
CBVB(Zi)
  v(Zi)riCB (4.31)
+
1
CB

kcatHC
HCO 3i
kmHC +HCO
 
3i
  kcatCB 
C
BCBi
kmCB + CBCBi

dHCO 3i
dt
= kcatCBi
CBCBi
kmCB + CBCBi
  kcatHC HCO
 
3i
kmHC +HCO
 
3i
(4.32)
 v(Zi)riHCO 3i
dTNFB
dt
=  
TB
TNFB   N0TNF
2
B
1 + "TNF 2B
+
NX
i=1
rp(Zi)(TNFi   TNFB)
NVB(Zi)
(4.33)
+
NX
i=1
NBi
dNABi
dt
=  NBNABi +
N0TNF
2
B
1 + "TNF 2B
  rv(Zi)NABi
VB(Zi)
  v(Zi)riNABi (4.34)
VB(Zi) =
VB0
1 +mvtbZi
v(Zi) = v0
VB0
VB(Zi)
Tissue Equation
dGTi
dt
=
DGTB(GBi  GTi)
GT VT (Zi)
+
DGTA(GA  GTi)
GT VT (Zi)
 D
GT
r2iGTi (4.35)
dCTi
dt
=
DCTB(CBi   CTi)
CT VT (Zi)
+
DCTA(CA   CTi)
GT VT (Zi)
 DCTr2iCTi (4.36)
dTNFi
dt
=  
T
TNFi +
rp(Zi)(TNFB   TNFi)
VT (Zi)
+ NAi +DTr2iTNFi (4.37)
dNAi
dt
=  NNAi +
rv(Zi)NABi
VT (Zi)
  ri(NAiriTNFi) (4.38)
dZi
dt
=  zZi +
kzg(TNFi + TNFB)
2
k2tz + (TNFi + TNFB)
2
(1  Zi) (4.39)
VT (Zi) = VT0 + VB0   VB0
1 +mvtbZi
+ VAmin 0   VAmin 0
1 +mvtaZi
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Alveolar Air Space Equations
dGA
dt
=
DGTA
GAVA(y; Zi)N
NX
i=1
(GTi  GA) +

Inspiration (Gair(t) GA)R
Expiration 0

(4.40)
dCA
dt
=
DCTA
CAVT (Zi)N
NX
i=1
(CTi   CA) +

Inspiration (Cair(t)  CA)R
Expiration 0

(4.41)
dy
dt
=
VC0sh(t)
 1
  y
 2
(4.42)
VA(y; Zi) = VAmin (Zi) + y
VAmin (Zi) =
VAmin0
1 +mvtaZi
Vc(Zi) =
Vc0
1 +mvtcZi
sh(t) =
1
1 + e (tin mod (t;tin+tout)
R =
1
VA0(y; Zi)
d
dt
y
Di¤usion Function
rp(x) = mpx+ b
rv(x) =
kqv
kq + xq
Explanations of parameter values are given in the parameter tables, Table 13-19. Most
gas exchange parameters are experimentally well characterized. Remaining parameters were
chosen to reproduce known biological behaviors of model subsystems. Parameterization of
the gas exchange subsystem was such that hemoglobin and oxygen dynamics stabilize in the
rst third of the capillary while bicarbonate and carbon dioxide reactions stabilize in the
rst tenth of the capillary [27]. For the immune subsystem we documented many parameter
values from literature and the remaining were estimated ([18], [58]).
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Param. Value Description Comments
L 0.22 cm Length of RU along the
capillary
Estimated by assuming that an indi-
vidual alveolus diameter is 0.02 cm and
that as the blood traverses the lung it
is in contact with half of the circumfer-
ence of seven alveoli [27].
H L/20=0.011cm Length of each unit of
space along the capillary
We use 20 spatial units in our calcula-
tions
tin 1 second Length of inspiration Total time for breathing cycle is as-
sumed to be 4 seconds, 15 breaths per
minute. The inhalation time is one
forth of the total time.
tout 3 seconds Length of expiration See above comment for tin.
v 0.2932 cm/s Speed of blood We estimated the range for v, 0.01788-
0.4398 cm/sec, by assuming transient
times for blood between 0.5 to 12.3
seconds with the capillary length cal-
culated above. We took 0.75 seconds
to be our transient time under normal
conditions [61].
GB0 40 mmHg Arterial partial pressure
of oxygen
[27]
CB0 45 mmHg Arterial partial pressure
of carbon dioxide
[27]
gair 150 mmHg Partial pressue of oxygen
in the air
[27]
cair 0 mmHg Partial pressue of carbon
dioxide in the air
[27]
Table 13: Table of parameters for the single RU model
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Param. Value Description Comments
iHb4 0.001717 M Arterial concentration of saturated
hemoglobin
Found by tting our oxy-
hemoglobin curve such that
hemoglobin is 50% saturated
at a PO2 of 27 mmHg and
99% saturated at a PO2 of
100 mmHg and assuming
GB0 is 40 mmHg [36].
iHCO 3 0:024M Arterial concentration of bicarbon-
ate
[27]
DGTB 6.7510 12
L/s
Rate constant for the di¤usion of
oxygen between tissue and blood.
DGTA 2.3610 12
L/s
Rate constant for the di¤usion of
oxygen between tissue and air.
DCTB 8.4810 11
L/s
Rate constant for the di¤usion of
carbon dioxide between tissue and
blood.
DCTA 7.63 10 10
L/s
Rate constant for the di¤usion of
carbon dioxide between tissue and
air.
GB = 
G
T 1.24 10 6
M/mmHg
[O2]=GBPO2 in the blood/ [O2]=
GTPO2 in the tissue.
Calculated from the solubil-
ity coe¢ cient for oxygen in
water [27].
GA 5.210 5
M/mmHg
[O2]= GAPO2 in the air Calculated from nRT = PV
Table 14: Table of parameters for the single RU model continued
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Param. Value Description Comments
CB = 
C
T 2.9510 5
M/mmHg
[CO2]=CBPCO2 in the
blood/ [CO2]= CTPCO2 in
the tissue.
CA 5.210 5
M/mmHg
[PO2]= CAPCO2 in the air
Numalv 1.2 107 Number of RUs in the lung. Calculated assuming that there
are 3108 alveoli in the lung
and that each RU consists of 25
alveoli [27].
VB0 90mL/Numalv =
7:5 10 9
Blood volume: blood vol-
ume in the capillaries of
a RU under normal condi-
tions.
There is between 70-140ml of
blood in the lung capillaries.
For our simulations, we assume
under normal condition that the
blood volume is 90ml [36].
VT0 500mL/Numalv =
4:17 10 8
Tissue Volume: tissue vol-
ume in a RU under normal
conditions.
Calculated assuming that there
is 500 ml of tissue in the lung .
VA0 2300mL/Numalv =
1:92 10 7
Minimum of the alveolar air
space: volume of the alveo-
lar air space in a RU at the
end of expiration under nor-
mal conditions.
Calculated assuming that the
minimum volume in the lung is
2300ml [27].
VC0 350mL/Numalv =
2:9 10 8
Tidal volume: the volume
inhaled into a RU during a
breath under normal condi-
tions.
Calculated assuming that the
tidal volume for the whole lung
was 350ml [27].
Table 15: Table of parameters for the single RU model continued
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Param. Value Description Comments
RH =
k =k+
177916 Ratio of the reverse and forward re-
action rates for the saturation of
hemoglobin.
This ratio was found by t-
ting the oxyhemoglobin satura-
tion curve as described for iHB4
[36].
m 3.6 Number of oxygen molecules need to
bind to Hbm to form Hb4.
This parameter was found by
tting the oxyhemoglobin sat-
uration curve as described for
iHB4 [36].
k+ 0.0005/s Rate at which m oxygen molecules
bind to Hbm to form Hb4.
This parameter was chosen to
ensure the hemoglobin and oxy-
gen dynamics stabilize in rst
third of the capillary [27].
THb 0.00224 M Concentration of total hemoglobin,
both Hb4 and Hbm.
Whole blood from contains from
14-16 g/dl of hemoglobin. We
assumed 15g/dl for our calcula-
tions of the total concentration
[27].
kcatCB 1106/s Maximum rate of the enzymatic re-
action with CO2 as the substrate.
Fit such that the carbon dioxide
and bicarbonate dynamics sta-
bilize in the rst tenth of the
capillary ([10],[27])
kmCB 0.013 M Michaelis-Menten Constant, concen-
tration were the reaction occurs at
half the maximum rate, for the enzy-
matic reaction with CO2 as the sub-
strate.
See comment for kcatCB
kcatHC 2.18105/s Maximum rate of the enzymatic re-
action with HCO 3 as the substrate.
See comment for kcatCB
Table 16: Table of parameters for the single RU model continued
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Param. Value Description Comments
kmHC 0.026 M Michaelis-Menten Constant,
concentration were reaction
occurs at half the maximum
rate, for the enzymatic reac-
tion with HCO 3 as the sub-
strate.
See comment for kcatCB
DGT 3.2410 5cm2/s The di¤usion constant for
di¤usion of oxygen within
the tissue.
DCT 0.00065 cm2/s The di¤usion constant for
di¤usion of carbon dioxide
within the tissue.
Di¤usion of carbon dioxide
is 20 times faster than that
of oxygen ([10], [27])
 20 This parameter determines
the rise in sh(t) our ap-
proximation to the Heavi-
side function.
Increasing this parameter
sharpens the rise in sh(t).
 1 0.5/s Time constant for inspira-
tion.
Chosen so that VC0 is in-
haled in tin seconds.
 2 0.7/s Time constant for expira-
tion.
Chosen so that VC0 is ex-
haled in tout seconds.
TB 1.8/s Decay rate of TNF in the
blood.
See comment for kcatCB
 8 /s/TNF units/N units Rate at which TNF are de-
pleted as neutrophils are ac-
tivated.
See comment for kcatCB
Table 17: Table of parameters for the single RU model continued
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Param. Value Description Comments
N0 1.2 N units Amount resting neutrophils avail-
able for activation.
" 1/ (TNF units)2 Determines level at which the acti-
vation term reaches half its maxi-
mum rate.
mp 110 5 Slope of the linear function of z
modeling the change of the di¤usion
rate for TNF.
B 0.001 Y-intercept of the linear function of
z modeling the change in the di¤u-
sion rate for TNF.
 3 TNF units/s/N units Production rate of the TNF from
neutrophils
NB 0.05/s Rate of at which neutrophils are
produced.
Decay of activated
neutrophils is faster
in the blood than in
tissue.
kv 12/s/TNF units Maximum di¤usion rate for acti-
vated neutrophils
k 8 /s/TNF units/N units Determines the level of average in-
ammation at which the rate of
neutrophil activation is half its
maximum.
T 1.8/s Decay rate of TNF in the tissue. TNF in tissue decays
slower than TNF in
the blood.
Table 18: Table of parameters for the single RU model continued
88
Param. Value Description
N 0.05/s Decay rate of neutrophil within the tissue.
 1 cm2=TNF units/s Chemotaxis constant for neutrophils.
z 0.008/s Decay rate of inammation.
kzg 0.1 Z units/s Growth rate of inammation
ktz 2 TNF units Determines level of TNF at which the growth rate
of inammation reaches half its maximum.
mvtb 0.4/z units Determines the e¤ect of inammation on the
swelling of tissue volume into the blood compart-
ment.
mvta 1/z units Determines the e¤ect of inammation on the
swelling of tissue volume into the blood compart-
ment.
closing 10/z units Determines the e¤ect of inammation on the
swelling of tissue volume into the alveolar air space.
T 1.8/s Determines the e¤ect of inammation on the de-
crease of tidal volume.
Table 19: Table of parameters for the single RU model continued
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4.2.10 Full Lung Model
We next linked the output of multiple RUs under various physiological conditions by the
method presented in Figure 28. We assumed that initial compartmental volumes were uni-
form across RUs. Therefore, all blood variable concentrations at the arterial end and initial
compartmental volumes, VT0, VB0, and VAmin 0, are the same on each RU. The insult is as-
sumed to start in the blood via TNF. So, the initial level of TNFB is the same on RUs. We
introduced heterogeneity by ranging ventilation/perfusion ratios from 0.31 to 1.15, following
a truncated normal distribution N~(0.73, 0.4). This was achieved by ranging tidal ventilation
from 150 ml and 550 ml using N~(350 ml, 104 ml2), while holding perfusion constant (480
ml/breath cycle). Ventilation/perfusion ratios refers to the ratio of the change in ventilation
to the change in perfusion. Here we alter this ratio on individual RUs in the full lung model
by altering ventilation.
Figure 28: Model schematics for the linking of multiple RUs to create a full lung model. The rst column
represents entering variable concentrations and partial pressures (orange), initial comparmental and tidal
volumes (blue) and blood speed (red) at the onset of inammation. All of these are the same on all RUs
except for the initial tidal volume, VC0. VC0 of the RUs were determined by a normal truncated distribution.
Simulation are run for the various RUs recording data for both the immune and gas exchange subsystems.
A weighted average dependent on the distribution is taken of the blood variables at the venous end. This
weighted average is used as the intial conditions for an ODE system that model venous end mixing. The
results of this mixing are the output of the full model.
Simulations were run on RU with the local venous partial pressures and concentrations
determined by the local inammation within the RU. Then, at the venous end, mixing of the
blood exiting the RUs is accounted for by the system of ODEs, equations (4.43) and (4.44),
which include the dynamics between hemoglobin and oxygen. Initial conditions for GB are
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calculated by averaging venous blood PO2 level from each RU. Initial Hb4 concentration is
calculated by determining the percent saturation of pooled blood. The system, including
equations (4.45) and (4.46), is simulated to steady state, yielding mixed PO2, PCO2 , HB4
and HCO 3 , the outputs of the multiscale full lung model.
dGB
dt
= m
 k+(THb  Hb4)GmB + k Hb4
GB
(4.43)
dHb4
dt
= k+(THb  Hb4)GmB   k Hb4 (4.44)
dCB
dt
=
1
CB

kcatHC
HCO 3
kmHC +HCO
 
3
  kcatCB 
C
BCB
kmCB + CBCB

(4.45)
dHCO 3
dt
= kcatCB
CBCB
kmCB + CBCB
  kcatHC HCO
 
3
kmHC +HCO
 
3
(4.46)
4.2.11 Implementing Shunting
In severely inamed alveoli, uid accumulates in air space and surfactant production is
compromised, resulting in increased surface tension in the alveolar wall, leading to alveolar
closure. Thus, supply of fresh alveolar air to the tissue is eliminated. In order to model
this e¤ect, the di¤usion rate between the air and tissue compartments is set to zero when
tidal volume falls below 140 ml, with all other dynamics remaining the same. We refer to
this critical value as the alveolar closure threshold. Once this tidal volume falls below this
threshold for the remainder of the simulation there are only interactions between the tissue
and blood compartments. In our modeling of shunting we have not included a recovery
mechanism.
4.3 RESULTS
4.3.1 Gas exchange during tidal breathing
Simulations of equations (4.29)-(4.39) in the absence of inammation models gas exchange
during health and give results similar to those observed experimentally [27]. PO2 in the
blood increases from 40 mmHg at the pulmonary arterial end (GB0) to 101.7 mmHg at the
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pulmonary venous end (GB20) as blood crosses the capillary, which is similar to the levels
seen in the tissue compartment (Figure 29A, B). Hb4 becomes saturated in the rst third of
the capillary, Figure 29C. The oscillations arise in Figure 29(A, B, C) due to varying PO2
levels in the alveolar air space during breathing. PO2 levels in alveolar air space oscillates
between 96.2 and 101.7 mmHg during the four-second breath cycle, see Figure 29D.
Figure 29: Tissue, blood, and air oxygen and saturated hemoglobin levels under normal conditions. A.
PO2 (mmHg) levels in blood. Zero on the X-axis represents the pulmonary arterial end of the capillary, while,
moving right in space, 20 is the pulmonary venous end. Y-axis is time, therefore the columns represent the
capillary PO2 levels in a space unit as time progresses. B. PO2 levels in the tissue with the same orientation.
C. Saturated hemoglobin in the blood with the same orientation.
Blood PCO2 drops from 45 to 40.7 mmHg as the blood transverses the capillary, see
Figure 30A. Enzymatic reactions between Bicarbonate and CO2 stabilize in the rst few
space units (Figure 30C). PCO2 in the alveolar space oscillates between 40.70 and 43.16
mmHg, similar oscillations occur in the tissue, see Figures 30B, D. The oscillations of PCO2
in the tissue occur over the entire length of the tissue unlike those of PO2 in the tissue. This
is due to the higher di¤usion coe¢ cient for carbon dioxide in the tissue. Carbon dioxide
decreases during inspiration, since inspired air has a PCO2 of zero.
4.3.2 The Immune Subsystem
The immune subsystem is bistable between health and sustained inammation. In health,
TNFi, TNFB, NAi, NABi and Zi return to zero in all compartments. For sustained in-
ammation, corresponding to an outcome of death, these variables evolve to a persistently
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Figure 30: Tissue, blood, and air oxygen and saturated hemoglobin levels under normal conditions. A.
PCO2 (mmHg) levels in blood. Zero on the X-axis represents the pulmonary arterial end of the capillary,
while, moving right in space, 20 is the pulmonary venous end. Y-axis is time, therefore the columns represent
the capillary PCO2 levels in a space unit as time progresses. B. PCO2 levels in the tissue with the same
orientation. C. Bicarbonate in the blood with the same orientation.
elevated value. Given an initial dose of TNFB below 2.23 this immune subsystem will resolve
itself to health. Above this level the outcome is death [22]. In our model, inammation can
also be triggered by initializing one of the other immune variables above its threshold for
survival (data not shown).
The dynamics of this subsystem determine the volumes of the compartments and the
tidal volume in the alveolar space during an inammatory response within a RU with nor-
mal initial compartmental volumes. In Figure 31 , we display the e¤ects of inammation
on the compartmental volumes: tissue swelling is accompanied by a corresponding reduc-
tion in other compartmental volumes. Figure 31A illustrates the volumes during an insult
of TNFB(0) = 2 (all other immune variables initially zero). The inammatory response
triggered by this insult resolves to health. Tissue volume is initially 0.5 L and swells to
approximately 0.522 ml before returning to baseline. The alveolar airspace volume at the
end of expiration is initially 2.3 ml and drops to approximately 2.228 L before returning
to baseline. Blood volume was initially 0.090 L and reaches a minimum of 0.088 L before
returning to baseline. The tissue swells mostly into the alveolar air space. The tidal volume
has dynamics similar to those of the blood volume. It starts at 0.35 L and reaches a minimum
of 0.264 L.
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Figure 31: Compartment volumes during insults initiated in the blood. A. Initial levels of TNF in
the blood (TNFB)=2. All variables recover to a healthy outcome levels. Note that in this plot the y-axis
starts are 2.2L and ends at 2.89L, the total initial unscaled lung volume, which corresponds to 2:2L# of alveoli
to 2:89L# of alveoli . B. Initial levels of TNF in the blood (TNFB) = 4. A death state is reached, where immune
variables remain elevated and lung volumes impaired. In this plot the unscaled volumes are plot from 0 to
2.89 L, , which corresponds to 0 to 2:89L# of alveoli .
Following a larger insult (TNFB(0) = 4), the subsystem evolves to death (Figure 31B).
All volumes have the same baseline volumes. Tissue volumes swells to 1.63 L, blood volume
drops to 0.0658 L and alveolar air space at the end at the expiration drops to 1.2 L. Tidal
volume dynamics are again similar to blood volume with minimum of 34.5 L. Velocity of the
blood increases with similar dynamics to those of the tissue volume with a maximum 0.297
cm/s following the survivable challenge, and 0.400 cm/s following the lethal challenge.
4.3.3 Simulations of a Single RU
Combining both the gas exchange and immune subsystems simulates the e¤ects of inam-
mation on gas exchange. During a lethal insult (TNFB(0) = 4) PO2 drops to 43.3 mmHg at
the venous end, hemoglobin no longer saturates in the capillary, and PCO2 also still drops
signicantly to 41.1 mmHg at the venous end. A non-lethal response (TNFB(0) = 2) is ac-
companied by minimal changes in the gas exchange subsystem. Transients for inammation
on single units are shown in Figure 34 and will be discussed in detail in comparison to the
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full lung model.
Figure 32: The e¤ects of lethal inammation on hemoglobin saturation. The bottom curve (blue) is
the percent of the capillary transversed before saturation with hemoglobin is complete. The top curve
(red-dotted) is the percent of the total hemoglobin that is fully saturated Hb4.
In Figure 32 we see the e¤ects of inammation on hemoglobin during a lethal insult in the
absence of shunting. At low PO2 hemoglobin is unable to saturate with O2. This is shown
in the top curve (red-dotted) of Figure 32, which is the percent of total hemoglobin that is
fully saturated, 100 Hb4
THB
, versus time. This curve drops signicantly in the second half of the
insult when the supply of O2 is limited. In the lower curve of Figure 32 we have plotted
the percent of the capillary transversed by the blood before steady state is reached between
O2 and Hb4 versus time. Before PO2 drops below levels at which hemoglobin saturates, the
point of steady state moves further along the capillary. Once there are insu¢ cient levels
O2 for full saturation to occur the point where steady state occur moves back along the
capillary, since the limited O2 is absorbed quickly by hemoglobin.
4.3.4 Full lung model
The time evolution of the distribution of RU volumes N~(350 ml, 104 ml) for a lethal insult
predicts that a signicant proportion of RUs will reach closing volume within 12 hours and
all are below closing volume by 24 hours (Figure 33) The overall structure of the distribution
remains unchanged as the average decreases, but its variance decreases in time. We display
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Figure 33: Distributions of the tidal volume at times 0, 12 and 24 hours. Initially, 500 RUs are normally
distributed with scaled tidal volumes between 150 and 550 ml (mean = 350 ml) (black bars). After 12 hours
the mean scaled volume has dropped to 127 ml (dark gray bars). At 24 hours the mean scaled tidal volume
average is 47 ml (pale grey bars). The dotted vertical line at 140 ml represents the scaled tidal volume below
which shunting is implemented.
predictions of venous PO2 of the full lung, and of transients of single RU (scaled to total
tidal volume) with lower limit (150 ml), mean (350 ml) and upper limit (550 ml) initial tidal
volumes in Figure 34. The full lung transient is always below the transient with initial tidal
volume 350 ml due to mixing of the pulmonary blood in the proximal pulmonary veins, in
accordance to experimental observations [27]. As we wished to evaluate the relative impact
of changes in lung volumes and shunting on gas exchange, we also displayed the prediction
of a model where shunting was not implemented, conrming the major role of shunting in
the rapid deterioration of gas exchange during a lethal inammatory stimulus ([49]).
Code used for implementing the model presented here in Appendix D.
4.4 DISCUSSION
Our model for gas exchange contains an immune subsystem and explicit lung tissue layer.
This model therefore is used to simulate inammation within a respiratory unit and deter-
mine the e¤ect of inammation on the ability for gas exchange to occur. A variety of stimuli
can trigger inammation, including infection and activated neutrophils ([1], [21], [20]). A
96
Figure 34: Transients during a lethal insult of TNF in the blood with and without shunting. The dashed
lines are transient for single RU with minimum scaled tidal volume, 150 ml (gray), normal scaled tidal
volume, 350 ml (dark gray), and maximum scaled tidal volume, 550 ml (black). The black, smooth curve
is the transient for the full lung with the distribution shown in Figure 4 without shunting. The solid dark
gray curve is the transient for full lung with shunting and the same distribution.
mild inammatory stimulus does not result in a signicant change in partial pressure for
either oxygen or carbon dioxide. Larger stimuli lead to a signicant reduction in partial
pressure of oxygen at the pulmonary venous end, and therefore systemic arterial circulation.
This e¤ect is driven by (1) impaired gas di¤usion caused by tissue swelling, (2) closure of
alveoli below a critical respiratory unit volume, and (3) oxygen remixing in the pulmonary
veins.
This model is the rst to incorporate a tissue layer allowing the explicit stimulation of
immune e¤ector cells or molecular mediators. Other mathematical models of the lung have
concentrated on lung mechanics, pulmonary circulation [72], gas exchange with the tissue
layer treated as a barrier ([7], [29], [28]), airway mechanics [39], and drug deposition in the
tracheo-bronchial tree ([77],[37]). With the exception of mycobacterial granuloma formation
modeling ([40], [41]), attempts at mathematical simulation of lung injury have been sparse,
although pulmonary immunity and injury are of immense clinical interest and relevance.
Immune-mediated lung injury has typically only been approached with experimental mod-
els. These experiments include both insults from the blood and those directly introduced
into the lung in the form of lipopolysaccharide instillation, chemical injury, and pathogen
97
deposition ([8], [21]). Although our primary goal was to model pulmonary response to a
systemic challenge, our model could capture these di¤erent modes of local injury, once RUs
are explicitly linked. We have built a road map to achieve this goal. The PDE formulation
of the RU model is computationally intensive to simulate, owing to the spatial description
and the wide range of time-scales involved. Yet, a detailed picture of gas exchange in the
capillary circulation is of limited value to a macroscopic description of the progression of
lung injury. It appears quite possible to derive, at the RU scale, an ODE approximation
with states of partial pressures of both gases in the alveolar air space, tissue, and at the pul-
monary venous end of the capillary. Once the numerical accuracy of this approximation is
conrmed, we will have derived a computationally e¢ cient model that allows multiple RUs
under heterogeneous conditions seen in the lung to be linked using a physiologically reason-
able implementation of di¤usion (simulating extension of a process to neighboring RUs) and
advection (simulating lymphatic transport of bacteria for example).
Our model is limited in a number of ways. Although the characterization of physico-
chemical parameters describing gas exchange is adequate, quantication of parameters char-
acterizing the immune response is di¢ cult. Our model contains only a very rudimentary
representation of innate immunity and should be expanded accordingly for a more realistic
representation of pulmonary immune physiology. Yet, there is a dearth of suitable datasets
to properly estimate these parameters. Such datasets would ideally contain information on
local concentrations of relevant immune mediators, counts of activated immune cells and
relative volume distribution of alveolar air space, capillary blood and lung tissue. We as-
sumed xed boundary conditions for pulmonary arterial gas and acid-base status. Clearly,
a closed loop model that included a metabolic component would be preferable, since, for ex-
ample, decreased oxygen delivery may result in increased extraction and lower input oxygen
partial pressures on the pulmonary arterial boundary. Accordingly, we would expect model
predictions to be more optimistic than observations for extreme hypoxia. We also assumed
an oxyhemoglobin dissociation curve that was independent of blood pH. Both of these sim-
plications could be addressed in extensions of our models. We achieved heterogeneity in
ventilation-perfusion by allowing ventilation to vary, while keeping perfusion constant on
each of the RUs in the full lung model. This resulted in a range of ventilation-perfusion
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ratios with in the full lung model which is typically less than that encountered experimen-
tally ([2], [45], [49]). The likely impact of a wider range of ventilation-perfusion ratios would
be to accelerate the deterioration of gas exchange impairment in mixed pulmonary venous
blood. Interestingly, promising experimental techniques allow less invasive and repetitive
measurement of ventilation-perfusion ratios ([59], [60]), o¤ering exciting new possibilities to
compare prediction of multiscale organ physiology to experimental paradigms of acute lung
injury.
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5.0 REDUCTION OF THE LUNG MODEL
5.1 INTRODUCTION
In the previous chapter, we developed a full lung model in order to model the e¤ect of
inammation on the lung. We developed a single respiratory unit (RU) model, which includes
dynamics within three compartments: the blood, tissue and alveolar air space. Space along
the capillary was included in the tissue and blood compartments due to the uptake of oxygen
and release of carbon dioxide as the blood transverses the capillary. We assumed that the
air space was well mixed. Therefore, the gas exchange subsystem of the model consists of
PDEs for the partial pressure of oxygen (PO2) and carbon dioxide (PCO2) in both the tissue
and blood and ODEs for PO2 and PCO2 in the alveolar air space. These ODEs include a
breathing mechanism, which consists of inspiration for one second during which air volume
increases and expiration for three seconds during which air volume returns to its level at the
beginning of inspiration. In this form the single RU model has excessive computation times.
Therefore, we have developed reduction methods that decrease computation time.
In the discretized form of single respiratory unit (RU) there are numerous equations due
to space along the capillary, equations (5.1) and (5.9). These equations are the gas exchange
subsystem from the previous chapter. To reduce this system, we created a spatial reduction
which eliminated space while retaining the pressure levels at the end of the capillary. It
is necessary to retain these spatial values, since partial pressure levels at the end of the
capillary are needed in determining the output of the full lung model.
We also eliminated the breathing mechanism in order reduce computation times. The
switches between inspiration and expiration require small step sizes, which slows simula-
tions. This mechanism was originally included so that variability in breathing cycle could
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be implemented into the model. At this time, we prefer to use the model to introduce more
accurate ventilation perfusion mismatch. Ventilation perfusion mismatch is an imbalance in
ventilation versus perfusion. This occurs in the lung during health conditions. For exam-
ple, when an individual is standing upright the upper part of the lung has high ventilation
with relatively low blood ow resulting in the ventilation perfusion mismatch [27]. In the
previous chapter, heterogeneity between RUs in the full lung model was due to changes
in ventilation. With the breathing mechanism removed we explore the e¤ects of altering
both ventilation and perfusion (changes in blood volumes). We refer to our model with the
breathing mechanism removed as the non-breathing model.
The equations for the immune system in the lung are not altered by these reductions.
Computation times for the immune subspace are reasonable even when space is included.
Therefore, space is not removed from these equations. There is no feedback from the gas
exchange subsystem to the immune subsystem, so temporal reductions on the gas exchange
subsystem do not a¤ect the immune subsystem.
Once the temporal reduction was applied to the model, we created a closed loop single
RU model in order to more accurately model the lung. We include whole body interaction
that involve the consumption of oxygen and production of carbon dioxide during metabolic
processes. This consumption of oxygen and production of carbon dioxide is not included in
the original or non-breathing form of the RU model. In these forms of the model arterial
(entering the lung) gas levels are xed and set to their levels in the absence of inammation.
Therefore, we have included metabolic reactions to determine the arterial gas levels from the
venous gas levels in the non-breathing model. This forms a closed loop model of the lung,
which we refer to as the closed RU model.
Equations for the original full lung model
dGA
dt
=
DGTA
GAVA(y; Zi)
NX
i=1
(GTi  GA) +

Inspiration (Gair(t) GA)R
Expiration 0

(5.1)
dGTi
dt
=
DGTB(GBi  GTi)
GT VT (Zi)
+
DGTA(GA  GTi)
GT VT (Zi)
 D
GT
r2iGTi (5.2)
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dGBi
dt
=
DGTB(GTi  GBi)
GBVB(Zi)
+m
 k+(THb  Hb4i)GmBi + k Hb4i
GB
(5.3)
 v(Zi)riGBi
dHb4i
dt
= k+(THb  Hb4i)GmBi   k Hb4i   v(Zi)riHb4i (5.4)
With k  = RHk+
dCA
dt
=
DCTA
CAVA(y; Zi)
NX
i=1
(CTi   CA) +

Inspiration (Cair(t)  CA)R
Expiration 0

(5.5)
dCTi
dt
=
DCTB(CBi   CTi)
CT VT (Zi)
+
DCTA(CA   CTi)
GT VT (Zi)
 DCTr2iCTi (5.6)
dCBi
dt
=
1
CB

kcatHC
HCO 3i
kmHC +HCO
 
3i
  kcatCB 
C
BCBi
kmCB + CBCBi

(5.7)
 v(Zi)riCB
dHCO 3i
dt
= kcatCB
CBCBi
kmCB + CBCBi
  kcatHC HCO
 
3i
kmHC +HCO
 
3i
(5.8)
 v(Zi)riHCO 3i
dy
dt
=
VC0sh(t)
 1
  y
 2
(5.9)
with VA(y; Zi) = VAmin(Zi) + y
VAmin(Zi) =
VAmin 0
1 +mvtaZi
Vc(Zi) =
Vc0
1 +mvtcZi
sh(t) =
1
1 + e (tin mod(t;tin+tout)
R =
1
VA0(y; Zi)
d
dt
VA0(y; Zi)
VT (Zi) = VT0 + VB0   VB0
1 +mvtbZi
+ VAmin 0   VAmin 0
1 +mvtaZi
VB(Zi) =
VB0
1 +mvtbZi
v(Zi) = v0
VB0
VB(Zi)
Note that Zi is the spatial average of the variable which tracks inammation, Z. Inam-
mation levels are determined by the immune subsystem, see equations 4.20 and 4.24.
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5.2 SPATIAL REDUCTION
Our rst attempt at shortening computation times of the RU model consisted of removing
space, signicantly reducing the number of equations in the discretized form of the model.
With space removed from the single RU model, the model consists of four di¤erential equa-
tions and two functions f and g, see equations (5.10)-(5.16). The function f determines from
look up tables the values of GB at the end of the capillary, GendB , and the spatial average
of GB over the length of the capillary, G
avg
B . The function g has similar output, but for
CB. The schematic for this reduction is illustrated in Figure 35. Recall that Gx and Cx
represent oxygen and carbon dioxide gas pressures on compartment x, respectively. The sub-
script x is either B for blood, T for tissue, or A for alveolar air space. Individual parameter
explanations are given in Table 13 of Chapter 3.
To develop equations (5.10)-(5.16) we rst assumed that the pressure for tissue oxygen
(GT ) and tissue carbon dioxide (CT ) are both uniform in space, step 1 in Figure 35. This
eliminates the di¤usion within the tissue terms in equations (5.2) and (5.6). Also in equations
(5.1) and (5.5), GTi and CTi is replaces with GT and CT , respectively, since there is now no
spatial discretization in the tissue compartment.
dGA
dt
=
DGTA
GAVA(y; Zi)
(GT  GA) +

Inspiration (Gair(t) GA)R
Expiration 0

(5.10)
dGT
dt
=
DGTB(G
avg
B  GT )
GT VT (Zi)
+
DGTA(GA  GT )
GT VT (Zi)
(5.11)
GavgB ; G
end
B

= f(VB(y; Zi); v(y; Zi); GT ) (5.12)
dCA
dt
=
DCTA
CAVA(y; Zi)
(CT   CA) +

Inspiration (Cair(t)  CA)R
Expiration 0

(5.13)
dCT
dt
=
DCTB(C
avg
B   CT )
CT VT (Zi)
+
DCTA(CA   CT )
GT VT (Zi)
(5.14)
CavgB ; C
end
B

= g(VB(y; Zi); v(y; Zi); CT ) (5.15)
dy
dt
=
VC0sh(t)
 1
  y
 2
(5.16)
In order to remove space from the blood we cannot simply use spatial averaging. We need
the levels GendB and C
end
B on each RU to determine the output of the full lung model. In order
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Figure 35: Schematic for the spatial reduction along the length of the capillary. In the original model
the air compartment is assumed to well mixed (blue) while the tissue (green) and blood (red) compartments
include space along the capillary (rst column). In step 1 of the reduction, we assume that the tissue
compartment is well mixed removing removed space along the capillary in the tissue. In step 2, we simulated
the subsystem 5.17 and 5.18 with ranges of xed levels of oxygen in the tissue (GT ); blood volume (VB) and
blood speed (v) for x = [0; L], where L is the length of the capillary in order to create, f . From each of the
combinations of GT , VB , and v simulated we recorded venous end PO2 (GendB ) and the spatial average of
PO2 along the capillary (G
avg
B ). In step 3, we replaced the GB equation with the function f and GB in the
di¤usion term of the GT equation with G
avg
B . During simulations of the full model, f(GT ; VB ; v) detemines
GavgB and G
end
B from the data collected in step 2.
to calculate GendB , C
end
B , G
avg
B , and C
avg
B , we assume steady state in the blood compartment
and that there is a constant input from the tissue compartment to the blood compartment
for both gases, GT and CT , during the time the blood transverses the capillary. Blood
transverses the length of the capillary in 3/4 of a second and the breath cycle is four seconds
under normal conditions. In the full model PO2 and PCO2 tissue levels oscillate due to
the breathing mechanism in the alveolar air space, but these oscillations have fairly small
amplitude and a four second period. Therefore, during the time the blood transverses the
capillary it is reasonable to assume constant levels of PO2 and PCO2 in the tissue.
Also, we assume that blood velocity (v) and volume (VB) are constant during the time the
blood transverses the capillary. This is also a reasonable assumption given that their values
are determined by immune system where changes occur a signicantly shorter timescale.
These assumptions allow us to rewrite the equations for blood variables, equations (5.3),
(5.4), (5.7) and (5.8), as ODEs with space as the only independent variable, see equations
(5.17)-(5.20).
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@GB
@x
=
1
v

DGTB(GT  GB)
GBVB
+m
 k+(THb  Hb4)GmB + k Hb4
GB

(5.17)
@Hb4
@x
=
1
v
 
k+(THb  Hb4i)GmB   k Hb4

(5.18)
@CB
@x
=
1
vCB

DCTB(CT   CB)
CBVB
+ kcatHC
HCO 3
kmHC +HCO
 
3

(5.19)
 kcatCB
vCB
CBCB
kmCB + CBCB
@HCO 3
@x
=
1
v

kcatCB
CBCB
kmCB + CBCB
  kcatHC HCO
 
3
kmHC +HCO
 
3

(5.20)
Step two of the reduction is to simulate equations 5.17-5.20 for ranges of GT , Vb, and v
in order to create the look-up tables used in determining GendB and G
avg
B :Before simulating
over the various levels of GT , v and VB, we simulated this system with these parameters
set to their baseline values. Oxygen and carbon dioxide levels are uncoupled in this system,
so we can simulate equations (5.17) and (5.18) separately from equations (5.19) and (5.20).
We rst focused on oxygen. Normal conditions for these parameters are v = 0:2933 cm/s,
VB = 7:5 10 9L, which is 90 ml=(# of alveoli) and GT = 100 mmHg. GT = 100 mmHg is
approximately the value that the full model GT oscillates around after the hemoglobin and
oxygen have reached steady state in the blood. With this parameter set, the hemoglobin
becomes saturated and GB reaches the GT level early along the capillary. Under normal
conditions hemoglobin saturates in approximately the rst 1/3 of the capillary. The dif-
fusion rate for oxygen crossing the tissue/blood barrier in the full model was t such that
hemoglobin saturates at an appropriate point along of the capillary. This is one of the few
free parameters in the full lung model. Given how this rate was determined for the full
model, we adjusted the di¤usion rate in the spatial reduction, such that GB reaches the level
of GT further along the capillary (see the new di¤usion constant curve in the Figure 36).
Once the di¤usion constant was adjusted, equations (5.17) and (5.18) were simulated
with a range of GT , v and VB and both GendB , G
avg
B were recorded. In Figure 37 we look at a
sample of the data collected. We have plotted the GavgB and G
end
B with GT=100 mmHg, VB
ranging from 20 ml=(# of alveoli) to 120 ml=(# of alveoli) and v from 0.055 to 1.47 cm/s.
Note that for ease of plotting, unscaled blood volumes are used, 20 ml to 120 ml. Under
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Figure 36: Transients from the blood compartment with the same xed oxygen tissue, blood velocity
and blood volume, but with di¤erent di¤usion constants. The di¤usion constant is set to the value from the
full model, 6.748310 12 L/s, for the curve labeled old di¤usion constant. Di¤usion constant is set to the
value from the spaceless model, 1.810 12 L/s, for the new di¤usion constant curve.
most conditions GendB reaches GT . G
end
B is a¤ected most by the changes in the blood speed.
When the blood is too fast the hemoglobin does not saturate and venous PO2 levels do not
increase to the levels seen in the tissue. Changes in VB a¤ect the di¤usion term, but if the
speed of the blood is slow enough this does not a¤ect the end blood level. Changes in both
VB and v, however, both do e¤ect the G
avg
B , since these change where hemoglobin steady
state occurs. Later saturation decreases GavgB : Only when saturation does not occur is G
end
B
a¤ected.
The data collected for GavgB and G
end
B from range GT between 20 and 165 mmHg and
the ranges of v and VB mentioned above and stored in matrices. These matrices are used to
determine the value of f at a given VB(t), v(t), and GT (t). GT (t) determines which matrix
of GendB values is called . We then linearly interpolate for G
end
B , from the four matrix values
corresponding the closest simulated v and VB above and below the actual v(t) and VB(t): The
same method is used to determine GavgB : Once f is determined, the nal step of the reduction
is to eliminate the PDE for GB and determine venous PO2 with f . We also replaced GB by
GavgB in the GT equation, which was also determined by f . This creates the spaceless form
of the model, equations 5.10-5.16.
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Figure 37: Average PO2 and end PO2 in the blood versus the speed of blood (v) and unscaled blood
volume (VB) with xed tissue PO2. PO2 in the tissue (GT ) is set to 100 mmHg. Actual volume used of
the blood was 1.710 9L

20ml
# of alveoli

to 110 8L

120 ml
# of alveoli

. For plotting purposes unscaled volumes,
20-120 ml, were used. On the left is the plot for average oxygen in the blood (GavgB ) versus v and VB . On
the right is the plot for venous PO2 in the blood (GendB ) versus v and VB .
We rst simulated this model in the absence of inammation. These simulation resulted
in a GendB = 95 mmHg, G
avg
B = 86:5 mmHg, GT = 90:34 mmHg and GA = 96:95 mmHg
(at the end of expiration). In the full model with space along the capillary with the same
condition we had GendB = 97 mmHg, GT = 96:82 mmHg, and GA = 96:77 mmHg. Therefore,
during health the spatial reduction reproduces results similar to that in the original model.
The running time for the rst 120 seconds during lethal inammation (TNFB = 4) of the
original RU model is 91.73 seconds for the model with space along the capillary. With
spatial reductions the same insult ran in 31.67 seconds. The same lethal insult used in the
previous chapter was also simulated here (TNFB = 4). During the initial stages of this
insult the spatial reduction method decreased computation times minimally. However, when
inammation accumulates the matrices used to determine GavgB and G
end
B changes. This is
due to the changes in GT during the insult. When the matrices change there was a signicant
increase in computation times. The non-spatial model actually had a longer running time
than the full method. Given the e¤ectiveness of the temporal reduction, this spatial reduction
was not applied to the model.
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5.3 TEMPORAL REDUCTION
The main cause of long computation times in the single RU model is the breathing mecha-
nism. Therefore, we removed this mechanism, altering the equations for alveolar PO2 (GA)
and PCO2 (CA) (equations (5.1) and (5.5)), and eliminating the y variable (equation (5.9)).
The last terms in equations (5.1) and (5.5) are replaced by a source term in GA equation
and a decay term in the CA, see the last terms in equations 5.21 and 5.25. This change is
equivalent to introducing a source for GA, since GA < Gair0 in lung, and a decay of CA, since
we assume Cair0 = 0. The e¤ects of inammation are still applied to this term via the ratio
VC(Zi)=VC0normal, where VC(Zi) is the tidal volume and VCnormal = 350 ml=(#ofalveoli).
When VC decreases there is less new air introduced on a breath cycle reducing the ability of
the alveolar space to supply O2 and remove CO2.
dGA
dt
= Pva(VG(Zi))
DGTA
GA
NX
i=1
(GTi  GA) + kG(Gair0  GA)VC(Zi)
VC0
(5.21)
dGTi
dt
=
DGTB(GBi  GTi)
GT VT (Zi)
+
DGTA(GA  GTi)
GT VT (Zi)
 D
GT
r2iGTi (5.22)
dGBi
dt
=
DGTB(GTi  GBi)
GBVB(Zi)
+m
 k+(THb  Hb4i)GmBi + k Hb4i
GB
(5.23)
 v(Zi)riGBi
dHb4i
dt
= k+(THb  Hb4i)GmBi   k Hb4i   v(Zi)riHb4i (5.24)
With k  = RHk+
dCA
dt
= Pva(VC(Zi))
DCTA
CA
NX
i=1
(CTi   CA) + kC(Cair0   CA)VC(Zi)
VC0
(5.25)
dCTi
dt
=
DCTB(CBi   CTi)
CT VT (Zi)
+
DCTA(CA   CTi)
GT VT (Zi)
 DCTr2iCTi (5.26)
dCBi
dt
=
1
CB

kcatHC
HCO 3i
kmHC +HCO
 
3i
  kcatCB 
C
BCBi
kmCB + CBCBi

(5.27)
 v(Zi)riCB
dHCO 3i
dt
= kcatCB
CBCBi
kmCB + CBCBi
  kcatHC HCO
 
3i
kmHC +HCO
 
3i
(5.28)
 v(Zi)riHCO 3i
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VAmin(Zi) =
VAmin 0
1 +mvtaZi
Vc(Zi) =
Vc0
1 +mvtcZi
VT (Zi) = VT0 + VB0   VB0
1 +mvtbZi
+ VAmin 0   VAmin 0
1 +mvtaZi
VB(Zi) =
VB0
1 +mvtbZi
v(Zi) = v0
VB0normal
VB(Zi)
We then eliminated the variable y. Recall that y tracks the changes in the alveolar air
space volume during a breath cycle. Changes in the alveolar air space volume caused by
inammation are retained in this reduction. To eliminate y in the equation for GA and
CA we took the temporal average of 1VA(t;Zi) over a breath cycle. Recall that VA(t; Zi) =
VAmin(Zi) + y, where VAmin(Zi) is the minimal alveolar volume and y grows from VAmin(Zi)
to VAmin(Zi) + VC(Zi) during inspiration (one second) and decays back to VAmin(Zi) during
expiration (three seconds). VAmin(Zi) and VC(Zi) are output of the immune subsystem and
we assume here they xed for a given breath cycle, since the immune subsystem runs of the
order of hours and the breath cycle is 4 seconds. With the breathing mechanism replaced
by the source/decay term, y only remains in the di¤usion terms in the alveolar air space
compartment (RU model equations 5.1 and 5.5). Therefore, the di¤usion term 1
VA(t;Zi)
was
replaced with its average over the breath cycle, which equals 1
4
R 4
0
1
VAmin(Zi)+y
dt.
Note that, y is dened by equation 5.9 and that VAmin(Zi) and VC(Zi) are assumed to be
constant the breathing cycle. Replacing sh(t) with the Heaviside function in the y equation,
on a single breath cycle we can rewrite this y equation as
dy1
dt
=
V c(Zi)
 1
  y1
 2
, with y1(0) = 0 for 0  t < 1
dy2
dt
=
y2
 2
, with y2(1) = y1(1) for 1  t  4:
Solving these ODEs we rewrite the average as
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14
Z 4
0
1
VAmin(Zi) + y
dt =
1
4
Z 1
0
1
VAmin(Zi) + y1
dt+
Z 4
1
1
VAmin(Zi) + y2
dt

=
1
4
Z 1
0
1
VAmin(Zi) +
Vc(Zi)2
1
(1  e t=2)
dt
+
1
4
Z 4
1
1
VAmin(Zi) + y1(1)e (t 1)=2
dt:
Setting parameters to their values from Tables 13-19 of Chapter 3 and integrating we get
the average as a function of VAmin(Zi) and VC(Zi);
1
4
Z 4
0
1
VAmin(Zi) + y
dt = 0:875
ln(5VAmin(Zi) + 5:322V c(Zi))  ln(VAmin(Zi))  0:181
5VAmin(Zi) + 7VC(Zi)
+0:175
ln(1 109VAmin(Zi) + 1:465 107VC(Zi)) + 4:286
VAmin(Zi)
 0:175ln(1 10
9VAmin(Zi) + 1:064 109VC(Zi))
VAmin(Zi)
:
We refer to this function as Pva(Zi): Replacing 1VA(t;Zi) with Pva(Zi) and the breathing
mechanism term with the source/decay term in the GA and CA equations, we have the model
for a single until RU without the breathing mechanism, equations (5.21)-(5.28).
Computation times are dramatically decreased with this reduction. To simulate 96 hours
of gas exchange with the same lethal inammation took only 19.07 seconds. Recall that in
the full model to simulate 120 seconds of lethal inammation took 91.73 seconds. In Figure
38 we compare the results of the RU model with and without breathing during a lethal
insult of TNFB=4. For the breathing model we have plotted GendB at the end of expiration,
which is the minimum during the breath cycle. However, in the non-breathing model, the
parameter KG in the source term was t so that our healthy level for GendB is approximately
the average GendB over a breath cycle in the full model, 100 mmHg. Hence in Figure 38, the
non-breathing model is initially above the breathing model. The e¤ects of inammation are
slightly greater in the non-breathing case. This is likely due to change in the implementation
of inammatory e¤ects on the intake of oxygen. The accumulation of inammation eventually
causes the non-breathing curve to fall below the breathing curve. However, overall the
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Figure 38: Comparsion of venous PO2 from the single RU model with and without the breathing
mechanism for various tidal volumes, during a lethal insult. Dashed transients are the results from the single
RU model with the breathing mechanism. The insult was trigger by setting TNFB = 4. The minimum
, normal and maximum tidal volume are 150 ml=(# of alveoli); 350 ml=(# of alveoli) and 550 ml=(# of
alveoli), respectively.
temporal reduction gives similar results to the full model. For the sake of computation times,
oxygen was separated from carbon dioxide and only the oxygen subsystem was simulated for
the breathing model. Therefore, there is no comparison presented here between these model
for PCO2: With the temporal reduction, simulations for both gases are run simultaneously
and the results for PCO2 are presented in a later gure.
5.4 FULL LUNG
As with the breathing RU model, multiple non-breathing RU models were linked to create
a full lung model. Again, we introduced ventilation perfusion mismatch into the full lung
model by implementing a truncated normal distribution in the initial tidal volume levels of
the linked RUs. Previously, we only considered oxygen. Here, we will study results for both
oxygen and carbon dioxide. This type of heterogeneity in the lung is caused by changes in
the ventilation. However, perfusion also di¤ers from RU to RU. Therefore, we also consider
a lung which has a normal truncated distribution in the initial blood volumes of the RUs.
111
Finally, we considered altering both ventilation and perfusion simultaneously as seen in an
actual lung. For this we introduced a uncorrelated bivariate truncated normal distribution
in the initial tidal and blood volumes of the linked RUs.
In all of our full lung models we considered the full lung with and without shunting.
Recall that shunting is when the alveolar air space collapses during severe inammation.
Shunting is typically assumed to be the main cause of PO2 drops during acute lung injury,
rather than changes in di¤usion. As we did in the breathing model, when tidal volume drops
below 40% of the normal tidal volume di¤usion across the tissue barrier is eliminated, by
taking DGTA = 0; D
C
TA = 0; if VC(Zi)=VC0Normal < 0:4, where VC0Normal = 350 ml=(# of
alveoli). When shunting is included in both the non-breathing and breathing models the
shunting curve is exactly the same as the results without shunting until VC(Zi)=VC0Normal
falls below 0:4. Note that, the time point where shunting occurs is determined by the immune
subsystem, so there is no di¤erence in the closure times for the breathing and non-breathing
model.
Figure 39: Model schematics for the linking of multiple RUs to create the Full lung-VC model. The
rst column represents entering variable concentrations and partial pressures (orange), initial comparmental
and tidal volumes (blue) and blood speed (red) at the onset of inammation. All of these are the same on
all RUs except for the initial tidal volume, VC0. VC0 of the RUs were determined by a normal truncated
distribution. Simulation were run for the various RUs. A weighted average dependent on the distribution is
taken of the blood variable values at the venous end. This weighted average is used as the intial conditions
for an ODE system that models venous end mixing. The results of this system are the output of the full
model.
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5.4.1 Full Lung-VC
We linked multiple RU models with various initial tidal volumes (VC0) to form a full lung
model, which we will refer to as the Full lung-VC model. With this method the ventilation
perfusion mismatch is introduced via di¤erences in air supply. No change were made to
account for di¤erence in blood supply. A schematic for creating the Full lung-VC model is
given Figure 39.
Figure 40: Venous PO2 from the non-breathing single RU model and Full lung-VC model with and
without shunting during a lethal insult. The insult was triggered by setting TNFB = 4. The minimum,
normal and maximum tidal scaled volume are 150ml# of alveoli ;
350ml
# of alveoli and
550ml
# of alveoli , respectively. Each single
unit transient is mark with a gray circle where shunting for that curve occurred.
As in the breathing model, each RU has the same compartmental volumes, entering blood
concentrations for HB4 and HCO 3 , entering PO2 and PCO2 and initial blood velocity (left
column of Figure 39). We took the same sample set from the truncated normal distribution
we used in the previous chapter, with minimum scaled volume, 150 ml, maximum scaled
volume, 550 ml, and the scaled mean, 350 ml. To model the full lung, the single RU model
is simulated over a range of tidal volumes. We then take weighted averages for GendB , Hb
end
4 ,
CendB , and HCO
 end
3 from the output of these single units. The weights for the average were
determined by the distribution. The weighted averages are then used as the initial conditions
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for a system of ODEs consisting of GB, Hb4, CB, andHCO 3 reactions from equations (5.23),
(5.24), (5.27), and (5.28) without the di¤usion and advection terms. This system models
the mixing of the blood when it leaves the lung.
In Figure 40 we compare the results from scaled 150 ml, scaled 350 ml, scaled 550 ml
and the Full lung-VC model with and without shunting. As in the breathing model there is
signicant PO2 loss during inammation. All transients approach the xed arterial blood
PO2 level, 40 mmHg. This value was xed throughout the simulation.
Each transient for the single RUs is marked with a circle where shunting occurred. At
this circle PO2 on that RU will drop to approximately 40 mmHg when shunting is included.
The higher the initial tidal volume the later the RU shunts. We binned the sample set such
that the simulations were run with initial tidal volume incremented by 10 ml from 150 to
550 ml. Therefore, all RUs in a bin shunt at the same time. This is what causes the "steps"
in the shunting curve. The full lung shunting curve has more severe drops in venous PO2
than without shunting. However, in the absence of shunting there are still signicant drops
due to limited di¤usion of oxygen during inammation.
Figure 41: Venous PCO2 from the non-breathing single RU model and Full lung-VC model with and
without shunting during a lethal insult. The insult was triggered by setting TNFB = 4. The minimum and
maximum tidal scaled volume are 150ml# of alveoli and
550ml
# of alveoli , respectively. Each single unit transient is mark
with a gray circle where shunting for that curve occurred.
Figure 41 shows results for venous PCO2 from the non-breathing RU model for various
tidal volumes and the Full lung-VC model with and without shunting during the same insult.
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Inammation hinders the removal of PCO2 from the blood. Therefore, for all tidal volumes
PCO2 increase during inammation. As in the simulations for PO2; curves approach the xed
arterial PCO2 level, 45 mmHg. Again, where shunting occurs for the single RU transients
is marked with a gray circle. When shunting occurs the PCO2 rises to approximately 45
mmHg. The curve for the full lung model with shunting shows more severe increases than
the curve without shunting.
5.4.2 Full Lung-VB
Next we considered a lung where heterogeneity in the lung is introduced via changes in
perfusion. This was modeled by introducing a distribution in the initial blood volumes (VB0)
of the RUs with initial tidal volumes equal on all units. We refer to this full model as the Full
lung-VB model. Overall schematics for the linking of the RUs is the same as in Figure 39,
but with the distribution now in VB0. The truncated normal distribution used to determine
the initial blood volumes of the RUs was assumed to have minimum, scaled 30 ml, maximum
,scaled 150 ml, and average scaled 90 ml.
Figure 42: PO2 level for various blood volumes and the full lung model which has a truncated normal
distribution in the blood volume, Full lung-VB model. PO2 transients from RUs with maximum (scaled 150
ml), normal (scaled 90 ml), and minimum (scaled 30 ml) blood volume and from full model which has the
blood volumes of the RUs from a normal distrubition truncated at the minimum and maximum volumes and
average approximately the normal blood volume.
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In Figures 42 and 43 we see the e¤ect of implementing mismatch via a truncated normal
distribution in VB on venous PO2 and PCO2. Inammation was introduced via the same
TNFB = 4 insult. For both oxygen and carbon dioxide results are similar to those seen
when tidal volume is varied. Due to the conservation of ow all RUs have the same initial
conditions. In each RU ow is conserved by adjusting blood speed for the di¤erences in the
blood volume. This allows the saturation of hemoglobin and su¢ cient uptake of oxygen as
the blood transverses in all RUs.
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Figure 43: PCO2 level for various blood volumes and the full lung model which has a truncated normal
distribution in the blood volume, Full lung-VB model. PCO2 transients from RUs with maximum (scaled
150 ml), normal (scaled 90 ml), and minimum (scaled 30 ml) blood volume and from full model which has
the blood volumes of the RUs from a normal distrubition truncated at the minimum and maximum volumes
and average approximately the normal blood volume.
Though changes in blood do not alter the initial level of PO2 and PCO2, the levels
of inammation on the RUs di¤er during an insult. Changes in blood volume a¤ect the
di¤usion of the immune variables, e¤ecting the inammation levels. Therefore, in Figures 42
and 43 transients for individual RUs di¤er despite having the same initial PO2 level. For the
minimum volume case an insult of TNFB = 4 is a non-lethal. When shunting is included
this unit does not shunt, since there are low levels of inammation on this unit. The normal
and minimum blood volume RUs shunt and their transients in Figures 42 and 43 are marked
with circles at the point when it occurs. This does not occur at the same point, despite
the fact that both units start with the same tidal volume, since inammation levels di¤ers
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on these units. Di¤erence in inammation levels between RUs does not occur in the Full
lung-VC model, since changes to the alveolar air space do not a¤ect the immune subsystem,
which is modeled in only the tissue and blood compartments.
As seen in Full lung-VC model, the Full lung-VB with shunting had more signicant drops
in venous PO2 (Figure 42) than without shunting. However, shunting e¤ects overall are seen
later in the Full lung-VB model. With or without shunting, the Full lung-VB model does not
drop to the arterial PO2 level as seen in the Full lung-VC model. This is due to the RUs that
do not have signicant levels of inammation to cause severe drops in venous PO2. Results
are similar for PCO2; but with increasing PCO2 levels during inammation (Figure 43).
Figure 44: Venous PO2 for Full lung-VC and Full lung-VB models with and without shunting during a
lethal insult. In both full lung models the insult was triggered by TNFB = 4.
In Figure 44 we compare the full models with and without shunting for the Full lung-
VC and Full lung-VB models. Without shunting the Full lung-VB model has more signicant
drops in PO2 in the rst 24 hours, since the di¤erences is VB0 e¤ect the inammation variable.
In the late stages of the insult the Full lung-VB model remains elevated due to RUs that did
not accumulate signicant inammation. With shunting we see that the Full lung-VB model
begins shunting at about 11 hours, which is much later that the Full lung-VC model.
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5.4.3 Full Lung-VCVB Model
Within the lung ventilation perfusion mismatch is caused by both heterogeneity in the blood
and air supply. Therefore, we created a full lung model following the schematic in Figure
39 but with both initial tidal and blood volumes varying between RUs. This heterogeneity
was introduced via an uncorrelated, bivariate, truncated normal distribution in VB0 and VC0,
with the same maximums, minimums, and averages used in the previous full models. We
refer to the model as the Full lung-VBVC model. In Figure 45A is the sample set used from
this distribution. Figure 45B shows the initial conditions for venous PO2 that arise from
this distribution.
Figure 45: The distrubtion used in the Full-VCVB and the associated initial conditions for venous PO2.
A. Realization of the bivariate truncated normal used in the full model with ventilation perfusion mismatch
introduced by varying both the tidal volume and blood volume. The height of the bar determines the portions
of RUs in the full model with that associated tidal and blood volume. B The initial condition associated
with each tidal and blood volume combination. Altering these volumes a¤ects the normal level of venous
PO2. The normal level is used as the initial condition for PO2 when inammation is introduced. The blue
circles represent the intial conditions assocated with a nonzero bar from A.
As seen in the previous full lung model initial venous PO2 is dependent only on VC0.
Following the lines in Figure 45B we see the e¤ect of increasing VC0 at a xed initial blood
volume. The circles plotted in Figure 45B correspond to the initial venous levels actually
used. Each circle corresponds to one for the bars in Figure 45A. In this realization, the ratio
of initial tidal volumes to initial blood volume on the RUs varied from 1.21 to 17 and had
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an average of 4.7. On a RU with normal VC0 = 350 and VB0 = 90 this ratio is 3.89. For
ranges of VC0 and VB0 considered in this distribution this ratio could have ranged from 1 to
18.33. Note that in the Full lung-VC and Full lung-VB models this ratio ranged from 1.67 to
6.1 and 2.33 to 11.67, respectively.
We compare the transients for the lethal inammation on various RUs in Figure 46. The
curve with the minimum initial venous PO2 has the minimum initial tidal volume. This
initial PO2 is comparable to the minimum initial PO2 level seen in the Full lung-VC model.
The circles on the curves mark the time point when shunting occurs for that given curve.
Shunting is determined by the both VC0 and VB0 levels. As in the Full lung-VB model there
are units that do not shunt.
Figure 46: Transients from single RUs and the Full lung-VBVC model. Transients for single RUs with
with various tidal and blood volume combinations are plotted for an insult triggerd by TNFB = 4. Circles
indicate the time point where shunting occured. Also included is the Full lung-VBVC model with and without
shunting.
In Figure 47 we compare the three full lung models with shunting. Venous PO2 level
for the Full lung-VBVC and Full lung-VC model are similar during early stages of the insult
since both models have RUs that shunt early. However, since all RUs are shunting in the
Full lung-VC model and there are non-shunting units in the Full lung-VBVC model, these
curves eventually pull farther apart. In the later stages of the insult the Full lung-VB and Full
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Figure 47: Comparsion of Full lung-VB , Full lung-VC , and Full lung-VBVC models with shunting. For
all model the insult was triggered by an insult of TNFB = 4.
lung-VBVC are similar, since they both have non-shunting RUs with high PO2 levels. Results
for carbon dioxide follow the same trends as PO2 with increases rather than decreases.
In all full lung models we see that shunting causes more severe drops during the time-
course of the insult. However, there are drops in the PO2 due to the changes in di¤usion
due to swelling of the tissue compartment. The Full lung-VBVC model is more accurate lung
model, since it accounts for di¤erence in both perfusion and ventilation and will be used in
future modeling of the full lung.
5.5 CLOSED LOOP RU MODEL
Once the temporal reduction is implemented the RUmodel runs with reasonable computation
times. However, as we saw in the above simulations venous PO2 levels fall at most to 40
mmHg and venous PCO2 levels rise to at most 45 mmHg. In order to have a more accurate
model we need to include variable arterial levels in the model. Up to this point we have
assumed that blood enters the lung with a PO2 of 40 mmHg and PCO2 of 45 mmHg, their
healthy levels. To correct this we have to created a closed loop RU model where arterial
120
pressures G0B and C
0
B are dependent on venous pressures, G
end
B and C
end
B .
In the absence of inammation, blood leaves the lung with PO2 approximately 100 mmHg
and CO2 approximately 40 mmHg. Metabolic processes consume O2 and produce CO2 when
the blood is not in the lung. Therefore, the blood levels during healthy conditions drop to
approximately 40 mmHg and 45 mmHg for O2 and CO2, respectively [27]. Once again, in
modeling the metabolic process we focused on oxygen rst. We calculate arterial PO2 by rst
determining content of oxygen at the venous end (V ). Oxygen content accounts for oxygen
both free and bound to hemoglobin in the blood and has units ml/100cc. Content is deter-
mined by a standard formula dependent on PO2 and hemoglobin [27]. Using normal cardiac
output (co) of 5000 ml/min and a constant metabolic rate of consumption of oxygen (),
150cc/min, we determine arterial content of O2 (A) with the formula A =
 

V
  100=co.
With A we numerically determine arterial PO2 and hemoglobin from the content formula
and the oxyhemoglobin dissociation curve.
For more accurate results we ret our hemoglobin parameters m, k+, and k  from equa-
tions (5.23) and (5.24). We then tKG, the parameter in the source term of the GA equation,
so that under normal condition arterial (entering the RU) and venous PO2 (exiting the RU)
match levels seen clinically for a normal lung, 40 mmHg and 100 mmHg, respectively. After
tting, in the closed model arterial PO2 (G0B) is 39.20 mmHg and venous (G
end
B ) PO2 is
100.06 mmHg with no inammation.
When modeling hemoglobin we considered two states for hemoglobin: fully saturated,
Hb4; and hemoglobin that has needs m oxygen to bind to it in order to become saturated
, Hbm. Not modeling a completely unsaturated hemoglobin does not properly capture the
hemoglobin dynamics when PO2 levels drop below the 40 mmHg (its minimum level in
previous results). In the future we will account for completely unsaturated PO2. At this
time we will compare the non-breathing and closed RU models for a nonlethal level of insult
of TNFB, TNFB = 2 (see Figure (48)). Results show that arterial PO2 now drops as venous
PO2 drops during inammation. Overall there is a more signicant drop in venous PO2 in
the closed RU model than in the non-breathing RU model. Once the hemoglobin equations
are reformulated we will implement the e¤ects of metabolism on PCO2.
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Figure 48: Venous and arterial blood PO2 levels from the closed RU model. The closed venous and
arterial PO2 are from a simulation of the closed model was with an insult of TNFB = 2: The non-breathing
RU model- venous PO2 curve is from the same insult to the non-breathing model.
5.6 DISCUSSION
We have reduced the RU model developed in the previous chapter in order to more e¢ ciently
simulate the full lung with ventilation perfusion mismatch. We developed a spatial reduction
that eliminated space along the capillary and a temporal reduction that eliminated the
breathing mechanism in the RUmodel. The spatial reduction method was designed such that
gas pressure levels at the end of the capillary were retained. However, the spatial reduction
as is was not an e¤ective method to eliminate long computation times. Therefore, we only
implemented a temporal reduction, which consisted of temporal averaging over the breathing
cycle. This eliminated the breathing mechanism, which consisted of switching back and forth
from inspiration (increasing alveolar air space volume) to expiration (decreasing alveolar air
space volume) with a period of four seconds. This drastically reduced computation times
and allowed us to implement more accurate ventilation perfusion mismatch.
In the breathing RU model we only considered mismatch introduced by varying the
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initial tidal volumes of the RUs, which alters only ventilation . However, within the actual
lung ventilation and perfusion, both can di¤er [27]. With the non-breathing model, we are
able to easily introduce any initial compartmental and tidal volumes on the RUs. The Full
lung-VBVC model has the most accurate full lung model we considered because it accounts
for changes in perfusion and ventilation. However, rst considering the Full lung-VC and Full
lung-VB models allowed us to explore how changing perfusion and ventilation contribute to
overall dynamics. We see that the changes in VB0 do not a¤ect the initial levels of PO2.
However, signicant decreases in VB0 give rise to RUs which do not have signicant drops in
PO2: Also, the e¤ects of shunting are observed in the later stages of the insult compared to
the Full lung-VC model. Changes in VC0 a¤ect the initial conditions with higher initial tidal
volume causing higher initial PO2 levels and shunting e¤ects are seen throughout the insult.
In the Full lung-VBVC we see a combination of these e¤ects with initial conditions similar to
those of the Full lung-VC model and venous levels slightly above the xed arterial level of 40
mmHg at the end of the insult as seen in the Full lung-VB model. Due to more variety in the
closing times of the RUs in the Full lung-VBVC model there is a more gradual decrease in the
shunting transient than in the other full lung models. There is a more gradual separation of
the with and without shunting transients than in the previous full lung models, since there
is more variety in the closing time among the RUs (Figure 47). Results are similar for PCO2
but with increasing instead of decreasing levels.
Once we had explored the e¤ects of altering perfusion and ventilation, we increased the
biological accuracy of the model by implementing feedback from venous PO2 onto arterial
PO2. Therefore, the arterial level is no longer xed and decreases due to drops in the venous
PO2. This causes more signicant drops in PO2 than seen in previous versions of the model.
During severe inammation these more signicant drops nullify an assumption we made
regarding the saturation levels of hemoglobin. Therefore, with the hemoglobin equations
as is, the closed model is only e¤ective at low levels of inammation. Reformulating our
derivation of the hemoglobin equation will create a model that is accurate during severe
inammation.
We have created a method to model the full lung with inammation and heterogeneity
within its units. This model allowed us to explore overall lung and single RU unit results
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during an insult. Once the closed RU unit is adjusted to account for severe drops in PO2; we
will look at the closed full lung model by linking the multiple closed RUs with the distribution
used in Full lung-VBVC model. With this model we can alter the immune subsystem so that
we model a specic disease, such as pneumonia and inuenza. In this form we can explore
the e¤ect of these diseases on PO2 and PCO2 levels. Additionally, ventilation and perfusion
ratios (rate of ventilation over the rate of perfusion), PO2 and PCO2 levels are measurable
in patients. This provides data during these insults for which we can calibrate and verify
are full model once metabolic consumption of oxygen is included.
The lung is a common site for secondary infections and typically the rst organ to fail
during MODS, even when the insult is not initially via the lungs. Therefore, we will also
consider the spread of inammation to and from the lung by connecting the closed full lung
model and the compartmental model. To increase the biological delity of the innate immune
responses within the lung, we can replace the simplied immune subsystem used in these
simulations with the compartmental model. With this more accurate immune system we can
explore PO2 levels during inammation that results in health, aseptic or septic death.
124
6.0 CONCLUSION
6.1 THESIS SUMMARY
We have developed and analyzed three mathematical models of acute inammation. These
models were developed in order to look at various aspects of multiple organ dysfunction
syndrome (MODS). This disease is the leading cause of death in ICU patients [11]. The
treatment options for MODS are limited and do not focus on the elimination of inammation
or stopping its spread from one organ to the next. These models serve as an initial step
in understanding the dynamics that drive the spread of inammation. Understanding these
complex interactions will facilitate the development of e¤ective treatment options for MODS.
Our rst model includes pro- and anti- inammation with pathogen as an initiating event.
Giving anti-inammatory therapy as a treatment for MODS were experimentally tested with
little success ([63], [65]). Therefore, we use this simple model to explore the role of anti-
inammatories during the immune response. The model was developed via a subsystem
approach. This allowed us to ensure that proper dynamics were captured between interacting
variables. These subsystems were combined to form the four variable ODE model, which we
refer to as the reduced model. This model has clinically relevant outcomes represented by
xed points (health, aseptic and septic death).
In order to analyze the e¤ects of anti-inammatories, we used this model to determine
the basins of attraction in various scenarios and to model the administration of an anti-
inammatory treatment. The results from these simulations showed that anti-inammatories
play a signicant role in restoring health during an infection. Our results also illustrate that
altering the levels of anti-inammatories either at a given time point or by xing their
levels during the response to an infection may compromise outcomes. This result has been
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observed clinically. Administration of steroids, an anti-inammatory mediator, to severely
septic patients has clearly decreased survival. ([63], [65]). Our model shows that repeatedly
administering anti-inammatories as a treatment is not e¤ective, since this eliminates the
dynamics in the anti-inammatory population, increasing sensitivity to secondary insults.
The reduced model gave us insight into the overall dynamics between pro- and anti-
inammation. However, to model the spread of inammation we needed a model that in-
cluded variables from specic pro- and anti- inammatory mediators and cells in both the
blood and tissue. Therefore, we expanded this model into our compartmental model, which
consists of immune components in the blood and tissue and has variables corresponding to
TNF and IL-10 levels. Modeling specic mediators will allow for calibration of the model to
data. Separating the blood and tissue allows us to explore the e¤ects of manipulating both
the local (tissue) and systemic (blood) responses on the spread of inammation between
multiple tissue units linked to the same blood unit. Complexity was added to the equations
as needed to capture known biological behavior of the system. Adding complexity to these
models makes the overall behavior of the system less intuitive.
The interactions between the tissue and blood are essential in eliminating the pathogen
and restoring homeostasis. This two compartment ODE model accounts for the communi-
cation between the tissue and blood and has the same outcomes as the reduced model. This
model is a minimal model of an organ. Therefore, we explore the spread of inammation
between organs by linking two tissue compartments to the same blood supply. We con-
sidered linked organs with the same parameter values, with various levels of pathogen and
neutrophil di¤usion, and with di¤erence in their source of resting macrophages. This allows
us to explore the e¤ect of altering the local versus the innate immune response initiated in
the blood.
Changing di¤usive properties within an organ alters the communication between com-
partments. When the organ is more di¤usive there is an increase in the inux of neutrophils,
this causes tissue damage to accumulate more readily while the infection is being eliminated.
Therefore, more di¤usive organs are more likely to enter aseptic death, but their increased
neutrophil levels protect them against septic death. When a normal and more di¤usive
organ are linked, the onset of death occurs at higher pathogen loads compared to a single
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normal organ. The more di¤usive organ accumulates more damage than the normal organ.
Therefore, there is a range of initial tissue pathogen of which inammation spreads to the
second organ despite a healthy outcome in the insulted organ. Exploring this phenomenon
further will likely give insight into why the lung is typically the rst organ to fail during
MODS, even when the initial insult is not in the lung [42].
Changing di¤usion alters the response via the blood. In order to study the e¤ects of
changing the immune response within the tissue we increased the levels of resting macrophages
in an organ. This increased the overall response without the damage associated with high
neutrophil inux to an infected organ, since the local macrophages have eliminated more of
the pathogen than in a normal organ. Linking a normal organ and an organ with increased
macrophages to the same blood supply increases the thresholds for death without increas-
ing tissue damage and therefore is the more e¤ective means of protecting an organ. We
hypothesize that protection via tissue macrophages allows the liver to be highly resistant
to infection, rarely becoming inamed despite being the rst organ to provide an immune
response to many types of insults via the gut [55].
Di¤erences in the accumulation of damage during the local and innate response is what
allows increases in local response to be more benecial. Minimal damage is produced when
pathogen is eliminated by macrophages compared to neutrophils. Validity of this assumption
need to be established before making conclusions of the e¤ectiveness of increasing the local
macrophages.
The lung is highly likely to be a¤ected during MODS. However, modeling the lung with
the compartmental model does not account for interaction with the air, which is essential to
the function of the lung. Therefore, we have developed a full lung model that accounts for gas
exchange and inammatory e¤ects that accounts for the air, blood and tissue compartment
dynamics. This model is multiscale in that it takes into account gas exchange within a single
respiratory unit (RU) and combines the output of single RUs to determine the full lung model
results. Heterogeneity between RUs was introduced by altering their compartment volumes.
To our knowledge, this is the rst gas exchange model to treat tissue as a compartment.
This allowed us to simulate the swelling of the tissue due to the immune response. Other
mathematical models of the lung have concentrated on many aspects of the lung function
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such as mechanics, gas exchange, drug deposition, and circulation. The models that include
gas exchange treat the tissue layer as a simply the barrier between the air and blood ([7],
[28], [29], [39], [46]).
In its original form the full model lung was computational expensive due to the breathing
mechanism. Both a temporal and spatial reduction were applied to the model. The temporal
average on the breathing cycle reduced running times drastically and allows the model to be
used with ease in various scenarios of ventilation perfusion mismatch. The spatial reduction
was not e¤ective compared to the temporal reduction and, in the end, was not applied to
the full lung model.
In the original breathing full model we only introduced ventilation perfusion mismatch
via a distribution in the initial tidal volumes on the single RUs. However, heterogeneity
in the lung is due to RUs di¤erences in air and blood supply. With the non-breathing
we introduced various distributions in the initial tidal and/or blood volumes of the RUs.
Our Full lung-VBVC model best mimics the conditions within the lung, since it accounts for
heterogeneity in both perfusion and ventilation. However, looking at the Full lung-VC and
Full lung-VB models allowed us to explore the e¤ects of changing perfusion and ventilation
independently. Changes in the initial blood volume do not a¤ect the initial levels of PO2.
However, signicant decreases in VB0 give rise to RUs which do not have signicant drops
in PO2, since changes in blood volume a¤ect the inammation variable: Also, the e¤ects
of shunting are seen in the later stages of the insult compared to the Full lung-VC model.
Changes in VC0 a¤ect the initial conditions with higher initial tidal volume causing higher
initial PO2 levels and shunting e¤ects are seen throughout the insult. In the Full lung-VBVC
we see the a combination of these e¤ects with initial conditions similar to those of the Full
lung-VC model and venous levels slightly above the xed arterial level of 40 mmHg at the
end of the insult as seen in the Full lung-VB model. More variety in the closing time among
the RUs in the Full lung-VBVC model causes a more gradual decrease in the shunting than
the other full lung models (Figure 47).
In all simulations of the breathing and non-breathing model, the venous PO2 and PCO2
approach their xed arterial levels. Dropping venous PO2 does not a¤ect the level of arterial
PO2 and rising PCO2 does not a¤ect arterial PCO2. However, outside of the lung metabolic
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process consume oxygen and produce carbon dioxide ([27]). A xed arterial level assume
that these metabolic processes are adjusted throughout inammation, so that the arterial
level is maintain. In actuality, the metabolic processes cause drops in venous PO2 to give rise
to drops in arterial PO2 and the opposite holds for PCO2. We have modeled this metabolic
process forming a close loop lung model. This model shows correlated arterial and venous
levels. This now allows PO2 levels to drop to levels which correspond to nearly unsaturated
hemoglobin. These levels were not seen in previous simulation and nullify the assumptions
made regarding hemoglobin dynamics. Therefore, this model is e¤ective for non-lethal insults
to the lung.
Once hemoglobin in the closed loop model is corrected we can consider a closed full lung
model. With this model we can assume a more accurate distribution that accounts for po-
sition of RUs within lung and compare results to experimental data collected for ventilation
perfusion during respiratory distress ([17], [59], [60], [2]). Additionally, the immune subsys-
tem can be replaced with a model of a specic disease, such as pneumonia or inuenza. With
this we can explore changes in PO2 and PCO2 levels during a specic disease.
With these three model we have explored main aspects of inammation. We have inves-
tigated the role of anti-inammation, the interactions between the blood and tissue during
an immune response, communication between organs, and inammatory e¤ects on the gas
exchange within a RU and on overall lung function during a lethal insult. All of these are
various aspects of inammation that play a role in the progression of MODS. These are model
are an initial step in developing models which can facilitate the advancement of treatment
development for MODS. They provided insight into the role of inammation and interaction
between the local and innate immune response. Using mathematical models to gain insight
into the underlying mechanisms of the immune response may provide a means by which to
steer the development of treatments such that they address the cause of the organ failure,
an overactive immune response. Also using the compartmental and lung models to explore
the spread of inammation to the lung and between organs may give hope to halting the
progression of organ failure which will increase the survivability of MODS.
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6.2 FUTURE DIRECTIONS
In order to create a usable closed lung model during severe inammation, we will augment the
hemoglobin equations, so that they are accurate during the more severe drop in PO2. With
this closed lung model we will simulate the lung with more accurate ventilation perfusion
distributions and compare results to the available data mentioned above.
We would also like to model in lung the spread of inammation from RU to RU via
the tissue rather than the blood. We would have to implement di¤usion between the tissue
units of RUs if they are spatially close to the inammation. More elaborate modeling tech-
niques are required to capture this phenomenon. Additionally, mathematical analysis for the
resulting tissue interactions may give insight to the spread of inammation within the lung.
We plan to implement the compartmental model as the immune system within the lung
model. This will increase the biological delity of the lung model and give more accurate
time courses for the inammation feeding into the gas exchange subsystem. We will then
examine venous PO2 during infection that results in health, aseptic and septic death. Also,
with the shortened computation times it is now possible to include feedback from the gas
exchange system onto the immune system, such as decreases in neutrophil function at low
PO2 [25]. This form of the model easily allows users to alter parameters within an RU and
evaluate their e¤ect on the full lung model.
The compartmental model was t to heuristics for TNF and IL-10. These cytokines
were included, since they are often measured experimentally. We will use data to further
calibrate this model. When using this model to explore organ to organ interaction, we will
introduce heterogeneity to model specic organs. This will allow us to study the spread of
inammation between specic organs, for example, the liver and kidneys.
After further calibration we hope to use these models as predictive tools and guide
experimentation to obtain a greater understanding of interactions on both the cellular and
organ levels.
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APPENDIX A
PARAMETER EXPLANATION FOR THE REDUCED MODEL
The standard parameter values for both the subsystems and the reduced model from Chap-
ter 2, equations A.1-A.4 (equations 4.9-??), are supplied in the tables provided. These
parameter values are selected to remain within the given ranges and constraints found in
the experimental literature as well as in unpublished data. Details on the derivation of
these ranges are given below. Parameters that could not be documented from existing data
were estimated such that the subsystems behave in a biologically appropriate manner for
all physiologically relevant levels of the anti-inammatory mediator. Furthermore, when the
pathogenic insult is replaced by endotoxin as an initiating event, as presented in Day et
al. [18], the resulting model exhibits observed biological behaviors of the immune mediators
during repeated endotoxin administrations
Units forN, CA, andD cannot be determined, since they represent various types of cells,
signaling proteins such as cytokines, and/or other mediators concurrently. These variables
quantify the response of the immune function they represent rather than, for example, an
exact cell count. Correspondingly, units of most parameters related to these variables are
not in conventional form, but rather in terms of the associated variable. How parameters
are estimated in relation to a given subsystem is detailed below along with comments for
documented parameters.
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Equations:
dP
dt
= kpg(

1  P
P1

  kpmsmP
m + kmpP
  kpnf(N)P (A.1)
dN
dt
=
snrR
nr +R
  nN (A.2)
dD
dt
= kdnfs(f(N
))  dD (A.3)
dCA
dt
= sc +
kcnf(N
 + kcndD)
1 + f(N + kcndD)
  cCA (A.4)
Where R = f(knnN + knpP + kndD) and
fs(V ) =
V 6
x6dn + V
6
Tables:
Name Range Value Description Comments Sources
kpm Estimated 0:6=Munits/ hr Rate at which the non-
specic local response
(M) eliminates pathogen
(P )
1, 5
kmp Estimated 0:011=Punits/ hr Rate at which the non-
specic local response
(M) is exhausted by
pathogen (P )
1,6
sm Estimated 0:005 Munits/hr Source of non-specic lo-
cal response (M)
1, 7
m 0.0013 -
0.0048/hr
0:002=hr Decay rate for the non-
specic local response
1, 8 ([34] [80])
kpg 0.021-2.44/hr Various The growth rate of
pathogen
1, 9 ([64]; [70])
p1 Estimated 20106 pg/cc Maximum pathogen pop-
ulation
1, 10 Vodovotz, per-
sonal communi-
cation
kpn Maximum
2.5/N -units/hr
1:81=Nunits/ hr Rate at which activated
phagocytes (N) con-
sume pathogen
2, 11 [13]
Table 20: Parameters for the reduced model of acute inammation
Comments:
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Name Range Value Description Comments Sources
knp Estimated 0:1=Nunits/ hr Activation of resting phago-
cytes (NR) by pathogen
2, 3
knn Estimated 0:01=Nunits/ hr Activation of resting phago-
cytes by already activated
phagocytes and their cy-
tokines
2, 3, 12
snr Estimated 0:08=NRunits/ hr Source of resting phago-
cytes
2, 3, 13.
nr 0.069-0.12/hr 0:12=hr Decay rate of resting
phagocytes (macrophages
and neutrophils)
2, 3, 14 [14]
n Less than nr 0:05=hr Decay rate of activated
phagocytes (macrophages
and neutrophils)
2, 3, 15 [14]
knd Less than knp 0:021=D units/hr Activation of phagocytes by
tissue damage (D)
3, 16 [3]
kdn Estimated 0:35=D units/ hr Max rate of damage pro-
duction by activated phago-
cytes (and/or associated
cytokines/free radicals)
3
xdn Estimated 0:06=N units/ hr Determines level of ac-
tivated phagocytes (N)
needed to bring damage
production up to half its
maximum
3
d 0.017 minimum 0:02=hr Decay rate of damage; com-
bination of repair, resolu-
tion, and regeneration of
tissue
3, 17 [76]
c1 Estimated 0.28 CAunits Controls the strength of the
anti-inammatory response
4, 18 [32]
sc Estimated 0:0125 CAunits/hr Source of the anti-
inammatory mediator
4, 19
kcn Estimated 0:04 CAunits/hr Maximum production rate
of the anti-inammatory
mediator
4
kcnd Estimated 48 Nunits=Dunits Relative e¤ectiveness of
activated phagocytes ver-
sus damage in inducing
the production of anti-
inammatory mediators
4
c 0.15-2.19/hr 0:1=hr Decay rate of the anti-
inammatory mediator
4, 20 [6], [12],
[24], [31]
Hill coe¤. for fs Postive integers 6 The Hill coe¢ cient used in
the production term of tis-
sue damage from the acti-
vated phagocytes
3, 21
Table 21: Table of parameters continued.
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1) The non-specic local immune response/pathogen (M=P ) subsystem with the M
equation in quasi state gave rise to the rst two terms of the pathogen equation, equation
A.1. The parameters in these terms were t such that the pathogen equation is bistable
for kpg below 1.5/hr, which is where the health state loses stability. The kpg level 1.5 was
chosen such that for most physically observed pathogen growth rates the outcome of health
is stable.
2) The activated phagocytes/pathogen (N=P ) subsystem was t such that for low
pathogen growth rate (kpg) health is the only stable state, and at a moderately high kpg
septic death exists and is stable. Parameters in this subsystem were rst estimated so that
these general dynamics occurred for a signicant range of the physiologically possible levels
of the anti-inammatory mediator. They were then adjusted so that the reduced model and
the altered model for endotoxin [18] exhibited observed biological behaviors of the immune
mediators in the presence of pathogen (see comment 4) and endotoxin, respectively.
3) The activated phagocytes/tissue damage (N=D) subsystem was initially t such that
for physiologically relevant levels of the anti-inammatory mediator the system is bistable
between health and aseptic death with a reasonable basin of attraction for the health state.
Adjustments were then made so that the reduced model and the altered model for endo-
toxin [18] exhibited observed biological behaviors of the immune mediators the presence of
pathogen (see comment 4) and endotoxin, respectively.
4) Once the anti-inammatory mediator (CA) was incorporated in the model as a dynamic
variable, the parameters where adjusted so that the reduced model now has the following
behavior (1) the model is bistable between the health and aseptic death states for low kpg
with a plausible basin of attraction for the health state, (2) for moderate to high kpg all
three states (health, aseptic death, and septic death) are stable, and (3) as kpg continues to
increase the health state and the aseptic death state lose stability.
5) The parameter, kpm, quanties the ability of the local non-specic immune response
to clear pathogen. This response is comprised of local factors such as defensins, local
macrophages, and non-specic antibodies (e.g. IgAs). This response is considered to be
less e¢ cient than the phagocyte driven response, which yields the constraint kpm<kpn. The
value of this parameter was estimated such that the local non-specic immune response can
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be overwhelmed with a modest to large inoculum of pathogen.
6) The rate at which the local non-specic immune response is exhausted, kmp, was set
so that kpmsm
m
= 1:5/hr.
7) The parameter, sm, representing the source of the local non-specic immune response
(M) was estimated to balance, m, the decay rate ofM . These parameters are closely related
since the ratio kpmsm
m
= 1:5/hr and at health state M = sm
m
.
8) The range for the decay rate of the non-specic local immune response, m, was
based on the reported half-lives of immunoglobulin G and A, which are non-specic anti-
bodies probably key in this response. These half-lives were documented in the textbook
Immunobiology Fig. 4.16 on page 143 [34] and Table 1 of Zouali et al. [80].
9) Though changed throughout our simulations, the physiologically relevant range for
the growth rate of pathogen, kpg, was taken from Todars Online Textbook of Bacteriology
[70], which uses references from Spectors textbook, Handbook of Biological Data [64].
10) The maximum pathogen level, p1, was estimated from a lethal model of E.coli rat
peritonitis from unpublished data received via personal communication with Y. Vodovotz.
11) We based our estimation for the maximum of kpn, the rate at which activated phago-
cytes consume pathogen, on the observed mean rate of phagocytosis by macrophages in the
presence of unlimited supply of particles up to 20 microns. This result is from the abstract of
Branwood et al. [13]. This is taken as the maximum since the supply of pathogen is limited
under normal circumstances.
12) The parameter, knn, corresponding to the rate of activation of resting phagocytes by
those previously activated, was estimated while to ensure n >
snrknn
nr
. This inequality must
hold for the health state to be stable.
13) The source of resting phagocytes, snr, was set to ensure a stable concentration of
resting phagocytes (NR) in the health state. As with the other source parameter, sm, this snr
was adjusted to balance the decay rate of resting phagocytes. These parameters are related
since at health NR = snrnr .
14) The range for the decay rate of the resting phagocytes, nr, was calculated from the
half-lives (6-20 hours) of circulating neutrophils presented in Coxon et al. [14].
15) The half-life of activated phagocytes, n, is longer than the half-life of resting phago-
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cytes, nr , due to delayed apoptosis in the activated population; therefore n < nr [14].
16) The peak of the activated phagocyte response elicited from pathogen, knp, is greater
than that triggered by damage, knd; therefore, knd < knp.
17) The minimum for d, which represents tissue repair, resolution, and regeneration,
was estimated from data in Wang et al. [76]. We used the half-life of HMG-1 (HMGb-1),
since it is a histone tethering protein leaked by damaged cells as a surrogate for the many
danger molecules that perpetuate the inammatory signal. Wang and colleagues give data
for HMG-1 levels during an inammatory response to bacterial lipopolysaccharide (LPS).
Therefore, we estimated the lower limit as the slope of the data shown in Fig. 1C of Wang
et al. [76] during the decay phase of HMG-1. It would be unrealistic to set d to a value
higher than the time constant of a recognized marker of cellular injury.
18) The value for c1 was set such that corresponds to 75% inhibition, i.e. , when
CA reaches maximum value in response to an insult. We set this to be approximately 75%
because Fig. 6B in Isler et al. [32] shows that when the anti-inammatory mediator, IL-10,
is blocked with anti-IL10 there is approximately a 75% increase in the production of IL-12
(a pro-inammatory cytokine produced by activated phagocytes).
19) Organisms have constitutive levels of anti-inammatory e¤ectors. Therefore the
source parameter, sc, was chosen to balance the corresonding documented half-life, c. These
parameters are related because at the health state CA = scc .
20) Anti-inammatory signals have downstream cellular e¤ects not explicitly modeled
herein, lasting longer than the e¤ector cytokines or molecules producing them. Therefore,
the value for c was set at the lower limit of reported half-lives of anti-inammatory e¤ectors,
which were estimated from pg. 130 of Bacon et al. [6], Table 1 on pg. 277 of Bocci [12], pg.
291 of Fuchs et al. [24], and the abstract of Huhn et al. [31].
21) The Hill coe¢ cient for Equation A.3 was set to six so that the response of tissue
damage to activated phagocytes is not hypersensitive. A lower Hill coe¢ cient would not
appropriately represent this. In other words, it is biologically plausible that low levels of
activated phagocytes do not trigger signicant amounts of damage that could lead to a
positive feedback capable of sustaining aseptic death. Also, for values six and higher, there
was not a signicant di¤erence in the sensitivity of damage to the activated phagocytes.
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Contrary to the common inference regarding the use of Hill coe¢ cients in enzymatic kinetics,
we are not implying that a cooperativity-based mechanism is at work.
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APPENDIX B
XPP CODE OF THE REDUCED MODEL AND ITS SUB-SYSTEMS
XPPAUT code for the development and analysis of the reduced model. Followed by the code
for the reduced model.
B.1 ACTIVATED PHAGOCYTES AND PATHOGEN
SUBSYSTEM:
#Code:
# key: #-comment, par-parameter, x-di¤erential equation for variable x, @-numeric
command
#Parameters
par ca=0, d=0
par kpm=0.6, pinf=20, sm=.005, kmp=.01, mum=.002, kpg=.3, kpn=1.8
par mun=.05, snr=.08, munr=.12, knd=0.02, knp=0.1, knn=.01
par mud=.02, kdn=.35, xdn=.06, qna=6
par sc=0.0125, cinf=0.28
par muc=.1, kcn=.04, kcnd=48
#Notes:
#1) qna=Hill coe¢ cient
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#2)  in equations from the main text was replaced by mu in the code above.
#3) d and ca are treated as parameters.
# Function Denitions
f(x,y)=x/(1+y^2)
R=f((knd*d+knp*p+knn*na),ca/cinf)
#Equations
p=kpg*p*(1-p/pinf)-kpm*sm*p/(mum+kmp*p)-kpn*f(na,ca/cinf)*p
na=snr*R/(munr+R)-mun*na
#Initial Conditions
na(0.0)=0.0
p(0.0)=0.0
#Numerical Specications
@ method=rk, tol=0.0001, dt=0.1, total=200.0, bounds=10000000
@ xlo=0, xhi=3, ylo=0, yhi=3, bell=0
@ maxstore=100000
done
B.2 ACTIVATED PHAGOCYTES/ TISSUE DAMAGE
SUBSYSTEM:
#Code:
# key: #-comment, par-parameter, x-di¤erential equation for variable x, @-numeric
command
#Parameters
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par p=0, ca=0
par kpm=0.6, pinf=20, sm=.005, kmp=.01, mum=.002, kpg=.3, kpn=1.8
par mun=.05, snr=.08, munr=.12, knd=0.02, knp=0.1, knn=.01
par mud=.02, kdn=.35, xdn=.06, qna=6
par sc=0.0125, cinf=0.28
par muc=.1, kcn=.04, kcnd=48
#Notes:
#1) qna= Hill coe¢ cient
#2)  in equations from the main text was replaced by mu in the code above.
#3) d and ca are treated as parameters.
#Function Denitions
fs(x,v,hill)=x^hill/(v^hill+x^hill)
f(x,y)=x/(1+y^2)
R=f((knd*d+knp*p+knn*na),ca/cinf)
#Equations
na=snr*R/(munr+R)-mun*na
d=kdn*fs(f(na,ca/cinf),xdn,qna)-mud*d
#Initial Conditions
d(0.0)=0.0
na(0.0)=0.0
#Numerical Specications
@ method=rk, tol=0.0001, dt=0.1, total=200.0, bounds=10000000
@ xlo=0, xhi=3, ylo=0, yhi=3, bell=0
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@ maxstore=100000
done
B.3 ACTIVATED PHAGOCYTES, PATHOGEN, AND TISSUE
DAMAGE SUBSYSTEM (THREE VARIABLE
SUBSYSTEM):
#Code:
# key: #-comment, par-parameter, x-di¤erential equation for variable x, @-numeric
command
#Parameters
par ca=0
par kpm=0.6, pinf=20, sm=.005, kmp=.01, mum=.002, kpg=.3, kpn=1.8
par mun=.05, snr=.08, munr=.12, knd=0.02, knp=0.1, knn=.01
par mud=.02, kdn=.35, xdn=.06, qna=6
par sc=0.0125, cinf=0.28
par muc=.1, kcn=.04, kcnd=48
#Notes:
#1) qna=hill coe¢ cient
#2)  in equations from the main text was replaced by mu in the code above.
#3) ca is treated as parameters
# Function Denitions
fs(x,v,hill)=x^hill/(v^hill+x^hill)
f(x,y)=x/(1+y^2)
R=f((knd*d+knp*p+knn*na),ca/cinf)
#Equations
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p=kpg*p*(1-p/pinf)-kpm*sm*p/(mum+kmp*p)-kpn*f(na,ca/cinf)*p
na=snr*R/(munr+R)-mun*na
d=kdn*fs(f(na,ca/cinf),xdn,qna)-mud*d
#Initial Conditions
d(0.0)=0.0
na(0.0)=0.0
p(0.0)=0.0
#Numerical Specication
@ method=rk, tol=0.0001, dt=0.1, total=200.0, bounds=10000000
@ xlo=0, xhi=2, ylo=0, yhi=2, bell=0
@ maxstore=100000
done
B.4 REDUCED MODEL (FULL MODEL):
#Code
# key: #-comment, par-parameter, x-di¤erential equation for variable x, @-numeric
command
#Parameters
par kpm=0.6, pinf=20, sm=.005, kmp=.01, mum=.002, kpg=.3, kpn=1.8
par mun=.05, snr=.08, munr=.12, knd=0.02, knp=0.1, knn=.01
par mud=.02, kdn=.35, xdn=.06, qna=6
par sc=0.0125, cinf=0.28
par muc=.1, kcn=.04, kcnd=48
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#Notes:
#1) qna=hill coe¢ cient
#2)  in equations from the main text was replaced by mu in the code.
#Function Denitions
fs(x,v,hill)=x^hill/(v^hill+x^hill)
f(x,y)=x/(1+y^2)
R=f((knd*d+knp*p+knn*na),ca/cinf)
#Equations
p=kpg*p*(1-p/pinf)-kpm*sm*p/(mum+kmp*p)-kpn*f(na,ca/cinf)*p
na=snr*R/(munr+R)-mun*na
d=kdn*fs(f(na,ca/cinf),xdn,qna)-mud*d
ca=-muc*ca+sc+kcn*f(na+kcnd*d,ca/cinf)/(1+f(na+kcnd*d,ca/cinf))
#Initial Conditions
ca(0.0)=0.125
d(0.0)=0.0
na(0.0)=0.0
p(0.0)=0.0
#Numerical Specications
@ method=rk, tol=0.0001, dt=0.1, total=200.0, bounds=10000000
@ xlo=0, xhi=200, ylo=0, yhi=10, bell=0
@ maxstore=100000
done
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APPENDIX C
XPP CODE FOR THE COMPARTMENTAL MODEL
XPP-AUT code for the compartmental model and the two organ system created by linking
two tissue compartments to the same blood supply.
C.1 SINGLE TISSUE UNIT CODE:
%CODE:
% KEY %-comments, par-parameters, x-di¤erential equation for variable x, @-numeric
commands
C.1.1 %PARAMETERS
% Source and decay rates
par sm=10, snb=10, sb=0.0075, sbb=0.0075
par mum=0.12, muma=0.05, mul=3, mulb=3, mut=1.8, mutb=1.8
par munb=0.12, munba=0.05, muna=0.05, muimin=0.005, muimax=.34
par muibmin=0.005, muibmax=0.34, mur=4, murb=4
% Growth rate and population maximum for pathogen in the tissue and the blood
par kpg=0.6, pinf=20000, pbinf=20
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% Tissue repair rate and the maximum of tissue integrity is set to one.
par ktg=2, tinf=1
% Di¤usion baseline (db_) and facilitate (df_)
par dbmol=10, dfmol=1, dbn=.005, dfn=50, dbp=1, dfp=1
% Portion of the neutrophil and macrophage population that remains when neutrophils
and macrophages t pathogen.
% For example, r1=0.98 means that the depletion term in the tissue neutrophils equation
for their interaction with pathogen is
% multiplied by (1-r1).
par r1=0.98,r2=0.98, q=1
% Background immune system parameters
par kpb=.46,kpbb=.46, mub=0.0023,mubb=0.0023,kbp=0.0001,kbbp=0.02
% Activation of macrophages and neutrophils
par kmp=40, kmtcell=20, kmtmol=5, kmrcell=0.01, knpbcell=5, knlbmol=0
par kntbcell=2, kntbmol=0.8, knrbcell=0.1
% Cytokine production
par kmai=1000
par kmat=3000
% Depletion of pathogen
par kmappath=2.8, kmapcell=0
par knappath=5.8,knapbpath=.04, knapcell=5, knapbcell=5
% Tissue depletion from radicals
par krtt=0.01
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%Radical production terms
par krtr=0.1, knar=0.01, knarb=0.01, knatr=0.01, krntp=0.2, krtmp=0.00001
% Inammation growth rate, decay rate, and Hill constant
par ktz=0.5, b=.01, xtz=20, kzti=0.1, thillz=2
% Threshold for tissue integrity. If TI falls below parameter a, TI cannot repair itself.
par a=.1
% Hill parameters for activation triggered by TNF
par xtb=2, xt=20, thill=2
% Inhibition parameters
par il10bar=200, ci=.05, il10bbar=200,cib=.05, il10tbar=60,cit=.000001
par il10tbbar=15,citb=.000001,il10nbar=80,cin=.15,il10nbbar=80,cinb=.15
par e=3, te=5, be=3, tbe=3, ne=1, nbe=1
% Parameters for the increase of resting neutrophil source during inammation
par ksnb=3, xsnb=200, hillsnb=2
% Hill parameters for the interactions involving pathogen
par xpma=200, xpna=1500, phill=3, xpb=.1, pbhill=1
%Di¤usion parameters
par utexp=2,ltexp=1
par at=50, bt=0.8, ab=2000
par b1=1, c1=1
% Compartmental volume
par vb=50
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par vt=.5
% Hill parameters for the production of TNF
par xma=80, mahill=2
% Hill parameters for the production of IL-10 and the changes in the decay rate of IL-10
during inammation
par vi=8, hilli=2, xmi=140,hillmi=2, pro=1, vib=8
% This parameter is set to zero to turn o¤ all neutrophil interactions
par naono¤=1
% This parameter is set to zero to turn o¤ all macrophage interactions
par maono¤=1
C.1.2 % FUNCTION DEFINITIONS
% Hill equation
f(x,v,hill)=x^hill/(v^hill+x^hill)
% Inhibition functions
(x,y)=x*((1-ci)/(1+(y/il10bar)^e)+ci)
n(x,y)=x*((1-cin)/(1+(y/il10nbar)^ne)+cin)
t(x,y)=x*((1-cit)/(1+(y/il10tbar)^te)+cit)
tb(x,y)=x*((1-citb)/(1+(y/il10tbbar)^tbe)+citb)
b(x,y)=x*((1-cib)/(1+(y/il10bbar)^be)+cib)
nb(x,y)=x*((1-cinb)/(1+(y/il10nbbar)^nbe)+cinb)
% Di¤usion functions
dmol=dbmol*(1+z*dfmol)
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dn=dbn*(1+z*dfn)
dp=dbp*(1+z*dfp)
% growth rate of the pathogen is assumed to be the same in the tissue and blood.
kpbg=kpg
% Di¤usion of pathogen from the blood to the tissue
pbdi¤(x,a)=a*x
% To reduce computation times p13(x) is used to estimate the cube root of x.
p13(x)=1.02*(1+x)^(1/3)*x/(.5+x)
% Di¤usion of pathogen from the tissue into the blood is dependent on surface area of
the population
ptdi¤(x,a,b,upperexp,lowerexp)=a*p13(x)*p13(x)/(1+b*p13(x))
% Allows you to plot the activation of macrophages due to TNF during simulations
aux tnfact=kmtcell*(m*f(tnf,xt,thill),il10)
% Allows you to plot the activation of macrophages due to pathogen during simulations
aux pact=kmp*(m,il10)*f(p,xpma,phill)
% Allows you to plot the decay rate of IL-10 in the tissue during simulations
aux mui=(muimax-pro*(muimax-muimin)*(il10^hilli)/(vi^hilli+il10^hilli))
% Allows you to plot the source rate of neutrophils during simulations
aux sourcen=snb+ksnb*f(b1*nba+c1*na,xsnb,hillsnb)
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C.1.3 %EQUATIONS: b-denotes blood
% PATHOGEN EQUATIONS
p=kpg*p*(1-p/pinf)-kmappath*(ma*f(p,xpma,phill),il10)
-knappath*n(na*f(p,xpna,phill),il10)-sb*kpb*p/(mub+kbp*p)
+dp*pbdi¤(pb,ab)/vt-dp*ptdi¤(p,at,bt,utexp,ltexp)/vt
pb=kpbg*pb*(1-pb/pbinf)-knapbpath*nb(nba*f(pb,xpb,pbhill),il10b)
+dp*ptdi¤(p,at,bt,utexp,ltexp)/vb -dp*pbdi¤(pb,ab)/vb
-sbb*kpbb*pb/(mubb+kbbp*pb)
% MACROPHAGE EQUATIONS
m=sm-mum*m-maono¤*(kmp*(m*f(p,xpma,phill),il10)
+kmtcell*(m*f(tnf,xt,thill),il10) +kmrcell*(m,il10)*rad)
ma=-muma*ma+maono¤*(kmp*(m*f(p,xpma,phill),il10)
+kmtcell*(m*f(tnf,xt,thill),il10) +kmrcell*(m,il10)*rad)
-(1-q)*kmapcell*(p*ma,il10)
% TNF EQUATIONS
tnf= -mut*tnf+dmol*(tnfb-tnf)/vt-kmtmol*(m*f(tnf,xt,thill),il10)
+kmat*t(f(ma,xma,mahill),il10)
tnfb= -mutb*tnfb+dmol*(tnf-tnfb)/vb-kntbmol*nb(nb*f(tnfb,xtb,thill),il10b)
% NEUTROPHIL EQUATIONS
nb=(snb+ksnb*f(b1*nba+c1*na,xsnb,hillsnb))-munb*nb
-naono¤*(kntbcell*nb(nb*f(tnfb,xtb,thill),il10b)+knrbcell*nb(nb*radb,il10b)
+knpbcell*b(nb*f(pb,xpb,pbhill),il10b))
na= -muna*na+dn*nba/vt-(1-r1)*knapcell*n(na*f(p,xpna,phill),il10)
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nba=-munba*nba-dn*nba/vb+naono¤*(knpbcell*nb(nb*f(pb,xpb,pbhill),il10b)
+kntbcell*nb(nb*f(tnfb,xtb,thill),il10b)+knrbcell*nb(nb*radb,il10b)
-(1-r2)*knapbcell*nb(nba*f(pb,xpb,pbhill),il10b))
% IL-10 EQUATIONS
il10= -(muimax-pro*(muimax-muimin)*(il10^hilli)/(vi^hilli+il10^hilli))*il10
+dmol*(il10b-il10)/vt+kmai*(f(ma,xmi,hillmi),il10)
il10b= -(muibmax-pro*(muibmax-muibmin)*(il10b^hilli)/(vib^hilli+il10b^hilli))*il10b
+dmol*(il10-il10b)/vb
% RADICAL EQUATIONS
rad= -mur*rad+dmol*(radb-rad)/vt+krtr*rad*(ti)+knar*n(na,il10)+knatr*na*(ti)
+krntp*na*p*(ti)+krtmp*ma*p*(ti)
radb=-murb*radb+dmol*(rad-radb)/vb+knarb*nb(nba,il10b)
% TISSUE INTEGRITY EQUATION
ti=ktg*ti*(1-ti/tinf)*(ti-a)-krtt*rad*ti
% INFLAMMATION EQUATIONS
z=ktz*(f(tnf,xtz,thillz)+kzti*(tinf-ti))*(1-z)-b*z
% INITIAL CONDITION FOR TISSUE INTEGRITY
ti(0)=1
C.1.4 %NUMERICS
@ method=qrk, tol=0.0001, dt=0.1, total=200.0, bounds=10000000
@ xp=t,yp=p, xlo=0, xhi=200, ylo=0, yhi=20, bell=0
@ maxstore=10000
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C.2 TWO ORGAN SYSTEM
The following XPP-AUT code simulates of multiple tissue compartments connected to the
same blood compartment.
%CODE:
% KEY %-comments, par-parameters, x-di¤erential equation for variable x, @-numeric
commands
% Up to three tissue units connected to one blood unit
C.2.1 %PARAMETERS: b-denotes blood
% Source and decay rates
par sm1=10, sm2=10,sm3=10, snb=10, sb1=0.0075, sb2=0.0075,sb3=0.0075,sbb=0.0075
par mum1=0.12, mum2=0.12, mum3=0.12, muma1=0.05, muma2=0.05,muma3=0.05
par mul1=3, mul2=3, mul3=3, mulb=3, mut1=1.8, mut2=1.8, mut3=1.8,mutb=1.8
par munb=0.12, munba=0.05, muna1=0.05, muna2=0.05, muna3=0.05,mui1min=0.005
par mui1max=.34,mui2min=0.005, mui2max=.34,mui3min=0.005, mui3max=.34
par muibmin=0.005, muibmax=.34, mur1=4,mur2=4, mur3=4, murb=4
% Growth rate and population maximum for pathogen in the tissue and the blood
par kpg1=0.6, kpg2=0.6, kpg3=.6, kpbg=.6
par pinf1=20000, pinf2=20000, pinf3=20000, pbinf=20
% Tissue repair rate and the maximum of tissue integrity is set to one.
par ktg1=2,ktg2=2,ktg3=2, tinf1=1,tinf2=1, tinf3=1
% Di¤usion baseline (db_) and facilitate (df_)
par dbmol1=10,dbmol2=10, dbmol3=10, dfmol1=1,dfmol2=1, dfmol3=1
par dbn1=0.005, dbn2=0.005, dbn3=0.005, par dfn1=50, dfn2=50, dfn3=50
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par dbp1=1,dbp2=1,dbp3=1, dfp1=1, dfp2=1, dfp3=1
% Portion of the neutrophil and macrophage population that remains when neutrophils
and macrophages t pathogen.
% For example, r1=0.98 means that the depletion term in the tissue neutrophils equation
for their interaction with pathogen is
% multiplied by (1-r1).
par r1=0.98,r2=0.98,r3=0.98,rb=0.98, q1=1, q2=1, q3=1
% Background immune system parameters
par kpb1=.46,kpb2=.46,kpb3=.46, kpbb=.46, mub1=0.0023,mub2=0.0023,mub3=0.0023
par mubb=0.0023, kbp1=0.0001,kbp2=0.0001, kbp3=0.0001,kbbp=0.02
% Activation of macrophages and neutrophils
par kmp1=40, kmp2=40, kmp3=40, kmtcell1=20, kmtcell2=20, kmtcell3=20
par kmrcell1=.01, kmrcell2=0.01, kmrcell3=0.01
par kmtmol1=5, kmtmol2=5, kmtmol3=5, knlbcell=0, knlbmol=0
par kntbcell=2, kntbmol=0.8, knrbcell=0.1, knpbcell=5
% Cytokine production
par kmai1=1000,kmai2=1000,kmai3=1000
par kmat1=3000,kmat2=3000,kmat3=3000
% Depletion of pathogen
par kmappath1=2.8,kmappath2=2.8,kmappath3=2.8
par kmapcell1=0,kmapcell2=0,kmapcell3=0
par knappath1=5.8, knappath2=5.8, knappath3=5.8, knapbpath=0.04
par knapcell1=5, knapcell2=5, knapcell3=5, knapbcell=5,
% Tissue depletion from radicals
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par krtt1=0.01, krtt2=0.01, krtt3=0.01
%Radical production terms
par krtr1=0.1,krtr2=0.1,krtr3=0.1,knar1=0.01,knar2=0.01,knar3=0.01,knarb=0.01
par knatr1=0.01, knatr2=0.01, knatr3=0.01, krntp1=0.2, krntp2=0.2, krntp3=0.2
par krtmp1=1e-5, krtmp2=1e-5, krtmp3=1e-5
% Inammation growth rate, decay rate, and Hill constant
par ktz1=.5, ktz2=.5, ktz3=.5, b1=.01, b2=.01,b3=.01, xtz1=20, xtz2=20, xtz3=20
% Threshold for tissue integrity. If TI falls below parameter a, TI cannot repair itself.
par a1=.1, a2=.1,a3=.1
% Hill parameters for activation triggered by TNF
par xtb=2, xt1=20,xt2=20, xt3=20, thill1=2, thill2=2, thill3=2,tbhill=2
% Inhibition parameters
par il10bar1=200,il10bar2=200,il10bar3=200, ci1=0.05,ci2=0.05, ci3=0.05
par il10bbar=200,cib=0.05, il10tbar1=60, il10tbar2=60,il10tbar3=60
par cit1=0.000001, cit2=0.000001, cit3=0.000001, il10tbbar=15, citb=.000001
par il10nbbar=80, cinb=.15, il10nbar1=80, cin1=.15, il10nbar2=80, cin2=.15
par il10nbar3=80,cin3=.15
par e1=3, te1=5,e2=3, te2=5,e3=3, te3=5, be=3, tbe=3
par ne1=1,ne2=1,ne3=1, nbe=1
% Parameters for the increase of resting neutrophil source during inammation
par ksnb=3, xsnb=200, hillsnb=2, b11=1, c1=1
% Hill parameters for the interactions involving pathogen
par xpma1=200, xpma2=200. xpma3=200, xpna1=1500,xpna2=1500 , xpna3=1500
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par phill1=3, phill2=3, phill3=3, xpb=0.1, pbhill=1
%Di¤usion parameters
par utexp=2,ltexp=1
par at=50, bt=0.8, ab=2000, bb=0
% Compartmental Volume
par vb=50
par vt1=.5, vt2=.5, vt3=.5
% Hill parameters for the production of TNF
par xma1=80,xma2=80,xma3=80, mahill1=2, mahill2=2, mahill3=2
% Hill parameters for the production of IL-10 and the changes in the decay rate of IL-10
during inammation
par vi1=8, vi2=8,vi3=8, vib=8, hilli1=2, hilli2=2,hilli3=2,hillib=2
par xmi1=140, xmi2=140, xmi3=140, hillmi1=2, hillmi2=2, hillmi3=2
par pro1=1, pro2=1, pro3=1, prob=1
par thillz1=2, thillz2=2, thillz3=2
par kzti1=0.1, kzti2=0.1, kzti3=0.1
% These parameters control whether there are two or three organs connected to the
blood supply
par y2=1, y3=1
% These parameters are set to zero to turn o¤ all neutrophil interactions in associate
organ
par na1ono¤=1,na2ono¤=1,na3ono¤=1
% These parameters are set to zero to turn o¤ all macrophage interactions in associate
organ
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par ma1ono¤=1,ma2ono¤=1,ma3ono¤=1
% This parameter is set to zero to turn o¤ all neutrophil interactions in the blood
par nbono¤=1
% Controls the relative di¤usion of each organ
par d1=1,d2=1,d3=1
C.2.2 % FUNCTION DEFINITIONS
% hill equation
f(x,v,hill)=x^hill/(v^hill+x^hill)
% Inhibition functions
1(x,y)=x*((1-ci1)/(1+(y/il10bar1)^e1)+ci1)
2(x,y)=x*((1-ci2)/(1+(y/il10bar2)^e2)+ci2)
3(x,y)=x*((1-ci3)/(1+(y/il10bar3)^e3)+ci3)
b(x,y)=x*((1-cib)/(1+(y/il10bbar)^be)+cib)
n1(x,y)=x*((1-cin1)/(1+(y/il10nbar1)^ne1)+cin1)
n2(x,y)=x*((1-cin2)/(1+(y/il10nbar2)^ne2)+cin2)
n3(x,y)=x*((1-cin3)/(1+(y/il10nbar3)^ne3)+cin3)
t1(x,y)=x*((1-cit1)/(1+(y/il10tbar1)^te1)+cit1)
t2(x,y)=x*((1-cit2)/(1+(y/il10tbar2)^te2)+cit2)
t3(x,y)=x*((1-cit3)/(1+(y/il10tbar3)^te1)+cit3)
tb(x,y)=x*((1-citb)/(1+(y/il10tbbar)^tbe)+citb)
nb(x,y)=x*((1-cinb)/(1+(y/il10nbbar)^nbe)+cinb)
% Di¤usion functions
dmol1=d1*dbmol1*(1+z1*dfmol1)
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dmol2=d2*dbmol2*(1+z2*dfmol2)
dmol3=d3*dbmol3*(1+z3*dfmol3)
dn1=d1*dbn1*(1+z1*dfn1)
dn2=d2*dbn2*(1+z2*dfn2)
dn3=d3*dbn3*(1+z3*dfn3)
dp1=d1*dbp1*(1+z1*dfp1)
dp2=d2*dbp2*(1+z2*dfp2)
dp3=d3*dbp3*(1+z3*dfp3)
% Di¤usion of pathogen from the blood to the tissue
pbdi¤(x,a)=a*x
% To reduce computation times p13(x) is used to estimate the cube root of x.
p13(x)=1.02*(1+x)^(1/3)*x/(.5+x)
% Di¤usion of pathogen from the tissue into the blood is dependent on surface area of
the population
ptdi¤(x,a,b,upperexp,lowerexp)=a*p13(x)*p13(x)/(1+b*p13(x))
C.2.3 % BLOOD EQUATIONS
% TNF EQUATION
tnfb= -mutb*tnfb+dmol1*(tnf1-tnfb)/vb+y2*dmol2*(tnf2-tnfb)/vb
+y3*dmol3*(tnf3-tnfb)/vb-kntbmol*nb(nb*f(tnfb,xtb,tbhill),il10b)
% RESTING NEUTROPHILS EQUATION
nb=nbono¤*((snb+ksnb*f(b11*nba+c1*(na1+y2*na2+y3*na3),xsnb,hillsnb))-munb*nb
-knpbcell*b(nb*f(pb,xpb,pbhill),il10b-kntbcell*nb(nb*f(tnfb,xtb,tbhill),il10b)
-knrbcell*nb(nb*radb,il10b))
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% ACTIVATED NEUTROPHILS EQUATION
nba=nbono¤*(-munba*nba-dn1*nba/vb-y2*dn2*nba/vb-y3*dn3*nba/vb
+knpbcell*nb(nb*f(pb,xpb,pbhill),il10b)+kntbcell*nb(nb*f(tnfb,xtb,tbhill),il10b)
+knrbcell*nb(nb*radb,il10b)-(1-rb)*knapbcell*nb(nba*f(pb,xpb,pbhill),il10b))
% IL-10 EQUATION
il10b= -(muibmax-prob*(muibmax-muibmin)*(il10b^hillib)/(vib^hillib+il10b^hillib))*il10b
+dmol1*(il101-il10b)/vb+y2*dmol2*(il102-il10b)/vb+y3*dmol3*(il103-il10b)/vb
% RADICAL EQUATION
radb=-murb*radb+dmol1*(rad1-radb)/vb+y2*dmol2*(rad2-radb)/vb
+y3*dmol3*(rad3-radb)/vb+knarb*nb(nba,il10b)
% PATHOGEN EQUATION
pb=kpbg*pb*(1-pb/pbinf)-nbono¤*knapbpath*nb(nba*f(pb,xpb,pbhill),il10b)
+dp1*ptdi¤(p1,at,bt,utexp,ltexp)/vb-dp1*pbdi¤(pb,ab)/vb
+y2*(dp2*ptdi¤(p2,at,bt,utexp,ltexp)/vb-dp2*pbdi¤(pb,ab)/vb)
+y3*(dp3*ptdi¤(p3,at,bt,utexp,ltexp)/vb-dp3*pbdi¤(pb,ab)/vb)-sbb*kpbb*pb/(mubb+kbbp*pb)
C.2.4 % TISSUE 1 EQUATIONS
% PATHOGEN EQUATION
p1=kpg1*p1*(1-p1/pinf1)-ma1ono¤*kmappath1
*1(ma1*f(p1,xpma1,phill1),il101)
-na1ono¤*knappath1*n1(na1*f(p1,xpna1,phill1),il101)
-sb1*kpb1*p1/(mub1+kbp1*p1)-dp1*ptdi¤(p1,at,bt,utexp,ltexp)/vt1
+dp1*pbdi¤(pb,ab)/vt1
% RESTING MACROPHAGE EQUATION
m1= ma1ono¤*(sm1-mum1*m1-kmp1*1(m1*f(p1,xpma1,phill1),il101)
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-kmtcell1*1(m1*f(tnf1,xt1,thill1),il101)-kmrcell1*1(m1*rad1,il101))
% ACTIVATED MACROPHAGE EQUATION
ma1=ma1ono¤*(-muma1*ma1+kmp1*1(m1*f(p1,xpma1,phill1),il101)
+kmtcell1*1(m1*f(tnf1,xt1,thill1),il101)+kmrcell1*1(m1*rad1,il101)
-(1-q1)*kmapcell1*1(p1*ma1,il101))
%TNF EQUATION
tnf1= -mut1*tnf1+dmol1*(tnfb-tnf1)/vt1
-ma1ono¤*kmtmol1*1(m1*f(tnf1,xt1,thill1),il101)
+ma1ono¤*kmat1*t1(f(ma1,xma1,mahill1),il101)
% ACTIVATED NEUTROPHIL EQUATION
na1= -muna1*na1
+dn1*nba/vt1-(1-r1)*na1ono¤*knapcell1*n1(na1*f(p1,xpna1,phill1),il101)
% IL-10 EQUATION
il101= -(mui1max-pro1*(mui1max-mui1min)
*(il101^hilli1)/(vi1^hilli1+il101^hilli1))*il101
+dmol1*(il10b-il101)/vt1+ma1ono¤*kmai1*1(f(ma1,xmi1,hillmi1),il101)
% RADICAL EQUATION
rad1= -mur1*rad1+dmol1*(radb-rad1)/vt1+krtr1*rad1*ti1
+na1ono¤*knar1*n1(na1,il101)
+na1ono¤*knatr1*na1*(ti1)+na1ono¤*krntp1*na1*p1*(ti1)
+ma1ono¤*krtmp1*ma1*p1*(ti1)
% TISSUE INTEGRITY EQUATION
ti1=(ktg1*ti1*(1-ti1/tinf1)*(ti1-a1)-krtt1*rad1*ti1)
% INFLAMMATION EQUATION
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z1=ktz1*(f(tnf1,xtz1,thillz1)+kzti1*(tinf1-ti1))*(1-z1)-b1*z1
C.2.5 % TISSUE 2 EQUATIONS
% PATHOGEN EQUATION
p2=y2*(kpg2*p2*(1-p2/pinf2)-ma2ono¤*kmappath2*2(ma2*f(p2,xpma2,phill2),il102)
-na2ono¤*knappath2*n2(na2*f(p2,xpna2,phill2),il102)-sb2*kpb2*p2/(mub2+kbp2*p2)
-dp2*ptdi¤(p2,at,bt,utexp,ltexp)/vt2+dp2*pbdi¤(pb,ab)/vt2)
% RESTING MACROPHAGE EQUATION
m2=y2*ma2ono¤*(sm2-mum2*m2-kmp2*2(m2*f(p2,xpma2,phill2),il102)
-kmtcell2*2(m2*f(tnf2,xt2,thill2),il102)-kmrcell2*2(m2,il102)*rad2)
% ACTIVATED MACROPHAGE EQUATION
ma2=y2*ma2ono¤*(-muma2*ma2+kmp2*2(m2*f(p2,xpma2,phill2),il102)
+kmtcell2*2(m2*f(tnf2,xt2,thill2),il102)-(1-q2)*kmapcell2*2(p2*ma2,il102)
+kmrcell2*2(m2,il102)*rad2)
%TNF EQUATION
tnf2=y2*(-mut2*tnf2+dmol2*(tnfb-tnf2)/vt2
-ma2ono¤*kmtmol2*2(m2*f(tnf2,xt2,thill2),il102)
+ma2ono¤*kmat2*t2(f(ma2,xma2,mahill2),il102))
% ACTIVATED NEUTROPHIL EQUATION
na2=y2*(-muna2*na2+dn2*nba/vt2
-na2ono¤*(1-r2)*knapcell2*n2(na2*f(p2,xpna2,phill2),il102))
% IL-10 EQUATION
il102=y2*(-(mui2max-pro2*(mui2max-mui2min)*(il102^hilli2)/(vi2^hilli2+il102^hilli2))*il102
+dmol2*(il10b-il102)/vt2+ma2ono¤*kmai2*2(f(ma2,xmi2,hillmi2),il102))
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% RADICAL EQUATION
rad2=y2*(-mur2*rad2+dmol2*(radb-rad2)/vt2+krtr2*rad2*ti2+na2ono¤*knatr2*na2*ti2
+na2ono¤*knar2*n2(na2,il102)+na2ono¤*krntp2*na2*p2*(ti2)
+ma2ono¤*krtmp2*ma2*p2*(ti2))
% TISSUE INTEGRITY EQUATION
ti2=y2*((ktg2*ti2*(1-ti2/tinf2)*(ti2-a2)-krtt2*rad2*ti2))
% INFLAMMATION EQUATION
z2=y2*(ktz2*(f(tnf2,xtz2,thillz2)+kzti2*(tinf2-ti2))*(1-z2)-b2*z2)
%TISSUE 3 EQUATIONS
% PATHOGEN EQUATION
p3=y3*(kpg3*p3*(1-p3/pinf3)
-ma3ono¤*kmappath3*3(ma3*f(p3,xpma3,phill3),il103)
-na3ono¤*knappath3*n3(na3*f(p3,xpna3,phill3),il103)
-sb3*kpb3*p3/(mub3+kbp3*p3)
-dp3*ptdi¤(p3,at,bt,utexp,ltexp)/vt3+dp3*pbdi¤(pb,ab)/vt3)
% RESTING MACROPHAGE EQUATION
m3=y3*(sm3-mum3*m3-ma3ono¤*kmp3*3(m3*f(p3,xpma3,phill3),il103)
-ma3ono¤*kmtcell3*3(m3*f(tnf3,xt3,thill3),il103)
-ma3ono¤*kmrcell3*3(m3,il103)*rad3)
% ACTIVATED MACROPHAGE EQUATION
ma3=y3*(-muma3*ma3+ma3ono¤*kmp3*3(m3*f(p3,xpma3,phill3),il103)
+ma3ono¤*kmtcell3*3(m3*f(tnf3,xt3,thill3),il103)
-ma3ono¤*(1-q3)*kmapcell3*3(p3*ma3,il103)
+ma3ono¤*kmrcell3*3(m3,il103)*rad3)
%TNF EQUATION
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tnf3=y3*(-mut3*tnf3+dmol3*(tnfb-tnf3)/vt3
-ma3ono¤*kmtmol3*3(m3*f(tnf3,xt3,thill3),il103)
+ma3ono¤*kmat3*t3(f(ma3,xma3,mahill3),il103))
% ACTIVATED NEUTROPHIL EQUATION
na3=y3*(-muna3*na3+dn3*nba/vt3
-(1-r3)*na3ono¤*knapcell3*n3(na3*f(p3,xpna3,phill3),il103))
% IL-10 EQUATION
il103=y3*(-(mui3max-pro3*(mui3max-mui3min)*(il103^hilli3)
/(vi3^hilli3+il103^hilli3))*il103
+dmol3*(il10b-il103)/vt3
+ma3ono¤*kmai3*3(f(ma3,xmi3,hillmi3),il103))
% RADICAL EQUATION
rad3=y3*(-mur3*rad3+dmol3*(radb-rad3)/vt3+krtr3*rad3*ti3
+na3ono¤*knatr3*na3*ti3+na3ono¤*knar3*n3(na3,il103)
+na3ono¤*krntp3*na3*p3*(ti3)
+ma3ono¤*krtmp3*ma3*p3*(ti3))
% TISSUE INTEGRITY EQUATION
ti3=y3*((ktg3*ti3*(1-ti3/tinf3)*(ti3-a3)-krtt3*rad3*ti3))
% INFLAMMATION EQUATION
z3=y3*(ktz3*(f(tnf3,xtz3,thillz3)+kzti2*(tinf3-ti3))*(1-z3)-b3*z3)
% Initial condition for tissue integrity
ti2(0)=1
ti1(0)=1
ti3(0)=1
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C.2.6 %NUMERICS
@ method=gear, tol=0.0001, dt=0.1, total=200.0, bounds=10000000
@ xlo=0, xhi=200, ylo=0, yhi=10, bell=0
@ maxstore=10000
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APPENDIX D
CODE FOR THE FULL LUNG MODEL
This appendix contains the Matlab code for the immune subsystem, single respiratory unit
and full lung. It also contains the XPP-AUT code for the immune subsystem and single
respiratory unit and pseudo code for the implementation of the full lung with a distribution
in the initial tidal volumes. The XPP-AUT code for the single respiratory unit requires tab
les created from the immune subsystem. These table are only created when the immune
subsystem is run in Matlab. Therefore, to run the single RU in XPP you must rst run
the immune subsystem Matlab Code in the directory that the XPP code will run from.
The Matlab immune subsystem code must also be run before the single RU Matlab code.
This code requires as input the matrix data, which is produced from the immune subsystem
Matlab code.
D.1 IMMUNE SUBSYSTEM
D.1.1 Matlab code for the immune subsystem:
D.1.1.1 immunepde.m: (main m-le of the system) This code must be run before
using the single RU is simulated in either XPP or Matlab.
CODE:
function [data,NewIC,v]=immunepde(ic,t0,tnal,tinc,vtidal0)
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% This code solves the system of ODE dened in dximmunepde.m with builtin Matlab
solver ode15s for sti¤ systems.
% Input parameters:
% ic is the initial conditions vector, which is of length 81. Changing ic(21) introduces
the inammtion in the blood by increasing tnfb. The lethal insult used throughout the
simulations of this thesis were initiated by setting ic(21)=4 in the command line.
% t0- is the initial time and this typically set to zero.
% tnal- is the total time the immune subsystem will run. (This system runs in hours)
% tinc- is the increment in time used when returning the data matrix. To use the data
matrix in XPP set this to 0.5.
%vtidal0- initial scaled tidal volume. In the normal RU we assume this is 350 ml. The
code will scale this to its corresponding volume on a sinlge RU. In the full lung this ranges
between 150 and 550 by increments of 10.
% Output paramters:
% data- matrix of the solutions to the ODE in dximmunepde
% The following entry in the command line of Matlab when in the directory that this
m-le exist will run the immune subsystem with no inammation and normal volumes. The
matrix data produced is needed in the single RU code to nd the initial conidition at health
from the vb0, vc0, vamin0 chosen.
% ic=zeros(1,81) followed by [data,NewIC,v]=immunepde(ic,0,2,.5,350,90,2300);
close all;
%following sets initial conditions and tolerences
k=ones(1,81);
nba1=ic(1);nba2=ic(2);nba3=ic(3);nba4=ic(4);nba5=ic(5);nba6=ic(6);nba7=ic(7);
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nba8=ic(8);nba9=ic(9);nba10=ic(10);nba11=ic(11);nba12=ic(12);nba13=ic(13);
nba14=ic(14);nba15=ic(15);nba16=ic(16);nba17=ic(17);nba18=ic(18);
nba19=ic(19);nba10=ic(10);nba20=ic(20);
tnfb=ic(21);
na1=ic(22);na2=ic(23);na3=ic(24);na4=ic(25);na5=ic(26);na6=ic(27);na7=ic(28);
na8=ic(29);na9=ic(30);na10=ic(31);na11=ic(32);na12=ic(33);na13=ic(34);
na14=ic(35);na15=ic(36);na16=ic(37);na17=ic(38);na18=ic(39);na19=ic(40);
na20=ic(41);tnf1=ic(42);tnf2=ic(43);tnf3=ic(44);tnf4=ic(45);tnf5=ic(46);tnf6=ic(47);
tnf7=ic(48);tnf8=ic(49);tnf9=ic(50);tnf10=ic(51);tnf11=ic(52);tnf12=ic(53);
tnf13=ic(54);tnf14=ic(55);tnf15=ic(56);tnf16=ic(57);tnf17=ic(58);tnf18=ic(59);
tnf19=ic(60);tnf20=ic(61);z1=ic(62);z2=ic(63);z3=ic(64);z4=ic(65);z5=ic(66);
z6=ic(67);z7=ic(68);z8=ic(69);z9=ic(70);z10=ic(71);z11=ic(72);z12=ic(73);
z13=ic(74);z14=ic(75);z15=ic(76);z16=ic(77);z17=ic(78);
z18=ic(79);z19=ic(80);z20=ic(81);
options = odeset(RelTol,1e-8,AbsTol,(1e-8).*k);
% This solves the ode system dened by the in dximmunepde.m from t0 to tnal with
ode solver ode15s
[T,Y] = ode15s(@dximmunepde,[t0:tinc:tnal],[nba1,nba2,nba3,nba4, nba5,nba6, nba7,
nba8,nba9,nba10,nba11,nba12,nba13,nba14,nba15, nba16,nba17,nba18, nba19, nba20,
tnfb, na1, na2,na3,na4,na5,na6,na7,na8,na9,na10,na11,na12, na13,na14,na15,na16,na17,
na18,na19,na20, tnf1, tnf2,tnf3,tnf4,tnf5,tnf6,tnf7,tnf8,tnf9,tnf10,tnf11,tnf12, tnf13,tnf14,
tnf15,tnf16,tnf17,tnf18,tnf19, tnf20, z1,z2,z3,z4,z5,z6,z7,z8,z9,z10,z11,z12,z13,z14,z15,
z16,z17,z18,z19,z20],options);
% plots results
gure;
plot(T,Y(:,1),-);YLABEL(nba1);xLABEL(time);gure;
plot(T,Y(:,21),-.);ylabel(tnfb);xLABEL(time);gure;
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plot(T,Y(:,41),.);YLABEL(na20);xLABEL(time);gure;
plot(T,Y(:,61),+);YLABEL(tnf20);xLABEL(time);gure;
plot(T,Y(:,81),*);YLABEL(z20);xLABEL(time);gure;
%creates tables for the single RU XPP code and the data maxtrix for the single RU
Matlab code. Also, the following code plots the compartmental volumes.
mvtb=.4; mvta=1; auc=.12e8;
vamin0=2300/(.12e8); vbnormal=90/(.12e8); vtnormal=500/(.12e8);
vachange0=vtidal0;closing=10;
vb=auc*(vbnormal./(1+(mvtb.*(sum(Y(:,62:81))/20))));
%plot(T,vb(:,1),*);YLABEL(vb);xLABEL(time);gure;
vt=auc*(vtnormal+vbnormal-vbnormal./(1+(mvtb.*(sum(Y(:,62:81))/20)))
+vamin0-vamin0./(1+(mvta.*(sum(Y(:,62:81))/20))));
%plot(T,vt(:,1),*);YLABEL(vt);xLABEL(time);gure;
vamin=auc*(vamin0./(1+mvta.*(sum(Y(:,62:81))/20)));
%plot(T,vamin(:,1),*);YLABEL(vamin);xLABEL(time);gure;
vc=(vachange0./(1+(closing.*(sum(Y(:,62:81))/20))));
%plot(T,vc(:,1),*);YLABEL(vchange);xLABEL(time);gure;
v0=.2932;
v=v0*90./vb;
%plot(T,v(:,1),*);YLABEL(v);xLABEL(time);
data=[T,Y,vb,vt,vamin,vc];
NewIC=Y(end,:);
na1v=[tnal*(1/tinc)+1; 0; tnal; data(:,23)];
na2v=[tnal*(1/tinc)+1; 0; tnal; data(:,24)];
na3v=[tnal*(1/tinc)+1; 0; tnal; data(:,25)];
na4v=[tnal*(1/tinc)+1; 0; tnal; data(:,26)];
na5v=[tnal*(1/tinc)+1; 0; tnal; data(:,27)];
na6v=[tnal*(1/tinc)+1; 0; tnal; data(:,28)];
na7v=[tnal*(1/tinc)+1; 0; tnal; data(:,29)];
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na8v=[tnal*(1/tinc)+1; 0; tnal; data(:,30)];
na9v=[tnal*(1/tinc)+1; 0; tnal; data(:,31)];
na10v=[tnal*(1/tinc)+1; 0; tnal; data(:,32)];
na11v=[tnal*(1/tinc)+1; 0; tnal; data(:,33)];
na12v=[tnal*(1/tinc)+1; 0; tnal; data(:,34)];
na13v=[tnal*(1/tinc)+1; 0; tnal; data(:,35)];
na14v=[tnal*(1/tinc)+1; 0; tnal; data(:,36)];
na15v=[tnal*(1/tinc)+1; 0; tnal; data(:,37)];
na16v=[tnal*(1/tinc)+1; 0; tnal; data(:,38)];
na17v=[tnal*(1/tinc)+1; 0; tnal; data(:,39)];
na18v=[tnal*(1/tinc)+1; 0; tnal; data(:,40)];
na19v=[tnal*(1/tinc)+1; 0; tnal; data(:,41)];
na20v=[tnal*(1/tinc)+1; 0; tnal; data(:,42)];
length(na1v)
dlmwrite(na1.tab, na1v, nline)
dlmwrite(na2.tab, na2v, nline)
dlmwrite(na3.tab, na3v, nline)
dlmwrite(na4.tab, na4v, nline)
dlmwrite(na5.tab, na5v, nline)
dlmwrite(na6.tab, na6v, nline)
dlmwrite(na7.tab, na7v, nline)
dlmwrite(na8.tab, na8v, nline)
dlmwrite(na9.tab, na9v, nline)
dlmwrite(na10.tab, na10v, nline)
dlmwrite(na11.tab, na11v, nline)
dlmwrite(na12.tab, na12v, nline)
dlmwrite(na13.tab, na13v, nline)
dlmwrite(na14.tab, na14v, nline)
dlmwrite(na15.tab, na15v, nline)
dlmwrite(na16.tab, na16v, nline)
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dlmwrite(na17.tab, na17v, nline)
dlmwrite(na18.tab, na18v, nline)
dlmwrite(na19.tab, na19v, nline)
dlmwrite(na20.tab, na20v, nline)
vtv=[tnal*(1/tinc)+1; 0; tnal; vt];
vbv=[tnal*(1/tinc)+1; 0; tnal; vb];
vaminv=[tnal*(1/tinc)+1; 0; tnal; vamin];
vcv=[tnal*(1/tinc)+1; 0; tnal; vc];
dlmwrite(vt.tab, vtv, nline)
dlmwrite(vb.tab, vbv, nline)
dlmwrite(vamin.tab, vaminv, nline)
dlmwrite(vc.tab, vcv, nline)
D.1.1.2 dximmunepde.m (equations for the right-hand side on the immune
subsystem) CODE:
function r = dximmunepde(t,X)
r=zeros(81,1);
% denes variables
nba1=X(1);nba2=X(2);nba3=X(3);nba4=X(4);nba5=X(5);nba6=X(6);
nba7=X(7);nba8=X(8);nba9=X(9);nba10=X(10);nba11=X(11);
nba12=X(12);nba13=X(13);nba14=X(14);nba15=X(15);nba16=X(16);
nba17=X(17);nba18=X(18);nba19=X(19);nba10=X(10);nba20=X(20);
tnfb=X(21);na1=X(22);na2=X(23);na3=X(24);na4=X(25);na5=X(26);
na6=X(27);na7=X(28);na8=X(29);na9=X(30);na10=X(31);na11=X(32);
na12=X(33);na13=X(34);na14=X(35);na15=X(36);na16=X(37);na17=X(38);
na18=X(39);na19=X(40);na20=X(41);tnf1=X(42);tnf2=X(43);tnf3=X(44);
tnf4=X(45);tnf5=X(46);tnf6=X(47);tnf7=X(48);tnf8=X(49);tnf9=X(50);
tnf10=X(51);tnf11=X(52);tnf12=X(53);tnf13=X(54);tnf14=X(55);
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tnf15=X(56);tnf16=X(57);tnf17=X(58);tnf18=X(59);tnf19=X(60);
tnf20=X(61);z1=X(62);z2=X(63);z3=X(64);z4=X(65);
z5=X(66);z6=X(67);z7=X(68);z8=X(69);z9=X(70);z10=X(71);
z11=X(72);z12=X(73);z13=X(74);z14=X(75);z15=X(76);z16=X(77);
z17=X(78);z18=X(79);
z19=X(80);z20=X(81);
% Parameters
% decat rate:
munba=.05;
muna=.05;
mutb=1.8;
mut=1.8;
%parameters in the activation of neutrophil terms
beta=12;
n0=1.2;
alpha=8;
eps=1;
% Di¤usion between compartments
kv=0.0001;
q=2;
k=0.7;
m=1e-5;
b=.001;
%production of TNF by neutrophils
gamma=3;
% Inammation parameters
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kzg=.1 ;
muz=0.008;
ktz=2;
%chemotaxsis
xi=1;
%Di¤ustion of TNF within the tissue
dtnf=1;
%number of space units
spaceunits=20;
% tissue length is .2199 cm so h=.2199/20
h=0.011;
% Speed of Blood
v0=.2932;
% Changes in compartmental volumes due to increasing inammation
mvtb=.4; mvta=1 ;
hillz=1;
% Initial Volumes (in liters)
vamin0=2300/(.12e8);
vbnormal=90/(.12e8) ;
vtnormal=500/(.12e8);
%Compartmental volumes
vamin=inline(vamin0/(1+mvta*x),x,vamin0,mvta);
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vb=inline(vbnormal/(1+mvtb*x),x,vbnormal,mvtb);
vt=inline(vtnormal+vbnormal-vbnormal/(1+mvtb*x)
+vamin0-vamin0/(1+mvta*x),x,vtnormal,vbnormal,mvta,mvtb,vamin0);
% Di¤usion functions
rv=inline((kv*x^q)/(k^q+x^q),x,k,kv,q);
rp=inline(m*x+b,x,m,b);
% hill function
fh=inline(x^hill/(x^hill+const^hill),x,hill,const);
v=v0*90/vb(sum(X(62:81,1))/20,vbnormal,mvtb);
%DEs for neutrophils in the blood
r(1)=-munba*nba1+(beta*n0*tnfb^2)/(1+eps*tnfb^2)
-rv(z1,k,kv,q)*nba1/vb(sum(X(62:81,1))/20,vbnormal,mvtb)-v*((nba1-nba1)/h);
for i=2:20
r(i)=-munba*X(i)+(beta*n0*tnfb^2)/(1+eps*tnfb^2)
-rv(X(i+61),k,kv,q)*X(i)/vb(sum(X(62:81,1))/20,vbnormal,mvtb)
-v*((X(i)-X(i-1))/h);
end
%DE for TNF in the blood
r(21)=-mutb*tnfb-(alpha*n0*tnfb^2)/(1+eps*tnfb^2)
+(rpsum(X,tnfb,m,b)/20)/vb(sum(X(62:81,1))/20,vbnormal,mvtb)
+gamma*sum(X(1:20,1))*h;
% DEs for Neutrophils in the tissue
r(22)=-muna*na1
+rv(z1,k,kv,q)*nba1/vt(sum(X(62:81,1))/20,vtnormal,vbnormal,mvta,mvtb,vamin0)
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+xi*(-(tnf1+tnf2)*na1+(tnf1)*(na1+na2));
for i=23:40
r(i)=-muna*X(i)
+rv(X(i+40),k,kv,q)*X(i-21)/vt(sum(X(62:81,1))/20,vtnormal,
vbnormal,mvta,mvtb,vamin0)
+xi*(-(X(i+19)+X(i+21))*X(i)+X(i+20)*(X(i-1)+X(i+1)));
end
r(41)=-muna*na20
+rv(z20,k,kv,q)*nba1/vt(sum(X(62:81,1))/20,vtnormal,vbnormal,mvta,mvtb,vamin0)
+xi*(-(tnf19+tnf20)*na20+(tnf20)*(na19+na20));
% DEs TNF in the tissue
r(42)=-mut*tnf1
+rp(z1,m,b)*(tnfb-tnf1)/vt(sum(X(62:81,1))/20,vtnormal,vbnormal,mvta,mvtb,vamin0)
+gamma*na1+dtnf*(tnf2-2*tnf1+tnf1)/(h^2);
for i=43:60
r(i)=-mut*X(i)
+rp(X(i+20),m,b)*(tnfb-X(i))/vt(sum(X(62:81,1))/20,vtnormal,vbnormal,
mvta,mvtb,vamin0)
+gamma*X(i-20)+dtnf*(X(i+1)-2*X(i)+X(i-1))/(h^2);
end
r(61)=-mut*tnf20
+rp(z20,m,b)*(tnfb-tnf20)/vt(sum(X(62:81,1))/20,vtnormal,vbnormal,mvta,
mvtb,vamin0)
+gamma*na20+dtnf*(tnf20-2*tnf20+tnf19)/(h^2);
% DEs for inlfammation
r(62)=kzg*fh(tnf1,hillz,ktz)*(1-z1)-muz*z1;
for i=63:80
r(i)=kzg*fh(X(i-20),hillz,ktz)*(1-X(i))-muz*X(i);
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end
r(81)=kzg*fh(tnf20,hillz,ktz)*(1-z20)-muz*z20;
D.1.2 XPP-AUTO- Immune Subsystem
% Immune Parameters
% We have 20 space units and tissue length is .2199 cm, so h=.2199/20
par h=0.011
% decay rate of neutrophils in tissue and blood
par munba=.05, muna=.05
% rate of activation of a neutrophil, source of resting neutrophils, consumption of tnf
during activiation, hill constant
par beta=12, n0=1.2, alpha=8, eps=1
% rate constant, hill coe¤, hill constant for velcro di¤usion, slope and intersect for mole-
cule di¤usion
par kv=0.0001, q=2, k=.7, m=1e-5, b=.001
% Di¤usion functions
rv(x,q)=(kv*x^q)/(k^q+x^q)
rp(x)=m*x+b
% decay rate of TNF in tissue and blood
par mutb=1.8, mut=1.8
% production of tnf from neutrophils
par gamma=3
% Inammation growth rate, inamation decay rate, hill constant with dependence on
TNF,
par kzg=.1, muz=.008, ktz=2
% consumption of oxygen by neutophils
par delta=0
% space parameter
173
%chemotaxis, di¤usion of tnf
par xi=1, dtnf=1,
%Chemotaxis function
f(x)=x
%numerical parameter
% time step for derivative approx., number of space units
par dt=.1, spaceunits=20
% Tissue and blood starting volumes for whole lung, converstion from total ml to ml on
a RU
par vtstart=500, vbstart=90, auc=12000000, vaminstart=2300
%function of on RU
vbnormal=vbstart/auc
vtnormal=vtstart/auc
vamin0=vaminstart/auc
% Volume changes during an infection for blood and air. Tissue volume increases by
what the
% other two compartments lose.
par mvtb=.4, mvta=1
vt(x)=vtnormal+vbnormal-vbnormal/(1+mvtb*x)+vamin0-vamin0/(1+mvta*x)
vb(x)=vbnormal/(1+mvtb*x)
aux vtf=auc*(vt(sum(0,19)of(shift(z1,i))/spaceunits))
aux vbf=auc*(vb(sum(0,19)of(shift(z1,i))/spaceunits))
% the e¤ect of the unit closing: the change in alveolus volume decreases
par closing=10
% the vachange and vamin are altered during an infection. The change is an e¤ect of the
% closing. The vamin decreases as the vloume of the tissue increases.
vamin=vamin0/(1+mvta*sum(0,19)of(shift(z1,i))/spaceunits)
vamax=vamin+(vachange0/(1
+closing*(vt(sum(0,19)of(shift(z1,i))/spaceunits)-vtnormal)))/auc
aux vc=(vachange0/(1+closing*(sum(0,19)of(shift(z1,i))/spaceunits)))
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aux vam=auc*(vamin0/(1+mvta*sum(0,19)of(shift(z1,i))/spaceunits))
% hill function used for inamations dependence on TNF
fh(x,const,hill)=x^hill/(x^hill+const^hill)
% Boundary Conditions
nba0=nba1
nba21=nba20
na0=na1
na21=na20
tnf0=tnf1
tnf21=tnf20
z0=0
z21=z20
par kvol=1, hillz=1
par v0=.2932
v=kvol*v0*(90/(vb(sum(0,19)of(shift(z1,i))/spaceunits)))
vachange0=0
% Inammation
z[1..20]=kzg*fh(tnf[j],ktz,hillz)*(1-z[j])-muz*z[j]
%%blood equations with nba(x,t) and tnfb(t)
nba[1..20]=-munba*nba[j]+(beta*n0*tnfb^2)/(1+eps*tnfb^2)
-rv(z[j],q)*nba[j]/vb(sum(0,19)of(shift(z1,i))/spaceunits)-v*((nba[j]-nba[j-1])/h)
tnfb=-mutb*tnfb-(alpha*n0*tnfb^2)/(1+eps*tnfb^2)
+(1/spaceunits)*sum(0,19)of(rp(shift(z1,i))*(shift(tnf1,i)-tnfb))
/vb(sum(0,19)of(shift(z1,i))/spaceunits)
+gamma*sum(0,19)of(shift(nba1,i)*h)
%%Tissue equations
na[1..20]=-muna*na[j]+rv(z[j],q)*nba[j]/vt(sum(0,19)of(shift(z1,i))/spaceunits)
+xi*(-f(tnf[j-1]+tnf[j+1])*na[j]+f(tnf[j])*(na[j-1]+na[j+1]))
tnf[1..20]=-mut*tnf[j]+rp(z[j])*(tnfb-tnf[j])/vt(sum(0,19)of(shift(z1,i))/spaceunits)
+gamma*na[j]+dtnf*(tnf[j+1]-2*tnf[j]+tnf[j-1])/(h^2)
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vachange0(0)=350
@ meth=gear,xp=t, dt=.01, yp=tnfb,xlo=0,xhi=100,ylo=0,yhi=20, total=100,
bound=500000
done
D.2 CODE FOR THE SINGLE RESPIRATORY UNIT
D.2.1 Matlab code for the single RU
D.2.1.1 breathingpde.m (main m-le) Code for a single respiratory unit:
function [va,T,Y]=breathingpdenew(ic,t0,tnal,data)
% Inputs:
% the matrix data is created when the immune subsystem is run inMatlab (immunepde.m)
% ic is a vector of length 123. To nd the proper initial conditions for this system,
immunepde should be run with no inammation for an hour and then feed in to this function
with ic=zeros(1,123) and run until it reaches a xed oscillation in the ga and ca. Then take
end point as your new starting initial conditions by setting ic=Y(end, :).
% t0=0 (initial time must conicide with the starting point for the immune system usually
0)
%tnal- end time (this system runs in seconds, so tnal=40 is 10 breathing cycles of 4
seconds)
%outputs:
% va is the alveolar airspace volume
% is a vector of times for the matrix of variable values Y during inammation
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close all;
k=ones(1,123);
%initial conditions
y=ic(1);ga=ic(2);
gt1=ic(3);gt2=ic(4);gt3=ic(5);gt4=ic(6);gt5=ic(7);gt6=ic(8);gt7=ic(9);gt8=ic(10);
gt9=ic(11);t10=ic(12);gt11=ic(13);gt12=ic(14);gt13=ic(15);gt14=ic(16);gt15=ic(17);
gt16=ic(18);gt17=ic(19);gt18=ic(20);gt19=ic(21);gt20=ic(22);
gb1=ic(23);gb2=ic(24);gb3=ic(25);gb4=ic(26);gb5=ic(27);gb6=ic(28);gb7=ic(29);
gb8=ic(30);gb9=ic(31);gb10=ic(32);gb11=ic(33);gb12=ic(34);gb13=ic(35);
gb14=ic(36);gb15=ic(37);gb16=ic(38);gb17=ic(39);gb18=ic(40);gb19=ic(41);
gb20=ic(42);hb41=ic(43);hb42=ic(44);hb43=ic(45);hb44=ic(46);hb45=ic(47);
hb46=ic(48);hb47=ic(49);hb48=ic(50);hb49=ic(51);hb410=ic(52);hb411=ic(53);
hb412=ic(54);hb413=ic(55);hb414=ic(56);hb415=ic(57);hb416=ic(58);hb417=ic(59);
hb418=ic(60);hb419=ic(61);hb420=ic(62);ca=ic(63);ct1=ic(64);ct2=ic(65);
ct3=ic(66);ct4=ic(67);ct5=ic(68);ct6=ic(69);ct7=ic(70);ct8=ic(71);ct9=ic(72);
ct10=ic(73);ct11=ic(74);ct12=ic(75);ct13=ic(76);ct14=ic(77);ct15=ic(78);ct16=ic(79);
ct17=ic(80);ct18=ic(81);ct19=ic(82);ct20=ic(83);cb1=ic(84);cb2=ic(85);
cb3=ic(86);cb4=ic(87);cb5=ic(88);cb6=ic(89);cb7=ic(90);cb8=ic(91);cb9=ic(92);
cb10=ic(93);cb11=ic(94);cb12=ic(95);cb13=ic(96);cb14=ic(97);
cb15=ic(98);cb16=ic(99);cb17=ic(100);cb18=ic(101);cb19=ic(102);cb20=ic(103);
hco31=ic(104);hco32=ic(105);hco33=ic(106);hco34=ic(107);hco35=ic(108);
hco36=ic(109);hco37=ic(110);hco38=ic(111);hco39=ic(112);hco310=ic(113);
hco311=ic(114);hco312=ic(115);hco313=ic(116);hco314=ic(117);
hco315=ic(118);hco316=ic(119);hco317=ic(120);hco318=ic(121);
hco319=ic(122);hco320=ic(123);
% Alveolor count
auc=.12e11;
% Tolerances
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options = odeset(RelTol,1e-11,AbsTol,(1e-11).*k);
% This function solve the system of ODES dened in dxbreathingnew with the ode
solver ode15s. [t0:40:tnal] reports output only every 40 seconds. This can be changed to
[t0:tnal] and output will be every second.
[T,Y] = ode15s(@dxbreathingpdenew,[t0: 40: tnal],[y, ga, gt1,gt2,gt3,gt4,gt5,gt6,gt7,
gt8,gt9,gt10,gt11,gt12,gt13,gt14,gt15,gt16,gt17,gt18,gt19, gt20, gb1,gb2,gb3,gb4,gb5,
gb6,gb7,gb8,gb9,gb10,gb11,gb12,gb13,gb14,gb15,gb16,gb17,gb18,gb19,gb20, hb41,
hb42,hb43,hb44,hb45,hb46,hb47,hb48,hb49,hb410,hb411,hb412,hb413,hb414,hb415,
hb416,hb417,hb418,hb419,hb420,ca, ct1,ct2,ct3,ct4,ct5,ct6,ct7,ct8,ct9,ct10,ct11,ct12,
ct13,ct14,ct15,ct16,ct17,ct18,ct19,ct20, cb1,cb2,cb3,cb4,cb5,cb6,cb7,cb8,cb9,cb10,
cb11,cb12,cb13,cb14,cb15,cb16,cb17,cb18,cb19,cb20,hco31,hco32,hco33,hco34,hco35,
hco36,hco37,hco38,hco39,hco310,hco311,hco312,hco313,hco314,hco315,hco316,
hco317,hco318,hco319,hco320],options,data);
%plots of several variables
gure;
plot(T,Y(:,1),*);YLABEL(y);xlabel(time);gure;
plot(T,Y(:,2),-);YLABEL(ga);xLABEL(time);gure;
plot(T,Y(:,22),-),YLABEL(gt20);xlabel(time);gure;
plot(T,Y(:,42),-.);ylabel(gb20);xLABEL(time);gure;
plot(T,Y(:,62),.);YLABEL(hb420);xLABEL(time);gure;
plot(T,Y(:,63),+);YLABEL(ca);xLABEL(time);gure;
plot(T,Y(:,83),*);YLABEL(ct20);xLABEL(time);gure;
plot(T,Y(:,103),*);YLABEL(cb20);xLABEL(time);gure;
plot(T,Y(:,123),*);YLABEL(hco320);xLABEL(time);gure;
% Determines alveolar air space volume from the data matrix
g=size(data);
max=g(1);
va=zeros(length(T),1);
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for i=1:length(T)
for counter=1:max
if data(counter,1)>=T(i,1)/(60^2)
va(i)=data(counter,g(2)-1)/auc;
else
counter=counter+1;
end
end
end
plot(T,auc*(va(:,1)+Y(:,1)),*);xlabel(time);ylabel(va);
D.2.1.2 dxbreathingpdenew.m (m-le of the right-hand side) Code:
function r = dxbreathingpdenew(t,X,data)
r=zeros(123,1);
% tissue length is .2199 cm so h=.2199/20
h=0.011;
% time for inspir and time for expir
tin=1;
tout=3;
%controls smoothness of the smooth Heaviside function
sh=20;
% Sets up variables
y=X(1);ga=X(2);
gt1=X(3);gt2=X(4);gt3=X(5);gt4=X(6);gt5=X(7);gt6=X(8);gt7=X(9);gt8=X(10);
gt9=X(11);gt10=X(12);gt11=X(13);gt12=X(14);gt13=X(15);gt14=X(16);
gt15=X(17);gt16=X(18);gt17=X(19);gt18=X(20);gt19=X(21);gt20=X(22);
gb1=X(23);gb2=X(24);gb3=X(25);gb4=X(26);gb5=X(27);gb6=X(28);gb7=X(29);
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gb8=X(30);gb9=X(31);gb10=X(32);gb11=X(33);gb12=X(34);gb13=X(35);gb14=X(36);
gb15=X(37);gb16=X(38);gb17=X(39);gb18=X(40);gb19=X(41);gb20=X(42);
hb41=X(43);hb42=X(44);hb43=X(45);hb44=X(46);hb45=X(47);hb46=X(48);
hb47=X(49);hb48=X(50);hb49=X(51);hb410=X(52);hb411=X(53);hb412=X(54);
hb413=X(55);hb414=X(56);hb415=X(57);hb416=X(58);hb417=X(59);hb418=X(60);
hb419=X(61);hb420=X(62);
ca=X(63);
ct1=X(64);ct2=X(65);ct3=X(66);ct4=X(67);ct5=X(68);ct6=X(69);ct7=X(70);ct8=X(71);
ct9=X(72);ct10=X(73);ct11=X(74);ct12=X(75);ct13=X(76);ct14=X(77);ct15=X(78);
ct16=X(79);ct17=X(80);ct18=X(81);ct19=X(82);ct20=X(83);cb1=X(84);cb2=X(85);
cb3=X(86);cb4=X(87);cb5=X(88);cb6=X(89);cb7=X(90);cb8=X(91);cb9=X(92);
cb10=X(93);cb11=X(94);cb12=X(95);cb13=X(96);cb14=X(97);cb15=X(98);cb16=X(99);
cb17=X(100);cb18=X(101);cb19=X(102);cb20=X(103);hco31=X(104);hco32=X(105);
hco33=X(106);hco34=X(107);hco35=X(108);hco36=X(109);hco37=X(110);hco38=X(111);
hco39=X(112);hco310=X(113);hco311=X(114);
hco312=X(115);hco313=X(116);hco314=X(117);hco315=X(118);hco316=X(119);
hco317=X(120);hco318=X(121);hco319=X(122);hco320=X(123);
% Hemglobin and bicarbonate parameters
hbtotal=2.24e-3;
ihb4=.001717;
th=3.6;
ihco3=.024;
ratio=177916;
kplus0=0.0005;
bo¤=1;
kminus=88.96;
kcatcb=880000;
kmcb=.01;
kcathco3=199800;
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kmhco3=0.0225;
% Partial pressure of Oxygen and Carbon Dioxide of the blood entering the RU
lowo2=40;
highco2=45;
% speed of the blood. Assuming 1 respiratory unit is crossed in 0.8secs and the length
scale is
% as above .22cm. Speed is cm/sec and applies to RBC. Plasma may be owing faster.
v0=.2932;
% Di¤usion
dgt=3.24e-5;
dct=0.00065;
%Sigmas such that []=P for oxygen and carbon dioxide in the blood (tissue is the same
) and the alveolar air space
sigmagBT=1.24e-6;
sigmacBT=2.95e-5;
sigmaair=5.2e-5;
% Di¤usion across the barrier
gtbb=0;
sf=1;
gtbm=6.7483e-12;
ctbb=0;
ctbm=8.477e-11;
gtab=0;
gtam=2.362e-12;
ctab=0;
ctam=7.6293e-10;
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% Gas levels in the air that is being inhaled
gair0=150;
cair0=0;
% time constants for the breathing mechanism
tau1=.5;
tau2=.7;
% Speed during inammation
v=90*(7.5e-09)/vbfunc(t,data);
% Alveolus count
auc=.12e8;
%DE for y-breathing variable
r(1)=(g(t,data,sh,auc,tin,tout)/tau1-y/tau2);
%DE for oxygen in the alveolar air space
r(2)=gtam*(1/20)*(sum(X(3:22),1)-20*ga)/(sigmaair*va(t,data,y))
+max(rv(t,data,sh,auc,tin,tout,tau1,tau2,y),0)*(gair0-ga);
% vtfunc is a function that determines the tidal volume from the data matrix
vtt=vtfunc(t,data);
% vbfunc is a function that determines the blood volume from the data matrix
vbb=vbfunc(t,data);
%DEs for oxygen in the tissue
r(3)=((gb1-gt1)*gtbm+(ga-gt1)*gtam)/(sigmagBT*vtt)+dgt*(gt2-2*gt1+gt1)/(h^2);
for i=4:21
r(i)=((X(i+20)-X(i))*gtbm+(ga-X(i))*gtam)/(sigmagBT*vtt)+dgt*(X(i+1)-2*X(i)+X(i-
1))/(h^2);
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end
r(22)=((gb20-gt20)*gtbm+(ga-gt20)*gtam)/(sigmagBT*vtt)
+dgt*(gt19-2*gt20+gt20)/(h^2);
%DEs for oxygen in the blood
r(23)=(gt1-gb1)*gtbm/(sigmagBT*vbb)+(th/sigmagBT)*
(-kplus0*(hbtotal-hb41)*gb1^th
+kminus*hb41)-v*((gb1-lowo2)/h);
for i=24:41
r(i)=(X(i-20)-X(i))*gtbm/(sigmagBT*vbb)+(th/sigmagBT)
*(-kplus0*(hbtotal-X(i+20))*X(i)^th
+kminus*X(i+20))-v*((X(i)-X(i-1))/h);
end
r(42)=(gt20-gb20)*gtbm/(sigmagBT*vbb)+(th/sigmagBT)*
(-kplus0*(hbtotal-hb420)*gb20^th
+kminus*hb420)-v*((gb20-gb19)/h);
%DE for Saturated Hemoglobin
r(43)=kplus0*(hbtotal-hb41)*gb1^th-kminus*hb41
-v*((hb41-ihb4)/h);
for i=44:61
r(i)=kplus0*(hbtotal-X(i))*X(i-20)^th-kminus*X(i)
-v*((X(i)-X(i-1))/h);
end
r(62)=kplus0*(hbtotal-hb420)*gb20^th-kminus*hb420
-v*((hb420-hb419)/h);
%DE for carbon dioxide in the alveolar air space
r(63)=ctam*(1/20)*(sum(X(65:84),1)-20*ca)/(sigmaair*va(t,data,y))
+max(rv(t,data,sh,auc,tin,tout,tau1,tau2,y),0)*(cair0-ca);
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%DEs for Carbon Dioxide in the tissue
r(64)=((X(84)-X(64))*ctbm+(ca-X(64))*ctam)/(sigmacBT*vtt)
+dct*(X(63)-2*X(64)+X(64))/(h^2);
for i=65:82
r(i)=((X(i+20)-X(i))*ctbm+(ca-X(i))*ctam)/(sigmacBT*vtt)
+dct*(X(i+1)-2*X(i)+X(i-1))/(h^2);
end
r(83)=((X(103)-X(83))*ctbm+(ca-X(83))*ctam)/(sigmacBT*vtt)
+dct*(X(83)-2*X(83)+X(82))/(h^2);
%DEs for Carbon Dioxide in the blood
r(84)=(X(64)-X(84))*ctbm/(sigmacBT*vbb)
+(kcathco3*X(104)/(kmhco3+X(104))
-(kcatcb*sigmacBT*X(84)/(kmcb+sigmacBT*X(84))))/sigmacBT
-v*((X(84)-highco2)/h);
for i=85:102
r(i)=(X(i-20)-X(i))*ctbm/(sigmacBT*vbb)
+(kcathco3*X(i+20)/(kmhco3+X(i+20))-
(kcatcb*sigmacBT*X(i)/(kmcb+sigmacBT*X(i))))/sigmacBT
-v*((X(i)-X(i-1))/h);
end
r(103)=(X(83)-X(103))*ctbm/(sigmacBT*vbb)
+(kcathco3*X(123)/(kmhco3+X(123))
-(kcatcb*sigmacBT*X(103)/(kmcb+sigmacBT*X(103))))/sigmacBT
-v*((X(103)-X(102))/h);
%DEs for hco3 in the blood
r(104)=(kcatcb*sigmacBT*X(84)/(kmcb+sigmacBT*X(84)))
-(kcathco3*X(104)/(kmhco3+X(104)))
-v*(X(104)-ihco3)/h;
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for i=105:122
r(i)=(kcatcb*sigmacBT*X(i-20)/(kmcb+sigmacBT*X(i-20)))
-(kcathco3*X(i)/(kmhco3+X(i)))-v*(X(i)-X(i-1))/h;
end
r(123)=(kcatcb*sigmacBT*cb20/(kmcb+sigmacBT*cb20))
-(kcathco3*hco320/(kmhco3+hco320))-v*(hco320-hco319)/h;
D.2.1.3 Additional m-les: These les extract volume levels from the data matrix by
interpolating and implement shunting.
Blood volume:
function [vbb]=vbfunc(t,data)
auc=.12e11;
g=size(data);
max=g(1);
for counter=1:max
if data(counter,1)>=t/(60^2)
if counter==1
vbb=data(counter,g(2)-3)/auc;
return
else
vbb=(((data(counter,g(2)-3)-data(counter-1,g(2)-3))/(data(counter,1)-data(counter-1,1)))
*(t/(3600)-data(counter,1))+data(counter,g(2)-3))/auc;
return
end
else
counter=counter+1;
end
end
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Tissue Volume:
function [vtb]=vtfunc(t,data)
auc=.12e8;
g=size(data);
max=g(1);
for counter=1:max
if data(counter,1)>=t/(60^2)
if counter==1
vtb=data(counter,g(2)-2)/(1000*auc);
return
else
vtb=(((data(counter,g(2)-2)-data(counter-1,g(2)-2))
/(data(counter,1)-data(counter-1,1)))
*(t/(3600)-data(counter,1))+data(counter,g(2)-2))/(1000*auc);
return
end
else
counter=counter+1;
end
end
Alveolar air space volume:
function x=va(t,data,y)
auc=.12e11;
x=(vafunc(t,data))+y;
(vafunc(t,data));
y;
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and
function [vaminb]=vafunc(t,data)
auc=.12e11;
g=size(data);
maxdata=g(1);
for counter=1:maxdata
if data(counter,1)>=t/(60^2)
if counter ==1
vaminb=(data(1,g(2)-1))/auc;
return
else
vaminb=(((data(counter,g(2)-1)-data(counter-1,g(2)-1))
/(data(counter,1)-data(counter-1,1)))
*(t/(3600)-data(counter,1))+data(counter,g(2)-1))/auc;
return
end
else
counter=counter+1;
end
end
Tidal volume:
function [vcb]=vcfunc(t,data)
auc=.12e11;
g=size(data);
max=g(1);
for counter=1:max
if data(counter,1)>=t/(60^2)
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if counter==1
vcb=data(counter,g(2))/auc;
return
else
vcb=(((data(counter,g(2))-data(counter-1,g(2)))
/(data(counter,1)-data(counter-1,1)))
*(t/(3600)-data(counter,1))+data(counter,g(2)))/auc;
return
end
else
counter=counter+1;
end
end
For the breathing mechanism:
function y=g(t,data, sh, auc, tin, tout)
y=(vcfunc(t,data))/(1+exp(-sh*(tin-mod(t,tin+tout))));
and
function rvf=rv(t,data,sh,auc,tin,tout,tau1,tau2,y)
rvf=(g(t,data,sh,auc,tin,tout)/tau1-y/tau2)/(va(t,data,y));
Di¤usion of TNF:
function sum=rpsum(X,tnfb,m,b)
sum=0;
rp=inline(m*x+b,x,m,b);
for i=1:20
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sum=sum+rp(X(i+61),m,b)*(X(i+41)-tnfb);
end
and
sum of inammation function:
function y=rvsum(z,spaceunits)
sum=0;
for i=1:spaceunits
sum=sum+z(i);
end
y=sum/spaceunits;
D.2.2 XPP-AUTO code for single RU
% Parameters
% length of spactial unit
par h=0.011
% time for inpiration and expiration
par tin=1, tout=3
% Hemoglobin and bicarbonate parameters
par hbtotal=2.24e-3, ihb4=.001717, th=3.6 ,ihco3=0.024
par ratio=177916, kplus0=0.0005, kplus1=0
kminus=ratio*kplus0
par kcatcb=900000, kmcb=0.01, kcathco3=188000, kmhco3=0.0225
%Partial pressures for the O2 and CO2 in the entering blood.
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par lowo2=40, highco2=45,
%speed of blood
par v0=.2932
% Di¤usion within the tissue
par dgt=3.24e-5, dct=0.00065,
%Sigmas such that []=P for oxygen and carbon dioxide in the blood (tissue is the same
) and the alveolar air space
par sigmagBT=1.24e-6, sigmacBT=2.95e-05, sigmaair=5.2e-5
%Di¤usion between compartmentsl
par gtbm=6.7483e-12, ctbm=9e-11, gtam=2.362e-12, ctam=9e-10
% Gas levels in new breath
par gair0=150, cair0=0
%time constants for the breathing mechanims
par tau1=.5, tau2=.7
% Alveolar breathing functions
sheav(x)=1/(1+exp(-sh*x))
par sh=20, auc=.12e8
sv(t)=sheav(tin-t)
g(t)=((vc(t/3600)/1000)/auc)*sv(mod(t,tin+tout))
% DE for the change in volume during a breathing cycle
y=(g(t)/tau1-y/tau2)
% derivative of alveolar air space volume. we assume that that this is y
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vap(x,t)=(g(t)/tau1-x/tau2)
%ratio between the yand actual alveolar air space volume
rvol(x,t)=vap(x,t)/va(x,t)
% this allows you to plot this ratio
aux r=rvol(y,t)
%alveolar air space volume
va(x,t)=x+(vamin(t/3600)/1000)/auc
% plots scaled alveolar air volume
aux vf=auc*va(y,t)
%number of space units
par spaceunits=20
% xes outside to gair0=150
gair(t)=gair0
% hill functioin
fh(x,const,hill)=x^hill/(x^hill+const^hill)
%Following Sets up the tables from the tab les created in Matlab
table vamin vamin.tab
table vc vc.tab
table vt vt.tab
table vb vb.tab
% Boundary Conditions
gt0=gt1
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gt21=gt20
hb40=ihb4
hb421=hb420
gb0=lowo2
gb21=gb20
ct0=ct1
ct21=ct20
cb0=highco2
cb21=cb20
hco30=ihco3
hco321=hco320
%speed of blood during inammation
v(t)=v0*90/vb(t/3600)
aux speed=v0*vb(t/3600)/90
% Blood equations
%oxygen
gb[1..20]=(gt[j]-gb[j])*gtbm/(sigmagBT*(vb(t/3600)/1000)/auc)-v(t)*((gb[j]-gb[j-1])/h)
+(th/sigmagBT)*(-kplus0*(hbtotal-hb4[j])*gb[j]^th+kminus*hb4[j])
%Hemoglobin
hb4[1..20]=-v(t)*((hb4[j]-hb4[j-1])/h)+kplus0*(hbtotal-hb4[j])*gb[j]^th-kminus*hb4[j]
%Carbon Dioxide
cb[1..20]=(ct[j]-cb[j])*ctbm/(sigmacBT*(vb(t/3600)/1000)/auc)
-v(t)*((cb[j]-cb[j-1])/h)+(kcathco3*hco3[j]/(kmhco3+hco3[j])
-(kcatcb*sigmacBT*cb[j]/(kmcb+sigmacBT*cb[j])))/sigmacBT
%Bicarbonate
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hco3[1..20]=(kcatcb*sigmacBT*cb[j]/(kmcb+sigmacBT*cb[j]))
-(kcathco3*hco3[j]/(kmhco3+hco3[j]))-v(t)*(hco3[j]-hco3[j-1])/h
%Tissue equations
%Oxygen
gt[1..20]= ((gb[j]-gt[j])*gtbm+(ga-gt[j])*gtam)/(sigmagBT*(vt(t/3600)/1000)/auc)
+dgt*(gt[j+1]-2*gt[j]+gt[j-1])/(h^2)
%Carbon Dioxide
ct[1..20]= ((cb[j]-ct[j])*ctbm+(ca-ct[j])*ctam)/(sigmacBT*(vt(t/3600)/1000)/auc)
+dct*(ct[j+1]-2*ct[j]+ct[j-1])/(h^2)
%Alveolar Airspace
% Oxygen
ga= gtam*(1/spaceunits)*sum(0,19)of(shift(gt1,i)-ga)/(sigmaair*va(y,t))
+max(rvol(y,t),0)*(gair0-ga)
%Carbon Dioxide
ca= ctam*(1/spaceunits)*sum(0,19)of(shift(ct1,i)-ca)/(sigmaair*va(y,t))
+max(rvol(y,t),0)*(cair0-ca)
% Initial Conditions
gb[0..20](0)=lowo2
gt[0..20](0)=lowo2
hb4[0..20](0)=ihb4
%Numerics
@meth=gear,xp=t, dt=.001, yp=ga,xlo=0,xhi=200,ylo=90,yhi=110, total=200, bound=500000
done
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D.3 PSEUDO CODE FOR THE FULL LUNG MODEL
1) From the normal truncated distribution of tidal volume select N random numbers and
bin these numbers using bins that have centers 150 to 550 incrementing by 10.
2) To get the correct initial conditions for each bin:
a) Simulate immune subsystem with each of the centers of the bins, 150, 160,
170,..540, 550 with icbreathing=zeroes(81), t0=0, tnal=2 and tinc=0.5
b) Feed each data le created in step 2 into to the breathingpde.m le with
ic=zeros(123), t0=0, tnal=2*3600 (2 hours) and the associated unscaled tidal volume. The
code will convert to the actual volume on an RU.
c) Save the end level of the Y vector for each created to use as you initial condition
from now on. For example, set icbreathing350=Y(:,end) for simulation ran with the tidal
volume of 350.
3) Run the immune subsystem on each bin with the same insult. Use ic=zereos(81),
ic(21)=4, to get a lethal insult.
4) Feed the data matrix and initial conditions saved in 2c in breathingpde.m for each
bin.
5) the weighted average determined by your bid count of the results for oxygen in the
blood Y(:,41) and saturated hemoglobin Y(:,61)
6) use these average at each time point as the initial conditions to mixing.m
7) the weighted average determined by your bin counts of the results for oxygen in the
blood Y(:,103) and saturated hemoglobin Y(:,123)
8) use these average at each time point as the initial conditions to mixingc.m
9) the results of mixing.m and mixingc.m are the outputs of the full lung model
Mixing.m
function [T]=mixing(output)
m=size(output);
ic=output(1,2:3)
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[lenameT1, lenameY1]=breathingend1(ic,0,0.1);
T=[output(1,1) lenameY1(end,:)];
for i=1:m(1)
ic=output(i,2:3);
[lenameT1, lenameY1]=breathingend1(ic,0,0.1);
T=[T;output(i,1) lenameY1(end,:)];
end
Mixingc.m
function [T]=mixingc(output)
m=size(output);
ic=output(1,2:3)
[lenameT1, lenameY1]=breathingend1c(ic,0,0.1);
T=[output(1,1) lenameY1(end,:)];
for i=40:40:m(1)
ic=output(i,2:3);
[lenameT1, lenameY1]=breathingend1c(ic,0,0.1);
T=[T;output(i,1) lenameY1(end,:)];
end
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